Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
AssayType

Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

2924 1640 43 None -10 7 Human 10.0 pEC50 = 10 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmc.2006.10.060
44398069 1640 43 None -10 7 Human 10.0 pEC50 = 10 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmc.2006.10.060
9908268 1640 43 None -10 7 Human 10.0 pEC50 = 10 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmc.2006.10.060
CHEMBL114606 1640 43 None -10 7 Human 10.0 pEC50 = 10 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmc.2006.10.060
11452022 3596 39 None -19 6 Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2010.02.006
6996 3596 39 None -19 6 Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2010.02.006
CHEMBL366208 3596 39 None -19 6 Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2010.02.006
25192005 7736 0 None -3 2 Human 9.8 pEC50 = 9.8 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1089004 7736 0 None -3 2 Human 9.8 pEC50 = 9.8 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
44406004 72715 10 None 5 4 Human 9.8 pEC50 = 9.8 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 337 14 4 4 2.9 CCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)COP(=O)(O)O 10.1016/j.bmcl.2005.09.038
CHEMBL199791 72715 10 None 5 4 Human 9.8 pEC50 = 9.8 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 337 14 4 4 2.9 CCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)COP(=O)(O)O 10.1016/j.bmcl.2005.09.038
25192001 8059 0 None -2 4 Human 9.7 pEC50 = 9.7 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 413 12 4 4 3.5 CCCCCCCCc1ccc2c(c1)CC[C@@H](C(N)(CO)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1091103 8059 0 None -2 4 Human 9.7 pEC50 = 9.7 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 413 12 4 4 3.5 CCCCCCCCc1ccc2c(c1)CC[C@@H](C(N)(CO)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
46884020 8440 0 None -30 4 Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1093686 8440 0 None -30 4 Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
10883396 3649 45 None 1 15 Human 9.4 pEC50 = 9.4 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.006
5283560 3649 45 None 1 15 Human 9.4 pEC50 = 9.4 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.006
911 3649 45 None 1 15 Human 9.4 pEC50 = 9.4 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.006
CHEMBL225155 3649 45 None 1 15 Human 9.4 pEC50 = 9.4 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gi dependent whole cell assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.006
10883396 3649 45 None 1 15 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
5283560 3649 45 None 1 15 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
911 3649 45 None 1 15 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
CHEMBL225155 3649 45 None 1 15 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
76332615 105554 0 None 5 2 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 555 12 3 8 5.0 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(CC)(CC)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121986 105554 0 None 5 2 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 555 12 3 8 5.0 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(CC)(CC)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
44565714 179297 0 None -6 4 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 484 11 4 5 4.1 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473238 179297 0 None -6 4 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 484 11 4 5 4.1 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
2924 1640 43 None -10 7 Human 8.9 pEC50 = 8.9 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm050242f
44398069 1640 43 None -10 7 Human 8.9 pEC50 = 8.9 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm050242f
9908268 1640 43 None -10 7 Human 8.9 pEC50 = 8.9 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm050242f
CHEMBL114606 1640 43 None -10 7 Human 8.9 pEC50 = 8.9 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm050242f
44218130 139890 0 None -1 2 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 552 14 3 8 4.3 CCc1cc(-c2noc(-c3cc(CN(C)CC(C)C)cc(C(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3799355 139890 0 None -1 2 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 552 14 3 8 4.3 CCc1cc(-c2noc(-c3cc(CN(C)CC(C)C)cc(C(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
10883396 3649 45 None 1 15 Human 8.8 pEC50 = 8.8 Functional
Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assayActivity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2006.10.014
5283560 3649 45 None 1 15 Human 8.8 pEC50 = 8.8 Functional
Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assayActivity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2006.10.014
911 3649 45 None 1 15 Human 8.8 pEC50 = 8.8 Functional
Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assayActivity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2006.10.014
CHEMBL225155 3649 45 None 1 15 Human 8.8 pEC50 = 8.8 Functional
Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assayActivity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2006.10.014
11222939 67575 9 None -4 4 Human 8.8 pEC50 = 8.8 Functional
Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assayActivity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2006.10.014
44438254 67575 9 None -4 4 Human 8.8 pEC50 = 8.8 Functional
Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assayActivity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2006.10.014
CHEMBL190006 67575 9 None -4 4 Human 8.8 pEC50 = 8.8 Functional
Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assayActivity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2006.10.014
44591250 189754 0 None -19 4 Human 8.0 pEC50 = 8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1F 10.1016/j.bmcl.2008.11.072
CHEMBL515921 189754 0 None -19 4 Human 8.0 pEC50 = 8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1F 10.1016/j.bmcl.2008.11.072
44591266 179300 0 None -19 4 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 443 13 4 5 4.2 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1F 10.1016/j.bmcl.2008.11.072
CHEMBL473269 179300 0 None -19 4 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 443 13 4 5 4.2 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1F 10.1016/j.bmcl.2008.11.072
44422606 85573 0 None -2 5 Human 7.0 pEC50 = 7 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 329 11 3 3 3.1 CCCCCCc1ccc(OC[C@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
CHEMBL228049 85573 0 None -2 5 Human 7.0 pEC50 = 7 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 329 11 3 3 3.1 CCCCCCc1ccc(OC[C@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
44219525 139942 0 None -47 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 13 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)cc(CN(C)CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3799686 139942 0 None -47 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 13 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)cc(CN(C)CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
44218450 139949 0 None -100 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN(C)CC 10.1016/j.ejmech.2016.03.048
CHEMBL3799718 139949 0 None -100 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN(C)CC 10.1016/j.ejmech.2016.03.048
76325739 106069 0 None -11 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 462 11 4 7 3.4 CCc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
CHEMBL3133595 106069 0 None -11 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 462 11 4 7 3.4 CCc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
76336567 106077 0 None -1 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 432 9 4 6 3.0 Cc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
CHEMBL3133602 106077 0 None -1 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 432 9 4 6 3.0 Cc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
76311231 106078 0 None -7 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 460 11 4 6 3.7 CCCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
CHEMBL3133603 106078 0 None -7 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 460 11 4 6 3.7 CCCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
CHEMBL3780292 106078 0 None -7 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 460 11 4 6 3.7 CCCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
76332957 106085 0 None -1 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 409 12 4 4 3.7 CCCCCCc1ccc2c(CCC(N)(CO)COP(=O)(O)O)cccc2c1 10.1039/C3MD00079F
CHEMBL3133610 106085 0 None -1 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 409 12 4 4 3.7 CCCCCCc1ccc2c(CCC(N)(CO)COP(=O)(O)O)cccc2c1 10.1039/C3MD00079F
45377937 84119 0 None -112 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 496 9 1 6 5.1 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CCC(C(=O)O)CC3)cc2)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207780 84119 0 None -112 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 496 9 1 6 5.1 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CCC(C(=O)O)CC3)cc2)s1 10.1016/j.bmcl.2012.09.110
66655587 167636 0 None -5 3 Human 6.0 pEC50 = 6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 435 6 1 4 4.8 O=C(O)CCN1CCC2(CC1)COc1cc(OCc3cc(Cl)ccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
CHEMBL4205714 167636 0 None -5 3 Human 6.0 pEC50 = 6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 435 6 1 4 4.8 O=C(O)CCN1CCC2(CC1)COc1cc(OCc3cc(Cl)ccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
CHEMBL4301563 167636 0 None -5 3 Human 6.0 pEC50 = 6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 435 6 1 4 4.8 O=C(O)CCN1CCC2(CC1)COc1cc(OCc3cc(Cl)ccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
46846906 140041 0 None -2290 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 444 8 1 7 4.5 CCCc1c(-c2ccccc2)noc1-c1nc(-c2ccc(CN3CC(C(=O)O)C3)cc2)no1 10.1021/acs.jmedchem.6b00089
CHEMBL3800257 140041 0 None -2290 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 444 8 1 7 4.5 CCCc1c(-c2ccccc2)noc1-c1nc(-c2ccc(CN3CC(C(=O)O)C3)cc2)no1 10.1021/acs.jmedchem.6b00089
70692256 74974 0 None -3162 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 468 8 1 4 6.1 CN(CCCc1ccc2oc(-c3ccc(-c4ccccc4)c(C(F)(F)F)c3)nc2c1)CC(=O)O 10.1016/j.bmcl.2012.04.095
CHEMBL2032429 74974 0 None -3162 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 468 8 1 4 6.1 CN(CCCc1ccc2oc(-c3ccc(-c4ccccc4)c(C(F)(F)F)c3)nc2c1)CC(=O)O 10.1016/j.bmcl.2012.04.095
70694327 74979 0 None -12589 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 494 6 1 4 6.8 O=C(O)CCN1CCC(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
CHEMBL2032434 74979 0 None -12589 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 494 6 1 4 6.8 O=C(O)CCN1CCC(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
11853835 104712 0 None -501 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 511 10 2 6 4.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CN1CC(C(=O)O)C1 10.1021/jm4014373
CHEMBL3105482 104712 0 None -501 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 511 10 2 6 4.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CN1CC(C(=O)O)C1 10.1021/jm4014373
46237828 8946 0 None -5 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 369 4 1 6 3.4 COc1cc(/C=C2\S/C(=N\N(C)C)N(c3ccccc3)C2=O)ccc1O 10.1021/jm100181s
CHEMBL1098013 8946 0 None -5 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 369 4 1 6 3.4 COc1cc(/C=C2\S/C(=N\N(C)C)N(c3ccccc3)C2=O)ccc1O 10.1021/jm100181s
57398845 70919 0 None -1548 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 489 9 1 7 5.9 CCc1ccccc1Oc1ccc(-c2nc(-c3sc(CN4CC(C(=O)O)C4)cc3CC)no2)cc1 10.1016/j.bmcl.2011.12.019
CHEMBL1951313 70919 0 None -1548 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 489 9 1 7 5.9 CCc1ccccc1Oc1ccc(-c2nc(-c3sc(CN4CC(C(=O)O)C4)cc3CC)no2)cc1 10.1016/j.bmcl.2011.12.019
42636433 116392 0 None -1258 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 455 7 1 6 4.7 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CCC(=O)O)CC4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359846 116392 0 None -1258 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 455 7 1 6 4.7 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CCC(=O)O)CC4)no2)cc1Cl 10.1021/jm5010336
44125704 116400 0 None -316 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 472 8 2 8 4.5 CC(C)Oc1ncc(-c2nc(-c3cccc4c3OCCNC4CCCC(=O)O)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359854 116400 0 None -316 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 472 8 2 8 4.5 CC(C)Oc1ncc(-c2nc(-c3cccc4c3OCCNC4CCCC(=O)O)no2)cc1Cl 10.1021/jm5010336
25182769 6265 0 None -4073 3 Human 4.0 pEC50 = 4 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 380 6 2 5 4.3 Cc1cc(O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL1081645 6265 0 None -4073 3 Human 4.0 pEC50 = 4 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 380 6 2 5 4.3 Cc1cc(O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
53319457 57390 0 None -69 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4nc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651851 57390 0 None -69 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4nc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1021/ml100306h
118716139 114872 0 None -79 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 432 9 4 6 3.0 Cc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341917 114872 0 None -79 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 432 9 4 6 3.0 Cc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
46236933 9054 0 None 7 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 338 3 1 4 4.3 CC(C)/N=C1\S/C(=C\c2cccc(O)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098771 9054 0 None 7 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 338 3 1 4 4.3 CC(C)/N=C1\S/C(=C\c2cccc(O)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
16736755 57359 0 None -64 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 413 8 1 4 5.4 CCCCOc1ccc2oc(-c3ccc(CN4CC(C(=O)O)C4)cc3Cl)cc2c1 10.1021/ml100227q
CHEMBL1651714 57359 0 None -64 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 413 8 1 4 5.4 CCCCOc1ccc2oc(-c3ccc(CN4CC(C(=O)O)C4)cc3Cl)cc2c1 10.1021/ml100227q
11853576 104720 0 None -204 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 441 10 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCNCCO 10.1021/jm4014373
CHEMBL3105490 104720 0 None -204 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 441 10 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCNCCO 10.1021/jm4014373
11224984 8717 23 None -44 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OC[C@@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
CHEMBL1095833 8717 23 None -44 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OC[C@@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
46236811 8975 0 None 1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 0 4 4.6 COc1ccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)cc1 10.1021/jm100181s
CHEMBL1098201 8975 0 None 1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 0 4 4.6 COc1ccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)cc1 10.1021/jm100181s
76325533 105768 0 None -537 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)c(C4CCCC4)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126613 105768 0 None -537 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)c(C4CCCC4)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
72793789 104396 0 None -380 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 495 10 1 5 5.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCN1CC(C(=O)O)C1 10.1021/jm4014373
CHEMBL3102986 104396 0 None -380 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 495 10 1 5 5.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCN1CC(C(=O)O)C1 10.1021/jm4014373
11363176 3149 47 None -12 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 10.1021/jm100181s
5446 3149 47 None -12 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 10.1021/jm100181s
9320 3149 47 None -12 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 10.1021/jm100181s
CHEMBL1096146 3149 47 None -12 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 10.1021/jm100181s
25182926 7941 0 None -173 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 451 11 3 6 3.8 O=C(O)CCNCc1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)cc1 10.1016/j.bmcl.2010.01.102
CHEMBL1090423 7941 0 None -173 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 451 11 3 6 3.8 O=C(O)CCNCc1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)cc1 10.1016/j.bmcl.2010.01.102
11852144 105575 0 None -323 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 430 8 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OC[C@H](O)CO 10.1021/jm401456d
CHEMBL3122006 105575 0 None -323 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 430 8 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OC[C@H](O)CO 10.1021/jm401456d
76318056 105542 0 None 1 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 541 11 3 8 4.7 CCCc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c2c1CC(C)(C)CC2 10.1021/jm401456d
CHEMBL3121974 105542 0 None 1 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 541 11 3 8 4.7 CCCc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c2c1CC(C)(C)CC2 10.1021/jm401456d
76321772 105556 0 None -2 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 553 10 3 8 4.8 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC3(CCCC3)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121988 105556 0 None -2 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 553 10 3 8 4.8 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC3(CCCC3)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
11689680 79640 0 None -3890 3 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S bindingAgonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S binding
ChEMBL 391 7 1 6 4.4 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.064
CHEMBL211505 79640 0 None -3890 3 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S bindingAgonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S binding
ChEMBL 391 7 1 6 4.4 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.064
24825338 77710 0 None -1288 3 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 434 7 1 5 5.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL208924 77710 0 None -1288 3 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 434 7 1 5 5.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.04.084
72793828 104693 0 None -109 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 439 6 2 6 5.0 Cc1cc(-c2cnc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)o2)cc(C)c1OCC(O)CO 10.1021/jm4014373
CHEMBL3105250 104693 0 None -109 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 439 6 2 6 5.0 Cc1cc(-c2cnc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)o2)cc(C)c1OCC(O)CO 10.1021/jm4014373
127046185 140017 0 None -363 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 496 11 3 9 2.8 CCc1cc(-c2noc(-c3cc(C)nc(OC4CCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800120 140017 0 None -363 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 496 11 3 9 2.8 CCc1cc(-c2noc(-c3cc(C)nc(OC4CCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
24825338 77710 0 None -1288 3 Human 7.0 pEC50 = 7.0 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 434 7 1 5 5.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL208924 77710 0 None -1288 3 Human 7.0 pEC50 = 7.0 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 434 7 1 5 5.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
1160618 30807 1 None 2 2 Human 7.0 pEC50 = 7.0 Functional
PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]
ChEMBL 389 6 0 6 4.9 O=C(CSc1nnc(-c2ccco2)o1)N(C1CCCCC1)C1CCCCC1 nan
CHEMBL1396471 30807 1 None 2 2 Human 7.0 pEC50 = 7.0 Functional
PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]
ChEMBL 389 6 0 6 4.9 O=C(CSc1nnc(-c2ccco2)o1)N(C1CCCCC1)C1CCCCC1 nan
44412883 77297 0 None -77 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 404 7 1 4 6.2 Cc1cc(CCCC(=O)O)ccc1-c1noc(-c2ccc(C3CCCCC3)cc2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL208224 77297 0 None -77 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 404 7 1 4 6.2 Cc1cc(CCCC(=O)O)ccc1-c1noc(-c2ccc(C3CCCCC3)cc2)n1 10.1016/j.bmcl.2006.04.084
11689680 79640 0 None -3890 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 391 7 1 6 4.4 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL211505 79640 0 None -3890 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 391 7 1 6 4.4 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
70686051 75273 0 None 1 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 466 4 2 4 5.2 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cccc(C(=O)O)c21 10.1021/ml200252b
CHEMBL2037123 75273 0 None 1 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 466 4 2 4 5.2 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cccc(C(=O)O)c21 10.1021/ml200252b
44625752 87593 0 None -2754 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 554 10 2 4 7.0 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(Br)c1 10.1021/ml300396r
CHEMBL2336066 87593 0 None -2754 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 554 10 2 4 7.0 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(Br)c1 10.1021/ml300396r
11689680 79640 0 None -3890 3 Human 6.0 pEC50 = 6.0 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 391 7 1 6 4.4 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL211505 79640 0 None -3890 3 Human 6.0 pEC50 = 6.0 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 391 7 1 6 4.4 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
57393585 70921 0 None -2454 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 503 9 1 7 6.5 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3C(C)C)cc2)n1 10.1016/j.bmcl.2011.12.019
CHEMBL1951315 70921 0 None -2454 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 503 9 1 7 6.5 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3C(C)C)cc2)n1 10.1016/j.bmcl.2011.12.019
57395264 71660 0 None -12882 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 423 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@H](C)Cc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935583 71660 0 None -12882 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 423 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@H](C)Cc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1963633 71660 0 None -12882 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 423 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@H](C)Cc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
53234382 148388 0 None -457 2 Human 5.0 pEC50 = 5.0 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 431 8 2 6 4.3 CC(C)Oc1ccc(-c2onc3c2CCc2cc(CNCCC(=O)O)ccc2-3)cc1C#N nan
CHEMBL3937499 148388 0 None -457 2 Human 5.0 pEC50 = 5.0 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 431 8 2 6 4.3 CC(C)Oc1ccc(-c2onc3c2CCc2cc(CNCCC(=O)O)ccc2-3)cc1C#N nan
24850258 57991 0 None 2 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 4 4.3 O=C(O)C1CN(Cc2ccc(-n3cc4cc(Cc5ccccc5)ccc4n3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672553 57991 0 None 2 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 4 4.3 O=C(O)C1CN(Cc2ccc(-n3cc4cc(Cc5ccccc5)ccc4n3)c(F)c2)C1 10.1021/ml100228m
118716140 114873 0 None -147 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 448 10 4 7 2.7 COc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341918 114873 0 None -147 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 448 10 4 7 2.7 COc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
76325531 105757 0 None -1584 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 11 3 8 2.5 CCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/jm4014696
CHEMBL3126602 105757 0 None -1584 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 11 3 8 2.5 CCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/jm4014696
76332955 106071 0 None -2 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 461 11 5 6 3.2 CCc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)c[nH]1 10.1039/C3MD00079F
CHEMBL3133597 106071 0 None -2 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 461 11 5 6 3.2 CCc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)c[nH]1 10.1039/C3MD00079F
76336566 106070 0 None -56 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 474 11 4 7 3.7 NC(CO)(CCc1ccc(Oc2ccc(-c3coc(C4CC4)n3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
CHEMBL3133596 106070 0 None -56 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 474 11 4 7 3.7 NC(CO)(CCc1ccc(Oc2ccc(-c3coc(C4CC4)n3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
57396084 70698 0 None -2238 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 476 7 3 6 4.3 N[C@@H](CC(=O)O)C(=O)Nc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
CHEMBL1950569 70698 0 None -2238 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 476 7 3 6 4.3 N[C@@H](CC(=O)O)C(=O)Nc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
11315069 8922 0 None -1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 382 6 1 5 3.9 CC(C)/N=C1\S/C(=C\c2ccc(OCCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097801 8922 0 None -1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 382 6 1 5 3.9 CC(C)/N=C1\S/C(=C\c2ccc(OCCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
46237178 8924 0 None 3 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 423 8 0 5 4.9 CC(C)/N=C1\S/C(=C\c2ccc(OCCCN(C)C)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097803 8924 0 None 3 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 423 8 0 5 4.9 CC(C)/N=C1\S/C(=C\c2ccc(OCCCN(C)C)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
46236270 9010 0 None -1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 370 3 1 4 4.7 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CC2)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098449 9010 0 None -1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 370 3 1 4 4.7 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CC2)N1c1ccccc1 10.1021/jm100181s
76325748 106091 0 None -33 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 475 11 4 5 3.9 NC(CO)(CCc1ccc(Oc2ccc(Cc3ccc(F)cc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
CHEMBL3133704 106091 0 None -33 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 475 11 4 5 3.9 NC(CO)(CCc1ccc(Oc2ccc(Cc3ccc(F)cc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
66636757 105540 0 None -1288 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 445 10 3 8 2.9 CCCc1ccc(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)s1 10.1021/jm401456d
CHEMBL3121971 105540 0 None -1288 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 445 10 3 8 2.9 CCCc1ccc(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)s1 10.1021/jm401456d
25182900 153007 0 None -60 2 Human 5.9 pEC50 = 5.9 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 401 6 1 5 4.8 O=C(Nc1ccnc2ccccc12)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL3975495 153007 0 None -60 2 Human 5.9 pEC50 = 5.9 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 401 6 1 5 4.8 O=C(Nc1ccnc2ccccc12)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
44565738 189753 0 None -19 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 445 11 4 5 3.8 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
CHEMBL515917 189753 0 None -19 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 445 11 4 5 3.8 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
46236398 8560 0 None 2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 380 7 1 4 5.3 CCCCCCN1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1094502 8560 0 None 2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 380 7 1 4 5.3 CCCCCCN1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
2924 1640 43 None -10 7 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm901776q
44398069 1640 43 None -10 7 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm901776q
9908268 1640 43 None -10 7 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm901776q
CHEMBL114606 1640 43 None -10 7 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm901776q
44565596 189546 0 None -104 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 422 11 4 5 2.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL514302 189546 0 None -104 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 422 11 4 5 2.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
24956673 8519 0 None -2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 372 3 1 4 4.9 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1094192 8519 0 None -2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 372 3 1 4 4.9 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
42622931 139677 0 None -199 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 516 13 3 9 3.3 CCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1C 10.1016/j.ejmech.2016.03.048
CHEMBL3797940 139677 0 None -199 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 516 13 3 9 3.3 CCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1C 10.1016/j.ejmech.2016.03.048
66829308 140093 0 None -169 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 14 3 9 3.7 CCCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1C 10.1016/j.ejmech.2016.03.048
CHEMBL3800591 140093 0 None -169 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 14 3 9 3.7 CCCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1C 10.1016/j.ejmech.2016.03.048
11540052 180567 0 None -33 4 Human 6.9 pEC50 = 6.9 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2010.02.098
CHEMBL475405 180567 0 None -33 4 Human 6.9 pEC50 = 6.9 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2010.02.098
11624780 77942 0 None -354 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 365 7 1 5 4.3 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(CC(C)C)cn2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL209566 77942 0 None -354 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 365 7 1 5 4.3 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(CC(C)C)cn2)n1 10.1016/j.bmcl.2006.04.084
11360553 58449 0 None -26 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 365 9 1 3 4.3 O=C(O)CCN1CC=C(c2ccc(OCCCc3ccccc3)cc2)CC1 10.1016/j.bmcl.2011.01.029
CHEMBL1683049 58449 0 None -26 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 365 9 1 3 4.3 O=C(O)CCN1CC=C(c2ccc(OCCCc3ccccc3)cc2)CC1 10.1016/j.bmcl.2011.01.029
53324339 57999 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 468 6 1 4 5.5 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccc(F)cc5F)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672561 57999 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 468 6 1 4 5.5 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccc(F)cc5F)ccc4s3)c(F)c2)C1 10.1021/ml100228m
127046096 139605 0 None -12 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 13 3 8 3.5 CCc1cc(-c2noc(-c3ccc(C)c(CN(C)CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3797452 139605 0 None -12 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 13 3 8 3.5 CCc1cc(-c2noc(-c3ccc(C)c(CN(C)CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
56949137 150592 0 None -8 2 Human 5.9 pEC50 = 5.9 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 368 5 0 3 5.9 Fc1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c(F)c1 nan
CHEMBL3955131 150592 0 None -8 2 Human 5.9 pEC50 = 5.9 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 368 5 0 3 5.9 Fc1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c(F)c1 nan
57391457 70902 0 None -109 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 447 7 1 7 5.1 Cc1ccc(Oc2ccc(-c3nc(-c4csc(CN5CC(C(=O)O)C5)c4)no3)cc2)cc1 10.1016/j.bmcl.2011.12.019
CHEMBL1951155 70902 0 None -109 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 447 7 1 7 5.1 Cc1ccc(Oc2ccc(-c3nc(-c4csc(CN5CC(C(=O)O)C5)c4)no3)cc2)cc1 10.1016/j.bmcl.2011.12.019
118707197 113044 0 None -5248 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 463 13 3 5 4.1 CCc1cc(C(=O)CCCc2ccc(C)cc2)ccc1COC[C@@](C)(N)COP(=O)(O)O 10.1016/j.bmc.2014.05.035
CHEMBL3311352 113044 0 None -5248 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 463 13 3 5 4.1 CCc1cc(C(=O)CCCc2ccc(C)cc2)ccc1COC[C@@](C)(N)COP(=O)(O)O 10.1016/j.bmc.2014.05.035
46846901 140094 0 None -7585 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 430 7 1 7 4.1 CCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
CHEMBL3800595 140094 0 None -7585 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 430 7 1 7 4.1 CCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
53318124 57389 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.10.069
CHEMBL1651850 57389 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.10.069
53318124 57389 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1651850 57389 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
53318124 57389 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651850 57389 0 None -28 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4s3)c(F)c2)C1 10.1021/ml100306h
118716182 114901 0 None -81 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 502 10 4 8 2.6 NC(CO)(CCc1ccc(-c2cn(-c3ccc(OC(F)(F)F)cc3)nn2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3342007 114901 0 None -81 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 502 10 4 8 2.6 NC(CO)(CCc1ccc(-c2cn(-c3ccc(OC(F)(F)F)cc3)nn2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
11852955 105569 0 None -81 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 513 9 3 8 4.0 CCc1cc(-c2noc(-c3sc(C)c4c3CCC(C)(C)C4)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3122000 105569 0 None -81 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 513 9 3 8 4.0 CCc1cc(-c2noc(-c3sc(C)c4c3CCC(C)(C)C4)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
44412827 77741 0 None -102 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 432 9 1 4 6.9 Cc1cc(CCCCCC(=O)O)ccc1-c1noc(-c2ccc(C3CCCCC3)cc2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL209008 77741 0 None -102 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 432 9 1 4 6.9 Cc1cc(CCCCCC(=O)O)ccc1-c1noc(-c2ccc(C3CCCCC3)cc2)n1 10.1016/j.bmcl.2006.04.084
46238366 8816 0 None -6 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 358 3 1 4 4.5 CC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1096788 8816 0 None -6 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 358 3 1 4 4.5 CC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
11224984 8717 23 None -44 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OC[C@@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
CHEMBL1095833 8717 23 None -44 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OC[C@@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
44439850 146027 0 None -588 3 Human 6.9 pEC50 = 6.9 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 446 6 1 5 5.7 Cc1cc([C@@H]2C[C@H]2C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL391870 146027 0 None -588 3 Human 6.9 pEC50 = 6.9 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 446 6 1 5 5.7 Cc1cc([C@@H]2C[C@H]2C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
76318197 105764 0 None -53 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 495 10 3 9 2.4 CCc1cc(-c2noc(-c3cnc(N4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126609 105764 0 None -53 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 495 10 3 9 2.4 CCc1cc(-c2noc(-c3cnc(N4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
46237179 8828 0 None -11 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 430 7 1 5 4.9 CCC/N=C1\S/C(=C\c2ccc(OCCO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
CHEMBL1096873 8828 0 None -11 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 430 7 1 5 4.9 CCC/N=C1\S/C(=C\c2ccc(OCCO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
46236400 8558 0 None 3 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 396 6 1 6 3.7 CCOC(=O)CCN1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1094491 8558 0 None 3 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 396 6 1 6 3.7 CCOC(=O)CCN1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
44199424 105772 0 None -251 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(C)cc(CC(C)C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126617 105772 0 None -251 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(C)cc(CC(C)C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
70690096 74986 0 None -1258 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 480 7 1 4 6.1 O=C(O)C1CN(CCCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
CHEMBL2032441 74986 0 None -1258 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 480 7 1 4 6.1 O=C(O)C1CN(CCCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
44219369 139954 0 None -346 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.9 CCc1cc(-c2noc(-c3cc(C)cc(CN(C)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3799748 139954 0 None -346 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.9 CCc1cc(-c2noc(-c3cc(C)cc(CN(C)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
66636736 105539 0 None -269 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 459 11 3 8 3.3 CCCCc1ccc(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)s1 10.1021/jm401456d
CHEMBL3121970 105539 0 None -269 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 459 11 3 8 3.3 CCCCc1ccc(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)s1 10.1021/jm401456d
66655198 163660 0 None -79 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 449 7 1 4 5.2 O=C(O)CCCN1CCC2(CC1)COc1cc(OCc3c(Cl)cccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
CHEMBL4204437 163660 0 None -79 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 449 7 1 4 5.2 O=C(O)CCCN1CCC2(CC1)COc1cc(OCc3c(Cl)cccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
70694326 74977 0 None -1000 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 480 5 1 4 6.9 O=C(O)CC1CCN(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
CHEMBL2032432 74977 0 None -1000 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 480 5 1 4 6.9 O=C(O)CC1CCN(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
44129373 116395 0 None -2511 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 418 6 2 7 3.7 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNC4CC(=O)O)no2)cc1C#N 10.1021/jm5010336
CHEMBL3359849 116395 0 None -2511 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 418 6 2 7 3.7 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNC4CC(=O)O)no2)cc1C#N 10.1021/jm5010336
11852437 105545 0 None -316 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 444 9 2 5 5.0 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC(C)(C)CC2 10.1021/jm401456d
CHEMBL3121977 105545 0 None -316 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 444 9 2 5 5.0 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC(C)(C)CC2 10.1021/jm401456d
46236662 8773 0 None 1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 402 4 1 5 4.9 COc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)cc1 10.1021/jm100181s
CHEMBL1096478 8773 0 None 1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 402 4 1 5 4.9 COc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)cc1 10.1021/jm100181s
73333750 106068 0 None -31 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 448 10 4 7 3.2 Cc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
CHEMBL3133594 106068 0 None -31 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 448 10 4 7 3.2 Cc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1039/C3MD00079F
46236271 9012 0 None 1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 384 3 1 4 5.1 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CCC2)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098450 9012 0 None 1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 384 3 1 4 5.1 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CCC2)N1c1ccccc1 10.1021/jm100181s
24957028 8928 0 None -3 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 406 3 1 4 5.6 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1cccc(Cl)c1 10.1021/jm100181s
CHEMBL1097808 8928 0 None -3 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 406 3 1 4 5.6 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1cccc(Cl)c1 10.1021/jm100181s
45255648 148913 0 None -19 2 Human 6.9 pEC50 = 6.9 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 454 10 3 9 2.2 CCOc1ccc(-c2nc(-c3cccc4c3CCN4CC(N)(CO)CO)no2)cc1OCC nan
CHEMBL3941765 148913 0 None -19 2 Human 6.9 pEC50 = 6.9 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 454 10 3 9 2.2 CCOc1ccc(-c2nc(-c3cccc4c3CCN4CC(N)(CO)CO)no2)cc1OCC nan
46205774 7917 0 None -8 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 491 11 4 5 4.3 NC(CO)(CCc1ccc(-c2ccc(OCc3ccccc3)cc2)cc1Cl)COP(=O)(O)O 10.1021/jm901776q
CHEMBL1090223 7917 0 None -8 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 491 11 4 5 4.3 NC(CO)(CCc1ccc(-c2ccc(OCc3ccccc3)cc2)cc1Cl)COP(=O)(O)O 10.1021/jm901776q
76336568 106010 0 None -1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 407 11 4 4 2.8 CCc1ccc(CCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
CHEMBL3132869 106010 0 None -1 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 407 11 4 4 2.8 CCc1ccc(CCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
46846912 139803 0 None -128 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 478 7 1 7 5.2 O=C(O)C1CN(Cc2ccc(-c3noc(-c4noc(-c5ccccc5)c4-c4ccccc4)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
CHEMBL3798784 139803 0 None -128 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 478 7 1 7 5.2 O=C(O)C1CN(Cc2ccc(-c3noc(-c4noc(-c5ccccc5)c4-c4ccccc4)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
70688177 75281 0 None -33 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 495 6 2 5 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cnc(CCC(=O)O)cc21 10.1021/ml200252b
CHEMBL2037131 75281 0 None -33 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 495 6 2 5 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cnc(CCC(=O)O)cc21 10.1021/ml200252b
58537228 139945 0 None -2951 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 444 8 1 7 4.5 CCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
CHEMBL3799693 139945 0 None -2951 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 444 8 1 7 4.5 CCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
57570486 87596 0 None -3235 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 516 11 2 4 7.1 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(C2CC2)c1 10.1021/ml300396r
CHEMBL2336069 87596 0 None -3235 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 516 11 2 4 7.1 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(C2CC2)c1 10.1021/ml300396r
56949017 144788 0 None 2 2 Human 5.9 pEC50 = 5.9 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 480 7 0 5 7.1 Clc1ncn(Cc2cccc(-c3noc(CCC4(c5ccccc5)CCCCC4)n3)c2)c1Cl nan
CHEMBL3909228 144788 0 None 2 2 Human 5.9 pEC50 = 5.9 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 480 7 0 5 7.1 Clc1ncn(Cc2cccc(-c3noc(CCC4(c5ccccc5)CCCCC4)n3)c2)c1Cl nan
53235407 149494 0 None -1000 2 Human 5.9 pEC50 = 5.9 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 404 6 1 5 4.4 CCCc1ccc(-c2noc3c2COc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1 nan
CHEMBL3946363 149494 0 None -1000 2 Human 5.9 pEC50 = 5.9 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 404 6 1 5 4.4 CCCc1ccc(-c2noc3c2COc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1 nan
57395297 70911 0 None -426 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 9 1 7 5.7 CCCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3)cc2)n1 10.1016/j.bmcl.2011.12.019
CHEMBL1951305 70911 0 None -426 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 9 1 7 5.7 CCCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3)cc2)n1 10.1016/j.bmcl.2011.12.019
46881538 7326 0 None -66 2 Human 5.9 pEC50 = 5.9 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 529 12 3 7 3.7 Cc1cc(S(=O)(=O)NCCCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL1086158 7326 0 None -66 2 Human 5.9 pEC50 = 5.9 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 529 12 3 7 3.7 Cc1cc(S(=O)(=O)NCCCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
44599024 57401 0 None -10 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 473 6 1 5 5.5 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CCC5)nc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651862 57401 0 None -10 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 473 6 1 5 5.5 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CCC5)nc4s3)c(F)c2)C1 10.1021/ml100306h
76321895 105762 0 None -13489 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 12 3 8 3.4 CCc1cc(-c2noc(-c3ccnc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126607 105762 0 None -13489 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 12 3 8 3.4 CCc1cc(-c2noc(-c3ccnc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
46224715 199258 0 None -123 4 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human SIP3 receptor by [35S]GTPgammaS binding assayAgonist activity at human SIP3 receptor by [35S]GTPgammaS binding assay
ChEMBL 371 3 1 5 2.5 Cc1nn(C(=O)/C=C/c2cccc(S(N)(=O)=O)c2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1016/j.bmcl.2009.11.045
CHEMBL590135 199258 0 None -123 4 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human SIP3 receptor by [35S]GTPgammaS binding assayAgonist activity at human SIP3 receptor by [35S]GTPgammaS binding assay
ChEMBL 371 3 1 5 2.5 Cc1nn(C(=O)/C=C/c2cccc(S(N)(=O)=O)c2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1016/j.bmcl.2009.11.045
11553524 104399 0 None -741 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 418 7 1 4 5.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(Cl)c1OCCO 10.1021/jm4014373
CHEMBL3102989 104399 0 None -741 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 418 7 1 4 5.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(Cl)c1OCCO 10.1021/jm4014373
46236931 9018 0 None 7 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 0 3 5.3 CC(C)/N=C1\S/C(=C\c2ccc(Br)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098484 9018 0 None 7 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 0 3 5.3 CC(C)/N=C1\S/C(=C\c2ccc(Br)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
46236929 8976 0 None -6 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 382 5 0 5 4.6 COc1ccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)cc1OC 10.1021/jm100181s
CHEMBL1098202 8976 0 None -6 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 382 5 0 5 4.6 COc1ccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)cc1OC 10.1021/jm100181s
118716177 114896 0 None -12 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 432 9 4 7 2.0 Cc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3342002 114896 0 None -12 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 432 9 4 7 2.0 Cc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
24956675 8636 0 None -4 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 3 1 4 5.2 Cc1ccccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1095152 8636 0 None -4 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 3 1 4 5.2 Cc1ccccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
44217839 105773 0 None -107 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(CC(C)C)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126618 105773 0 None -107 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(CC(C)C)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
118716186 114905 0 None -5 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 443 9 4 8 1.5 N#Cc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3342011 114905 0 None -5 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 443 9 4 8 1.5 N#Cc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
118716155 114890 0 None -3 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 500 10 4 6 3.7 NC(CO)(CCc1ccc(-c2coc(Cc3ccc(C(F)(F)F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341933 114890 0 None -3 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 500 10 4 6 3.7 NC(CO)(CCc1ccc(-c2coc(Cc3ccc(C(F)(F)F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
44591265 179981 0 None -23 4 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 425 13 4 5 4.1 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2008.11.072
CHEMBL474689 179981 0 None -23 4 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 425 13 4 5 4.1 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2008.11.072
46238363 8814 0 None -2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 373 3 1 5 4.0 CN(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1096786 8814 0 None -2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 373 3 1 5 4.0 CN(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
127046549 140060 0 None -199 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cnc(OC4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800402 140060 0 None -199 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cnc(OC4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
11852143 105574 0 None -549 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 430 8 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OC[C@@H](O)CO 10.1021/jm401456d
CHEMBL3122005 105574 0 None -549 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 430 8 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OC[C@@H](O)CO 10.1021/jm401456d
67266022 140064 0 None -70 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 516 13 4 9 3.2 CCc1cc(-c2noc(-c3cc(C)c(CNCC(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3800430 140064 0 None -70 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 516 13 4 9 3.2 CCc1cc(-c2noc(-c3cc(C)c(CNCC(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
44217997 139584 0 None -933 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 498 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(OC)cc(CC(C)C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3797365 139584 0 None -933 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 498 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(OC)cc(CC(C)C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
127046568 139587 0 None -128 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cc(OC4CCCC4)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3797376 139587 0 None -128 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cc(OC4CCCC4)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
57391821 71659 0 None -707 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC(C)CCc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935581 71659 0 None -707 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC(C)CCc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1963632 71659 0 None -707 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC(C)CCc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
57437353 105563 0 None -234 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 515 12 3 6 4.4 CCc1cc(CCC(=O)c2sc(CC)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121995 105563 0 None -234 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 515 12 3 6 4.4 CCc1cc(CCC(=O)c2sc(CC)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
46237176 8863 0 None 6 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 412 7 2 6 3.3 CC(C)/N=C1\S/C(=C\c2ccc(OC(CO)CO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097183 8863 0 None 6 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 412 7 2 6 3.3 CC(C)/N=C1\S/C(=C\c2ccc(OC(CO)CO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
46236523 8962 0 None -3 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 420 3 1 4 5.9 Cc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)cc1Cl 10.1021/jm100181s
CHEMBL1098143 8962 0 None -3 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 420 3 1 4 5.9 Cc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)cc1Cl 10.1021/jm100181s
57397897 70695 0 None -724 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 447 8 2 5 4.8 O=C(O)CNCCc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
CHEMBL1950566 70695 0 None -724 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 447 8 2 5 4.8 O=C(O)CNCCc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
16737345 57352 0 None -1 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 390 5 1 4 4.6 O=C(O)C1CN(Cc2ccc(-c3cc4cc(N5CCCCC5)ccc4o3)cc2)C1 10.1021/ml100227q
CHEMBL1651708 57352 0 None -1 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 390 5 1 4 4.6 O=C(O)C1CN(Cc2ccc(-c3cc4cc(N5CCCCC5)ccc4o3)cc2)C1 10.1021/ml100227q
66829311 139809 0 None -288 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 13 3 9 3.6 CCc1cc(-c2noc(-c3cc(C)c(CN(C)CC(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3798837 139809 0 None -288 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 13 3 9 3.6 CCc1cc(-c2noc(-c3cc(C)c(CN(C)CC(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
67170110 143764 0 None -7079 2 Human 4.8 pEC50 = 4.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 499 4 1 6 5.4 O=C(O)C1CN(c2cc3c(cc2F)-c2noc(-c4onc(-c5ccccc5)c4C(F)(F)F)c2CC3)C1 nan
CHEMBL3900885 143764 0 None -7079 2 Human 4.8 pEC50 = 4.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 499 4 1 6 5.4 O=C(O)C1CN(c2cc3c(cc2F)-c2noc(-c4onc(-c5ccccc5)c4C(F)(F)F)c2CC3)C1 nan
76332741 105742 0 None -147 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 508 10 3 8 3.9 CCc1cc(-c2noc(-c3cc(C)nc(C4CCCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126586 105742 0 None -147 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 508 10 3 8 3.9 CCc1cc(-c2noc(-c3cc(C)nc(C4CCCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76321770 105435 0 None -6 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 8 1 6 6.4 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OC[C@@H](C)CO 10.1021/jm401456d
CHEMBL3120183 105435 0 None -6 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 8 1 6 6.4 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OC[C@@H](C)CO 10.1021/jm401456d
76336212 105533 0 None -9 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 499 8 3 8 3.8 Cc1cc(-c2noc(-c3sc(C)c4c3CCC(C)(C)C4)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121964 105533 0 None -9 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 499 8 3 8 3.8 Cc1cc(-c2noc(-c3sc(C)c4c3CCC(C)(C)C4)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
66829279 139594 0 None -117 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 502 12 3 9 2.9 CCc1cc(-c2noc(-c3cc(C)c(CN(C)CC)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3797412 139594 0 None -117 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 502 12 3 9 2.9 CCc1cc(-c2noc(-c3cc(C)c(CN(C)CC)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
11603726 76830 0 None -6760 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 400 7 1 5 5.2 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL206940 76830 0 None -6760 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 400 7 1 5 5.2 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.084
57391920 69886 0 None -21 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 422 3 1 3 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1021/ml200252b
CHEMBL1938937 69886 0 None -21 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 422 3 1 3 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1021/ml200252b
57391920 69886 0 None -21 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 422 3 1 3 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938937 69886 0 None -21 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 422 3 1 3 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
57570498 87612 0 None -5011 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 476 10 2 4 6.3 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
CHEMBL2336086 87612 0 None -5011 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 476 10 2 4 6.3 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
127048143 139847 0 None -354 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 525 14 3 9 3.1 CCCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1016/j.ejmech.2016.03.048
CHEMBL3799148 139847 0 None -354 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 525 14 3 9 3.1 CCCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1016/j.ejmech.2016.03.048
127046566 139997 0 None -338 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(C4CCCC4)cc(OC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3799976 139997 0 None -338 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(C4CCCC4)cc(OC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
53235479 150562 0 None -1737 2 Human 5.8 pEC50 = 5.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 475 6 1 6 4.8 CC(C)Cc1onc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)c1C(F)(F)F nan
CHEMBL3954922 150562 0 None -1737 2 Human 5.8 pEC50 = 5.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 475 6 1 6 4.8 CC(C)Cc1onc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)c1C(F)(F)F nan
44422590 85529 0 None -12 2 Human 4.8 pEC50 = 4.8 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 370 12 4 3 3.4 CCCCCCCCc1ccc(NC(=O)[C@@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
CHEMBL227530 85529 0 None -12 2 Human 4.8 pEC50 = 4.8 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 370 12 4 3 3.4 CCCCCCCCc1ccc(NC(=O)[C@@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
57397066 70912 0 None -199 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 8 1 7 5.9 CC(C)c1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3)cc2)n1 10.1016/j.bmcl.2011.12.019
CHEMBL1951306 70912 0 None -199 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 8 1 7 5.9 CC(C)c1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3)cc2)n1 10.1016/j.bmcl.2011.12.019
11978048 70917 0 None -3801 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 491 9 1 8 5.3 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3OC)cc2)n1 10.1016/j.bmcl.2011.12.019
CHEMBL1951311 70917 0 None -3801 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 491 9 1 8 5.3 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3OC)cc2)n1 10.1016/j.bmcl.2011.12.019
46881875 7330 0 None -7 4 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 371 13 3 3 4.3 CCCCCCCOc1ccc(CC[C@](C)(N)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2010.01.118
CHEMBL1086170 7330 0 None -7 4 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 371 13 3 3 4.3 CCCCCCCOc1ccc(CC[C@](C)(N)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2010.01.118
25031771 105735 0 None -5011 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 10 3 8 2.4 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1021/jm4014696
CHEMBL3126434 105735 0 None -5011 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 10 3 8 2.4 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1021/jm4014696
44218002 105766 0 None -776 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(C)c(CC(C)C)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126611 105766 0 None -776 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(C)c(CC(C)C)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
118716157 114892 0 None -23 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 412 12 4 6 2.8 CCCCCc1nc(-c2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)co1 10.1016/j.ejmech.2014.07.081
CHEMBL3341935 114892 0 None -23 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 412 12 4 6 2.8 CCCCCc1nc(-c2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)co1 10.1016/j.ejmech.2014.07.081
57396172 70672 0 None -512 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 433 7 2 5 4.8 O=C(O)CNCc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
CHEMBL1950481 70672 0 None -512 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 433 7 2 5 4.8 O=C(O)CNCc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
66655362 163619 0 None -79 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 423 8 1 4 4.6 CCc1cccc(CC)c1COc1ccc2c(c1)OCC21CCN(CCC(=O)O)CC1 10.1016/j.bmcl.2017.12.018
CHEMBL4203755 163619 0 None -79 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 423 8 1 4 4.6 CCc1cccc(CC)c1COc1ccc2c(c1)OCC21CCN(CCC(=O)O)CC1 10.1016/j.bmcl.2017.12.018
68082485 167520 0 None 1 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 395 8 1 4 3.9 O=C(O)CCN1CCC2(CC1)COc1cc(OCCCc3ccccc3)ccc12 10.1016/j.bmcl.2017.12.018
CHEMBL4207162 167520 0 None 1 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 395 8 1 4 3.9 O=C(O)CCN1CCC2(CC1)COc1cc(OCCCc3ccccc3)ccc12 10.1016/j.bmcl.2017.12.018
CHEMBL4300006 167520 0 None 1 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 395 8 1 4 3.9 O=C(O)CCN1CCC2(CC1)COc1cc(OCCCc3ccccc3)ccc12 10.1016/j.bmcl.2017.12.018
70695743 73186 0 None -39810 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assay
ChEMBL 516 9 1 6 6.1 CCCCN(C(=O)c1ccc(C(F)(F)F)cc1)c1nnc(-c2cccc3c2ccn3CCC(=O)O)s1 10.1016/j.bmcl.2012.02.016
CHEMBL2011746 73186 0 None -39810 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assay
ChEMBL 516 9 1 6 6.1 CCCCN(C(=O)c1ccc(C(F)(F)F)cc1)c1nnc(-c2cccc3c2ccn3CCC(=O)O)s1 10.1016/j.bmcl.2012.02.016
24824717 120857 0 None -6 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 496 6 1 7 6.1 O=C(O)c1cnn(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)c1 10.1021/jm5010336
CHEMBL3360358 120857 0 None -6 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 496 6 1 7 6.1 O=C(O)c1cnn(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)c1 10.1021/jm5010336
CHEMBL3558705 120857 0 None -6 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 496 6 1 7 6.1 O=C(O)c1cnn(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)c1 10.1021/jm5010336
54758399 65958 0 None -794 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 448 7 2 8 2.8 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(C(CO)CO)CC4)no2)cc1C#N 10.1021/jm200609t
CHEMBL1836172 65958 0 None -794 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 448 7 2 8 2.8 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(C(CO)CO)CC4)no2)cc1C#N 10.1021/jm200609t
44124898 116419 0 None -398 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 369 4 1 5 4.5 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNC4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3360365 116419 0 None -398 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 369 4 1 5 4.5 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNC4)no2)cc1Cl 10.1021/jm5010336
44129142 116421 0 None -125 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 385 4 1 6 4.3 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNCCO4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3360367 116421 0 None -125 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 385 4 1 6 4.3 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNCCO4)no2)cc1Cl 10.1021/jm5010336
11222939 67575 9 None -4 4 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.02.006
44438254 67575 9 None -4 4 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.02.006
CHEMBL190006 67575 9 None -4 4 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.02.006
44591249 180636 0 None -7 4 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 402 13 4 5 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2008.11.072
CHEMBL475495 180636 0 None -7 4 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 402 13 4 5 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2008.11.072
44412882 77288 0 None -316 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 390 6 1 4 5.8 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(C3CCCCC3)cc2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL208168 77288 0 None -316 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 390 6 1 4 5.8 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(C3CCCCC3)cc2)n1 10.1016/j.bmcl.2006.04.084
11626664 77928 0 None -1584 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 455 7 1 6 5.1 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2cnc(OC(C)C(F)(F)F)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL209484 77928 0 None -1584 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 455 7 1 6 5.1 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2cnc(OC(C)C(F)(F)F)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.084
16038017 139418 0 None -14454 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 431 7 1 6 4.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OCC(F)(F)F)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL379380 139418 0 None -14454 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 431 7 1 6 4.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OCC(F)(F)F)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
10174255 85217 0 None -158 4 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 485 6 1 6 5.7 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)C1 10.1016/j.bmcl.2011.12.019
CHEMBL225575 85217 0 None -158 4 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 485 6 1 6 5.7 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)C1 10.1016/j.bmcl.2011.12.019
70681815 75277 0 None -8 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 480 5 2 4 5.1 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccc(CC(=O)O)cc21 10.1021/ml200252b
CHEMBL2037127 75277 0 None -8 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 480 5 2 4 5.1 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccc(CC(=O)O)cc21 10.1021/ml200252b
46835922 139455 13 None -4466 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
CHEMBL3794064 139455 13 None -4466 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
57570459 87611 0 None -2630 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 462 10 2 4 5.9 C/C(=N\OCc1ccc(C2CCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
CHEMBL2336085 87611 0 None -2630 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 462 10 2 4 5.9 C/C(=N\OCc1ccc(C2CCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
127046183 140076 0 None -56 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 518 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)nc(-c4ccccc4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800496 140076 0 None -56 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 518 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)nc(-c4ccccc4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
56949019 145995 0 None -79 2 Human 4.8 pEC50 = 4.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 392 7 0 5 5.6 COc1ccc(OC)c(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c1 nan
CHEMBL3918461 145995 0 None -79 2 Human 4.8 pEC50 = 4.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 392 7 0 5 5.6 COc1ccc(OC)c(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c1 nan
69144915 104436 0 None -107 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 370 7 1 4 4.5 Cc1sc(C(=O)CCc2ccc(OCCO)cc2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
CHEMBL3103661 104436 0 None -107 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 370 7 1 4 4.5 Cc1sc(C(=O)CCc2ccc(OCCO)cc2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
46236274 8559 0 None -2 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 338 3 1 4 4.1 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1C(C)C 10.1021/jm100181s
CHEMBL1094501 8559 0 None -2 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 338 3 1 4 4.1 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1C(C)C 10.1021/jm100181s
67172159 142879 0 None -1174 2 Human 4.8 pEC50 = 4.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 497 6 2 6 5.5 CC(N)(CCc1ccc2c(c1)CCc1c-2noc1-c1noc(-c2ccccc2)c1C(F)(F)F)C(=O)O nan
CHEMBL3893505 142879 0 None -1174 2 Human 4.8 pEC50 = 4.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 497 6 2 6 5.5 CC(N)(CCc1ccc2c(c1)CCc1c-2noc1-c1noc(-c2ccccc2)c1C(F)(F)F)C(=O)O nan
46236930 8977 0 None -1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 365 4 0 4 4.6 CC(C)/N=C1\S/C(=C\c2ccc(N(C)C)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098203 8977 0 None -1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 365 4 0 4 4.6 CC(C)/N=C1\S/C(=C\c2ccc(N(C)C)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
10174255 85217 0 None -158 4 Human 7.8 pEC50 = 7.8 Functional
Activity at human S1P3 receptor expressed in CHO cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay
ChEMBL 485 6 1 6 5.7 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)C1 10.1021/jm0492507
CHEMBL225575 85217 0 None -158 4 Human 7.8 pEC50 = 7.8 Functional
Activity at human S1P3 receptor expressed in CHO cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay
ChEMBL 485 6 1 6 5.7 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)C1 10.1021/jm0492507
127046550 139863 0 None -11 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cnc(OC)c(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3799227 139863 0 None -11 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cnc(OC)c(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
127048099 139581 0 None -602 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 518 13 4 10 1.9 CCc1cc(-c2noc(-c3cc(C)c(CN(C)CCO)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3797357 139581 0 None -602 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 518 13 4 10 1.9 CCc1cc(-c2noc(-c3cc(C)c(CN(C)CCO)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
56948899 148513 0 None 1 2 Human 5.8 pEC50 = 5.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 392 7 0 5 5.6 COc1cc(OC)cc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c1 nan
CHEMBL3938390 148513 0 None 1 2 Human 5.8 pEC50 = 5.8 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 392 7 0 5 5.6 COc1cc(OC)cc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c1 nan
24851764 105782 0 None -295 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccc(CC(C)C)nc3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126627 105782 0 None -295 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccc(CC(C)C)nc3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76322127 106092 0 None -6 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 491 11 4 5 4.5 NC(CO)(CCc1ccc(Oc2ccc(Cc3ccc(Cl)cc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
CHEMBL3133705 106092 0 None -6 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 491 11 4 5 4.5 NC(CO)(CCc1ccc(Oc2ccc(Cc3ccc(Cl)cc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
76321769 105534 0 None -26 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 501 11 3 8 4.0 CCc1c(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)sc(C)c1CC(C)C 10.1021/jm401456d
CHEMBL3121965 105534 0 None -26 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 501 11 3 8 4.0 CCc1c(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)sc(C)c1CC(C)C 10.1021/jm401456d
76318058 105553 0 None -194 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 499 10 3 8 3.6 CCc1cc(-c2noc(-c3sc(CC)c4c3CCCC4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121985 105553 0 None -194 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 499 10 3 8 3.6 CCc1cc(-c2noc(-c3sc(CC)c4c3CCCC4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
16737679 57362 0 None -70 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4cc(Cc5ccccc5)ccc4o3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1651717 57362 0 None -70 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4cc(Cc5ccccc5)ccc4o3)c(F)c2)C1 10.1021/ml100228m
76329327 106011 0 None -10 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 485 12 4 5 4.4 CCc1ccc(Cc2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)cc1 10.1039/C3MD00079F
CHEMBL3132870 106011 0 None -10 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 485 12 4 5 4.4 CCc1ccc(Cc2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)cc1 10.1039/C3MD00079F
46237180 8864 1 None -14 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OCC(O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
CHEMBL1097184 8864 1 None -14 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OCC(O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
11852234 105559 0 None -407 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 513 10 2 6 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CN1CC(C(=O)O)C1 10.1021/jm401456d
CHEMBL3121991 105559 0 None -407 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 513 10 2 6 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CN1CC(C(=O)O)C1 10.1021/jm401456d
44218903 105765 0 None -63 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 509 11 3 9 2.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1N1CCCC1 10.1021/jm4014696
CHEMBL3126610 105765 0 None -63 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 509 11 3 9 2.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1N1CCCC1 10.1021/jm4014696
76318199 105784 0 None -389 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 11 3 8 2.5 CCCc1ccc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cn1 10.1021/jm4014696
CHEMBL3126629 105784 0 None -389 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 11 3 8 2.5 CCCc1ccc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cn1 10.1021/jm4014696
76311230 106072 0 None -26 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 441 12 4 5 3.7 CCCCc1ccc(Oc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2F)cc1 10.1039/C3MD00079F
CHEMBL3133598 106072 0 None -26 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 441 12 4 5 3.7 CCCCc1ccc(Oc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2F)cc1 10.1039/C3MD00079F
46236399 8561 0 None -1 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 378 3 1 4 5.1 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1C1CCCCC1 10.1021/jm100181s
CHEMBL1094503 8561 0 None -1 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 378 3 1 4 5.1 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1C1CCCCC1 10.1021/jm100181s
25192001 8059 0 None -2 4 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 413 12 4 4 3.5 CCCCCCCCc1ccc2c(c1)CC[C@@H](C(N)(CO)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1091103 8059 0 None -2 4 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 413 12 4 4 3.5 CCCCCCCCc1ccc2c(c1)CC[C@@H](C(N)(CO)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
118707193 113040 0 None -58 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 449 12 3 5 3.9 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)c(C)c2)cc1 10.1016/j.bmc.2014.05.035
CHEMBL3311348 113040 0 None -58 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 449 12 3 5 3.9 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)c(C)c2)cc1 10.1016/j.bmc.2014.05.035
127046400 139610 0 None -162 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 512 13 3 9 3.4 CCc1cc(-c2noc(-c3cc(C(CC)CC)cc(OC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3797486 139610 0 None -162 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 512 13 3 9 3.4 CCc1cc(-c2noc(-c3cc(C(CC)CC)cc(OC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
53322738 58004 0 None -22 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 446 6 1 4 5.5 Cc1ccc(Cc2ccc3sc(-c4ccc(CN5CC(C(=O)O)C5)cc4F)nc3c2)cc1 10.1021/ml100228m
CHEMBL1672566 58004 0 None -22 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 446 6 1 4 5.5 Cc1ccc(Cc2ccc3sc(-c4ccc(CN5CC(C(=O)O)C5)cc4F)nc3c2)cc1 10.1021/ml100228m
46846921 139800 0 None -549 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 442 7 1 7 4.5 O=C(O)C1CN(Cc2ccc(-c3noc(-c4noc(-c5ccccc5)c4C4CC4)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
CHEMBL3798775 139800 0 None -549 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 442 7 1 7 4.5 O=C(O)C1CN(Cc2ccc(-c3noc(-c4noc(-c5ccccc5)c4C4CC4)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
58907649 86569 0 None -27 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 336 12 3 4 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@H](N)CC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
CHEMBL2315814 86569 0 None -27 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 336 12 3 4 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@H](N)CC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
11697277 104402 0 None -380 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 412 8 1 4 5.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCO 10.1021/jm4014373
CHEMBL3102992 104402 0 None -380 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 412 8 1 4 5.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCO 10.1021/jm4014373
46236666 8789 0 None 5 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 5 1 4 5.0 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1CCc1ccccc1 10.1021/jm100181s
CHEMBL1096541 8789 0 None 5 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 5 1 4 5.0 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1CCc1ccccc1 10.1021/jm100181s
76322117 106083 0 None 1 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 449 13 4 4 4.1 CC(C)c1ccc(CCCCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
CHEMBL3133608 106083 0 None 1 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 449 13 4 4 4.1 CC(C)c1ccc(CCCCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
11496072 146024 0 None -1513 3 Human 6.7 pEC50 = 6.7 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 448 7 1 5 6.1 Cc1cc(C(C)CC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL391869 146024 0 None -1513 3 Human 6.7 pEC50 = 6.7 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 448 7 1 5 6.1 Cc1cc(C(C)CC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
59202022 105541 0 None -436 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 431 9 3 8 2.5 CCc1ccc(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)s1 10.1021/jm401456d
CHEMBL3121972 105541 0 None -436 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 431 9 3 8 2.5 CCc1ccc(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(C)c3)no2)s1 10.1021/jm401456d
24956674 8857 0 None -2 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 372 4 1 4 4.9 CCC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097103 8857 0 None -2 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 372 4 1 4 4.9 CCC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
72793810 104691 0 None -28 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 6 2 7 4.4 Cc1cc(-c2nc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)no2)cc(C)c1OC[C@@H](O)CO 10.1021/jm4014373
CHEMBL3105248 104691 0 None -28 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 6 2 7 4.4 Cc1cc(-c2nc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)no2)cc(C)c1OC[C@@H](O)CO 10.1021/jm4014373
44406749 75036 0 None -1 3 Human 7.7 pEC50 = 7.7 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 565 18 4 10 4.7 C[C@@](N)(CCc1ccc(OCCCCCCCCNc2ccc([N+](=O)[O-])c3nonc23)cc1)COP(=O)(O)O 10.1016/j.bmcl.2005.09.038
CHEMBL203475 75036 0 None -1 3 Human 7.7 pEC50 = 7.7 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 565 18 4 10 4.7 C[C@@](N)(CCc1ccc(OCCCCCCCCNc2ccc([N+](=O)[O-])c3nonc23)cc1)COP(=O)(O)O 10.1016/j.bmcl.2005.09.038
134319702 166565 0 None -190 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human EDG3-Ga15-bla expressed in HEK293T cells after 45 mins by [35S]GTPgammaS binding assayAgonist activity at human EDG3-Ga15-bla expressed in HEK293T cells after 45 mins by [35S]GTPgammaS binding assay
ChEMBL 496 11 3 7 4.2 CCCCOCCOc1nc2c(s1)-c1ccc([C@H]3CC[C@](N)(COP(=O)(O)O)C3)cc1CC2 10.1039/C6MD00539J
CHEMBL4279752 166565 0 None -190 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human EDG3-Ga15-bla expressed in HEK293T cells after 45 mins by [35S]GTPgammaS binding assayAgonist activity at human EDG3-Ga15-bla expressed in HEK293T cells after 45 mins by [35S]GTPgammaS binding assay
ChEMBL 496 11 3 7 4.2 CCCCOCCOc1nc2c(s1)-c1ccc([C@H]3CC[C@](N)(COP(=O)(O)O)C3)cc1CC2 10.1039/C6MD00539J
127046741 140002 0 None -190 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cc(C)nc(OC4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800019 140002 0 None -190 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cc(C)nc(OC4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
23121374 58446 0 None -57 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 353 11 2 3 4.2 C/C(=C\c1ccc(OCCCc2ccccc2)cc1)CNCCC(=O)O 10.1016/j.bmcl.2011.01.029
CHEMBL1683046 58446 0 None -57 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 353 11 2 3 4.2 C/C(=C\c1ccc(OCCCc2ccccc2)cc1)CNCCC(=O)O 10.1016/j.bmcl.2011.01.029
46846904 139791 0 None -3548 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 466 7 1 7 4.7 CC(F)(F)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
CHEMBL3798735 139791 0 None -3548 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 466 7 1 7 4.7 CC(F)(F)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
57570463 87592 0 None -3162 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 510 10 2 4 6.9 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(Cl)c1 10.1021/ml300396r
CHEMBL2336065 87592 0 None -3162 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 510 10 2 4 6.9 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(Cl)c1 10.1021/ml300396r
16737504 57348 0 None -7 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 363 6 1 3 4.8 CC(C)Cc1ccc2oc(-c3ccc(CN4CC(C(=O)O)C4)cc3)cc2c1 10.1021/ml100227q
CHEMBL1651704 57348 0 None -7 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 363 6 1 3 4.8 CC(C)Cc1ccc2oc(-c3ccc(CN4CC(C(=O)O)C4)cc3)cc2c1 10.1021/ml100227q
118716183 114902 0 None -36 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 446 10 4 7 2.2 CCc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3342008 114902 0 None -36 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 446 10 4 7 2.2 CCc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
53326641 57998 0 None -57 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 450 6 1 4 5.3 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccc(F)cc5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672560 57998 0 None -57 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 450 6 1 4 5.3 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccc(F)cc5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
118716138 114871 0 None -20 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 412 12 4 7 1.9 CCCCCn1cc(-c2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)nn1 10.1016/j.ejmech.2014.07.081
CHEMBL3341916 114871 0 None -20 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 412 12 4 7 1.9 CCCCCn1cc(-c2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)nn1 10.1016/j.ejmech.2014.07.081
70681687 74975 0 None -6309 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 454 8 2 4 5.8 O=C(O)CCNCCc1ccc2oc(-c3ccc(-c4ccccc4)c(C(F)(F)F)c3)nc2c1 10.1016/j.bmcl.2012.04.095
CHEMBL2032430 74975 0 None -6309 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 454 8 2 4 5.8 O=C(O)CCNCCc1ccc2oc(-c3ccc(-c4ccccc4)c(C(F)(F)F)c3)nc2c1 10.1016/j.bmcl.2012.04.095
25182782 7627 0 None -691 2 Human 5.7 pEC50 = 5.7 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 431 7 2 6 3.2 CCCN(c1cc(C(=O)Nc2ccc(S(N)(=O)=O)cc2C)ncn1)C1CCCCC1 nan
CHEMBL1088178 7627 0 None -691 2 Human 5.7 pEC50 = 5.7 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 431 7 2 6 3.2 CCCN(c1cc(C(=O)Nc2ccc(S(N)(=O)=O)cc2C)ncn1)C1CCCCC1 nan
145947403 167668 0 None -125 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 443 8 1 4 5.1 CCCc1cccc(Cl)c1COc1ccc2c(c1)OCC21CCN(CCC(=O)O)CC1 10.1016/j.bmcl.2017.12.018
CHEMBL4205878 167668 0 None -125 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 443 8 1 4 5.1 CCCc1cccc(Cl)c1COc1ccc2c(c1)OCC21CCN(CCC(=O)O)CC1 10.1016/j.bmcl.2017.12.018
CHEMBL4301965 167668 0 None -125 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 443 8 1 4 5.1 CCCc1cccc(Cl)c1COc1ccc2c(c1)OCC21CCN(CCC(=O)O)CC1 10.1016/j.bmcl.2017.12.018
44129144 116385 0 None -15 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 457 7 1 7 4.5 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CN(CCC(=O)O)CCO4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359839 116385 0 None -15 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 457 7 1 7 4.5 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CN(CCC(=O)O)CCO4)no2)cc1Cl 10.1021/jm5010336
44128909 116391 0 None -501 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 432 6 1 7 3.5 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CC(=O)O)CC4)no2)cc1C#N 10.1021/jm5010336
CHEMBL3359845 116391 0 None -501 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 432 6 1 7 3.5 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CC(=O)O)CC4)no2)cc1C#N 10.1021/jm5010336
44125470 116431 0 None -3 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 441 8 1 6 5.0 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CN(CCCC(=O)O)C4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3360377 116431 0 None -3 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 441 8 1 6 5.0 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CN(CCCC(=O)O)C4)no2)cc1Cl 10.1021/jm5010336
70692257 74978 0 None -1995 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 480 5 1 4 6.4 O=C(O)CN1CCC(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
CHEMBL2032433 74978 0 None -1995 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 480 5 1 4 6.4 O=C(O)CN1CCC(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
70692258 74980 0 None -5011 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 481 5 1 5 5.4 O=C(O)CN1CCN(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
CHEMBL2032435 74980 0 None -5011 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 481 5 1 5 5.4 O=C(O)CN1CCN(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
70696411 74983 0 None -3981 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 508 7 1 4 6.9 O=C(O)C1CCCN(CCCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
CHEMBL2032438 74983 0 None -3981 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 508 7 1 4 6.9 O=C(O)C1CCCN(CCCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
70681689 74984 0 None -199 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 438 4 1 4 5.7 O=C(O)C1CN(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
CHEMBL2032439 74984 0 None -199 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 438 4 1 4 5.7 O=C(O)C1CN(c2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
44125704 116400 0 None -316 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 472 8 2 8 4.5 CC(C)Oc1ncc(-c2nc(-c3cccc4c3OCCNC4CCCC(=O)O)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359854 116400 0 None -316 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 472 8 2 8 4.5 CC(C)Oc1ncc(-c2nc(-c3cccc4c3OCCNC4CCCC(=O)O)no2)cc1Cl 10.1021/jm5010336
118716180 114899 0 None -47 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 452 9 4 7 2.3 NC(CO)(CCc1ccc(-c2cn(-c3ccc(Cl)cc3)nn2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3342005 114899 0 None -47 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 452 9 4 7 2.3 NC(CO)(CCc1ccc(-c2cn(-c3ccc(Cl)cc3)nn2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
11452022 3596 39 None -19 6 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmc.2014.05.035
6996 3596 39 None -19 6 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmc.2014.05.035
CHEMBL366208 3596 39 None -19 6 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmc.2014.05.035
10883396 3649 45 None 1 15 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2012.11.053
5283560 3649 45 None 1 15 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2012.11.053
911 3649 45 None 1 15 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2012.11.053
CHEMBL225155 3649 45 None 1 15 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2012.11.053
76325528 105745 0 None -7 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 508 11 3 8 3.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C2CCCC2)n1 10.1021/jm4014696
CHEMBL3126589 105745 0 None -7 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 508 11 3 8 3.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C2CCCC2)n1 10.1021/jm4014696
10883396 3649 45 None 1 15 Human 8.6 pEC50 = 8.6 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
5283560 3649 45 None 1 15 Human 8.6 pEC50 = 8.6 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
911 3649 45 None 1 15 Human 8.6 pEC50 = 8.6 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
CHEMBL225155 3649 45 None 1 15 Human 8.6 pEC50 = 8.6 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
11222939 67575 9 None -4 4 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.01.118
44438254 67575 9 None -4 4 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.01.118
CHEMBL190006 67575 9 None -4 4 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.01.118
66829334 139905 0 None -39 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 14 3 9 3.6 CCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1CC 10.1016/j.ejmech.2016.03.048
CHEMBL3799441 139905 0 None -39 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 14 3 9 3.6 CCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1CC 10.1016/j.ejmech.2016.03.048
118707012 112996 0 None -28 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 435 12 3 5 3.5 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)cc2)cc1 10.1016/j.bmc.2014.05.035
CHEMBL3311106 112996 0 None -28 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 435 12 3 5 3.5 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)cc2)cc1 10.1016/j.bmc.2014.05.035
46236403 8637 0 None -1 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 3 1 4 5.2 Cc1cccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c1 10.1021/jm100181s
CHEMBL1095153 8637 0 None -1 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 3 1 4 5.2 Cc1cccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c1 10.1021/jm100181s
57394951 70904 0 None -57 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 447 7 1 7 5.1 Cc1ccccc1Oc1ccc(-c2nc(-c3csc(CN4CC(C(=O)O)C4)c3)no2)cc1 10.1016/j.bmcl.2011.12.019
CHEMBL1951157 70904 0 None -57 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 447 7 1 7 5.1 Cc1ccccc1Oc1ccc(-c2nc(-c3csc(CN4CC(C(=O)O)C4)c3)no2)cc1 10.1016/j.bmcl.2011.12.019
44219368 139723 0 None -251 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 482 11 3 8 2.5 CCc1cc(-c2noc(-c3cc(C)cc(CN(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3798218 139723 0 None -251 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 482 11 3 8 2.5 CCc1cc(-c2noc(-c3cc(C)cc(CN(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
11853580 104395 0 None -181 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 469 11 2 5 5.2 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNCC(=O)O 10.1021/jm4014373
CHEMBL3102985 104395 0 None -181 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 469 11 2 5 5.2 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNCC(=O)O 10.1021/jm4014373
76332956 106073 0 None -3 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 441 12 4 5 3.7 CCCCc1ccc(Oc2ccc(CCC(N)(CO)COP(=O)(O)O)c(F)c2)cc1 10.1039/C3MD00079F
CHEMBL3133599 106073 0 None -3 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 441 12 4 5 3.7 CCCCc1ccc(Oc2ccc(CCC(N)(CO)COP(=O)(O)O)c(F)c2)cc1 10.1039/C3MD00079F
57400585 69882 0 None -48 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 471 5 1 6 4.2 CC1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
CHEMBL1938933 69882 0 None -48 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 471 5 1 6 4.2 CC1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
57402358 69877 0 None -19 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 461 7 1 5 5.6 CCC(c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1)c1ccccn1 10.1016/j.bmcl.2011.10.069
CHEMBL1938927 69877 0 None -19 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 461 7 1 5 5.6 CCC(c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1)c1ccccn1 10.1016/j.bmcl.2011.10.069
57402280 71492 0 None -31622 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 4.7 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCC(C)Cc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935580 71492 0 None -31622 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 4.7 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCC(C)Cc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1962533 71492 0 None -31622 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 4.7 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCC(C)Cc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
76311232 106080 0 None 1 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 421 12 4 4 3.2 CCCc1ccc(CCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
CHEMBL3133605 106080 0 None 1 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 421 12 4 4 3.2 CCCc1ccc(CCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
127046325 139625 0 None -208 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.5 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN(CC)CC 10.1016/j.ejmech.2016.03.048
CHEMBL3797596 139625 0 None -208 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.5 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN(CC)CC 10.1016/j.ejmech.2016.03.048
127047083 139992 0 None -346 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)c(C4CCCC4)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3799953 139992 0 None -346 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)c(C4CCCC4)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
76322118 106084 0 None -2 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 409 12 4 4 3.7 CCCCCCc1ccc2cc(CCC(N)(CO)COP(=O)(O)O)ccc2c1 10.1039/C3MD00079F
CHEMBL3133609 106084 0 None -2 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 409 12 4 4 3.7 CCCCCCc1ccc2cc(CCC(N)(CO)COP(=O)(O)O)ccc2c1 10.1039/C3MD00079F
127046456 139654 0 None -138 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 4 8 3.2 CCc1cc(-c2noc(-c3cc(C)cc(CNCC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3797802 139654 0 None -138 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 4 8 3.2 CCc1cc(-c2noc(-c3cc(C)cc(CNCC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
118716144 114878 0 None -28 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 502 10 4 7 3.6 NC(CO)(CCc1ccc(-c2coc(-c3ccc(OC(F)(F)F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341922 114878 0 None -28 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 502 10 4 7 3.6 NC(CO)(CCc1ccc(-c2coc(-c3ccc(OC(F)(F)F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
46236805 8790 0 None 8 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 428 7 1 4 5.7 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1CCCCc1ccccc1 10.1021/jm100181s
CHEMBL1096542 8790 0 None 8 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 428 7 1 4 5.7 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1CCCCc1ccccc1 10.1021/jm100181s
46236934 9055 0 None 2 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 368 4 1 5 4.3 COc1ccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)cc1O 10.1021/jm100181s
CHEMBL1098772 9055 0 None 2 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 368 4 1 5 4.3 COc1ccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)cc1O 10.1021/jm100181s
76322128 106095 0 None -6 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 473 11 4 6 3.9 COc1cccc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)c1 10.1039/C3MD00079F
CHEMBL3133708 106095 0 None -6 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 473 11 4 6 3.9 COc1cccc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)c1 10.1039/C3MD00079F
127047020 140020 0 None -72 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 496 11 3 9 2.8 CCc1cc(-c2noc(-c3cc(OC)nc(C4CCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800133 140020 0 None -72 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 496 11 3 9 2.8 CCc1cc(-c2noc(-c3cc(OC)nc(C4CCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
118707196 113043 0 None -54 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 469 12 3 5 4.2 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)c(Cl)c2)cc1 10.1016/j.bmc.2014.05.035
CHEMBL3311351 113043 0 None -54 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 469 12 3 5 4.2 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)c(Cl)c2)cc1 10.1016/j.bmc.2014.05.035
59982944 87591 0 None -7244 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 494 10 2 4 6.4 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(F)c1 10.1021/ml300396r
CHEMBL2336064 87591 0 None -7244 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 494 10 2 4 6.4 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(F)c1 10.1021/ml300396r
11633613 104432 0 None -346 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 442 9 2 5 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(CO)CO 10.1021/jm4014373
CHEMBL3103657 104432 0 None -346 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 442 9 2 5 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(CO)CO 10.1021/jm4014373
56949269 144429 0 None -21 2 Human 5.7 pEC50 = 5.7 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 333 5 0 4 5.0 c1ccc(C2(CCc3nc(-c4cccnc4)no3)CCCCC2)cc1 nan
CHEMBL3906369 144429 0 None -21 2 Human 5.7 pEC50 = 5.7 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 333 5 0 4 5.0 c1ccc(C2(CCc3nc(-c4cccnc4)no3)CCCCC2)cc1 nan
56948778 146989 0 None -4 2 Human 5.7 pEC50 = 5.7 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 346 5 0 3 5.9 Cc1cccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c1 nan
CHEMBL3926389 146989 0 None -4 2 Human 5.7 pEC50 = 5.7 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 346 5 0 3 5.9 Cc1cccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)c1 nan
57400476 71658 0 None -36307 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 5.0 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCC(C)c3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935579 71658 0 None -36307 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 5.0 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCC(C)c3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1963631 71658 0 None -36307 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 405 8 1 3 5.0 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCC(C)c3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
76329326 106090 0 None -1 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 471 11 4 5 4.1 Cc1ccc(Cc2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)cc1 10.1039/C3MD00079F
CHEMBL3133703 106090 0 None -1 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 471 11 4 5 4.1 Cc1ccc(Cc2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)cc1 10.1039/C3MD00079F
46236664 8527 0 None 1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 373 3 1 5 4.3 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1cccnc1 10.1021/jm100181s
CHEMBL1094247 8527 0 None 1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 373 3 1 5 4.3 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1cccnc1 10.1021/jm100181s
44422604 85448 0 None -10 5 Human 7.6 pEC50 = 7.6 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 432 15 4 4 4.4 CCCCCCCCCCc1ccc(NC(=O)[C@H](N)CC(F)OP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
CHEMBL226612 85448 0 None -10 5 Human 7.6 pEC50 = 7.6 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 432 15 4 4 4.4 CCCCCCCCCCc1ccc(NC(=O)[C@H](N)CC(F)OP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
11575913 78122 0 None -5 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 444 7 1 5 5.3 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(Br)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL210316 78122 0 None -5 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 444 7 1 5 5.3 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(Br)c2)n1 10.1016/j.bmcl.2006.04.084
127046179 139807 0 None -41 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 544 13 3 9 3.9 CCc1cc(-c2noc(-c3sc(CN(C)CC(C)C)c(C)c3C)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3798807 139807 0 None -41 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 544 13 3 9 3.9 CCc1cc(-c2noc(-c3sc(CN(C)CC(C)C)c(C)c3C)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
46880801 6266 0 None -6 2 Human 5.6 pEC50 = 5.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 314 7 2 5 3.1 CCCN(CCC)c1cc(C(=O)Nc2ccc(O)cc2)ncn1 nan
CHEMBL1081646 6266 0 None -6 2 Human 5.6 pEC50 = 5.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 314 7 2 5 3.1 CCCN(CCC)c1cc(C(=O)Nc2ccc(O)cc2)ncn1 nan
46880801 6266 0 None -6 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 314 7 2 5 3.1 CCCN(CCC)c1cc(C(=O)Nc2ccc(O)cc2)ncn1 10.1016/j.bmcl.2010.01.102
CHEMBL1081646 6266 0 None -6 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 314 7 2 5 3.1 CCCN(CCC)c1cc(C(=O)Nc2ccc(O)cc2)ncn1 10.1016/j.bmcl.2010.01.102
25182774 6127 0 None -11 2 Human 5.6 pEC50 = 5.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 364 4 2 5 3.7 Cc1cc2[nH]ncc2cc1NC(=O)c1cc(N(C)C2CCCCC2)ncn1 nan
CHEMBL1080881 6127 0 None -11 2 Human 5.6 pEC50 = 5.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 364 4 2 5 3.7 Cc1cc2[nH]ncc2cc1NC(=O)c1cc(N(C)C2CCCCC2)ncn1 nan
25182928 145969 0 None -81 2 Human 6.6 pEC50 = 6.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 463 9 2 6 3.8 O=C(Nc1ccc(CN2CC(C(=O)O)C2)cc1)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL3918272 145969 0 None -81 2 Human 6.6 pEC50 = 6.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 463 9 2 6 3.8 O=C(Nc1ccc(CN2CC(C(=O)O)C2)cc1)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
46881623 6763 0 None -389 3 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 477 9 2 6 4.1 Cc1cc(CN2CC(C(=O)O)C2)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 10.1016/j.bmcl.2010.01.102
CHEMBL1083828 6763 0 None -389 3 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 477 9 2 6 4.1 Cc1cc(CN2CC(C(=O)O)C2)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 10.1016/j.bmcl.2010.01.102
23729211 105537 0 None -154 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 473 10 3 8 3.4 Cc1cc(-c2noc(-c3cc(CC(C)C)c(C)s3)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121968 105537 0 None -154 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 473 10 3 8 3.4 Cc1cc(-c2noc(-c3cc(CC(C)C)c(C)s3)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
118716146 114880 0 None -10 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 10 4 6 3.9 CC(C)c1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341924 114880 0 None -10 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 10 4 6 3.9 CC(C)c1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
76310852 105555 0 None -21 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 525 10 3 8 4.0 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC3(CC3)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121987 105555 0 None -21 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 525 10 3 8 4.0 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC3(CC3)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
76310992 105740 0 None -239 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 480 10 3 8 3.1 CCc1cc(-c2noc(-c3cc(C)nc(C4CCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126584 105740 0 None -239 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 480 10 3 8 3.1 CCc1cc(-c2noc(-c3cc(C)nc(C4CCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76321896 105779 0 None -120 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 508 11 3 8 3.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1C1CCCC1 10.1021/jm4014696
CHEMBL3126624 105779 0 None -120 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 508 11 3 8 3.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1C1CCCC1 10.1021/jm4014696
46237175 8862 0 None -1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 412 7 2 6 3.3 CC(C)/N=C1\S/C(=C\c2ccc(OCC(O)CO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097182 8862 0 None -1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 412 7 2 6 3.3 CC(C)/N=C1\S/C(=C\c2ccc(OCC(O)CO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
46881912 6766 0 None -5 4 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 425 13 2 5 2.8 CCCCCCCOc1ccc(CC[C@](C)(N)CCN2CC(=O)NS2(=O)=O)cc1 10.1016/j.bmcl.2010.01.118
CHEMBL1083841 6766 0 None -5 4 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 425 13 2 5 2.8 CCCCCCCOc1ccc(CC[C@](C)(N)CCN2CC(=O)NS2(=O)=O)cc1 10.1016/j.bmcl.2010.01.118
57437389 105565 0 None -186 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 555 11 3 6 4.8 CCc1cc(CCC(=O)c2sc(C(F)(F)F)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121997 105565 0 None -186 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 555 11 3 6 4.8 CCc1cc(CCC(=O)c2sc(C(F)(F)F)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
5309153 37498 10 None 24 4 Human 6.6 pEC50 = 6.6 Functional
PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]
ChEMBL 318 5 0 3 4.7 CCCc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 nan
CHEMBL1455786 37498 10 None 24 4 Human 6.6 pEC50 = 6.6 Functional
PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]PUBCHEM_BIOASSAY: Dose Response Cell-Based Assay for Agonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3): Purchased Analogues. (Class of assay: confirmatory) [Related pubchem assays: 373, 439 ]
ChEMBL 318 5 0 3 4.7 CCCc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 nan
53322737 58002 0 None -93 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 446 6 1 4 5.5 Cc1ccccc1Cc1ccc2sc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)nc2c1 10.1021/ml100228m
CHEMBL1672564 58002 0 None -93 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 446 6 1 4 5.5 Cc1ccccc1Cc1ccc2sc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)nc2c1 10.1021/ml100228m
118716141 114874 0 None -15 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 436 9 4 6 2.9 NC(CO)(CCc1ccc(-c2coc(-c3ccc(F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341919 114874 0 None -15 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 436 9 4 6 2.9 NC(CO)(CCc1ccc(-c2coc(-c3ccc(F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
46236522 8929 0 None -7 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 420 3 1 4 5.9 Cc1c(Cl)cccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1097809 8929 0 None -7 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 420 3 1 4 5.9 Cc1c(Cl)cccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
66636847 105538 0 None -407 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 459 10 3 8 3.1 Cc1cc(-c2noc(-c3ccc(CC(C)C)s3)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121969 105538 0 None -407 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 459 10 3 8 3.1 Cc1cc(-c2noc(-c3ccc(CC(C)C)s3)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
46880964 7598 0 None -416 2 Human 5.6 pEC50 = 5.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 457 8 2 6 3.5 CNS(=O)(=O)c1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)c(C)c1 nan
CHEMBL1087909 7598 0 None -416 2 Human 5.6 pEC50 = 5.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 457 8 2 6 3.5 CNS(=O)(=O)c1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)c(C)c1 nan
76328931 105546 0 None -63 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 472 11 2 5 5.8 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC(CC)(CC)CC2 10.1021/jm401456d
CHEMBL3121978 105546 0 None -63 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 472 11 2 5 5.8 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC(CC)(CC)CC2 10.1021/jm401456d
76336214 105564 0 None -19 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 529 13 3 6 4.8 CCCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c2)c2c1CC(C)(C)CC2 10.1021/jm401456d
CHEMBL3121996 105564 0 None -19 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 529 13 3 6 4.8 CCCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c2)c2c1CC(C)(C)CC2 10.1021/jm401456d
76325529 105746 0 None -12 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 522 11 3 8 4.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C2CCCCC2)n1 10.1021/jm4014696
CHEMBL3126590 105746 0 None -12 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 522 11 3 8 4.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C2CCCCC2)n1 10.1021/jm4014696
76314625 105777 0 None -251 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cnc(C4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126622 105777 0 None -251 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cnc(C4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
25192001 8059 0 None -2 4 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 413 12 4 4 3.5 CCCCCCCCc1ccc2c(c1)CC[C@@H](C(N)(CO)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1091103 8059 0 None -2 4 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 413 12 4 4 3.5 CCCCCCCCc1ccc2c(c1)CC[C@@H](C(N)(CO)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
57391921 69887 0 None -61 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1nc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938938 69887 0 None -61 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1nc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
57395370 69888 0 None 1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ncccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938939 69888 0 None 1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ncccc21 10.1016/j.bmcl.2011.10.085
57402391 69889 0 None -104 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938940 69889 0 None -104 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
57395371 69890 0 None -87 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccncc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938941 69890 0 None -87 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccncc21 10.1016/j.bmcl.2011.10.085
57395372 69891 0 None -13 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cccnc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938942 69891 0 None -13 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cccnc21 10.1016/j.bmcl.2011.10.085
57393649 69892 0 None -60 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)n2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938943 69892 0 None -60 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)n2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
57395373 69893 0 None -2 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2cc(C(F)(F)F)c(-c3ccccc3)cn2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938944 69893 0 None -2 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2cc(C(F)(F)F)c(-c3ccccc3)cn2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
57395374 69894 0 None 1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2cnc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938945 69894 0 None 1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2cnc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
57402392 69895 0 None -41 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccn3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938946 69895 0 None -41 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccn3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
57400586 69896 0 None -8 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3cccnc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938947 69896 0 None -8 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3cccnc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
57400587 69897 0 None -5 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccncc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938948 69897 0 None -5 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 423 3 1 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccncc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1016/j.bmcl.2011.10.085
56834955 69898 0 None -125 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 424 3 1 5 4.3 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)n2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938949 69898 0 None -125 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 424 3 1 5 4.3 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)n2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
57400588 69899 0 None -12 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 424 3 1 5 4.3 Cn1cc(C(=O)Nc2ccc(-c3ccccn3)c(C(F)(F)F)c2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938950 69899 0 None -12 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 424 3 1 5 4.3 Cn1cc(C(=O)Nc2ccc(-c3ccccn3)c(C(F)(F)F)c2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
57398897 69900 0 None -12 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 425 3 1 6 3.7 Cn1cc(C(=O)Nc2ccc(-c3ccccn3)c(C(F)(F)F)n2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
CHEMBL1938951 69900 0 None -12 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 425 3 1 6 3.7 Cn1cc(C(=O)Nc2ccc(-c3ccccn3)c(C(F)(F)F)n2)c(=O)c2cnccc21 10.1016/j.bmcl.2011.10.085
57570467 87590 0 None -147 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 466 10 2 5 5.9 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)o1 10.1021/ml300396r
CHEMBL2336063 87590 0 None -147 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 466 10 2 5 5.9 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)o1 10.1021/ml300396r
16737513 57353 0 None -11 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 379 8 1 4 4.8 CCCCOc1ccc2cc(-c3ccc(CN4CC(C(=O)O)C4)cc3)oc2c1 10.1021/ml100227q
CHEMBL1651709 57353 0 None -11 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 379 8 1 4 4.8 CCCCOc1ccc2cc(-c3ccc(CN4CC(C(=O)O)C4)cc3)oc2c1 10.1021/ml100227q
44125589 116397 0 None -100 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 457 7 2 7 4.6 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNC(CCC(=O)O)CO4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359851 116397 0 None -100 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 457 7 2 7 4.6 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNC(CCC(=O)O)CO4)no2)cc1Cl 10.1021/jm5010336
70694325 74973 0 None -7943 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 454 8 2 4 5.8 O=C(O)CNCCCc1ccc2oc(-c3ccc(-c4ccccc4)c(C(F)(F)F)c3)nc2c1 10.1016/j.bmcl.2012.04.095
CHEMBL2032428 74973 0 None -7943 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 454 8 2 4 5.8 O=C(O)CNCCCc1ccc2oc(-c3ccc(-c4ccccc4)c(C(F)(F)F)c3)nc2c1 10.1016/j.bmcl.2012.04.095
53323421 57399 0 None -75 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 461 6 1 5 5.3 CC(C)(c1ccccc1)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2n1 10.1021/ml100306h
CHEMBL1651860 57399 0 None -75 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 461 6 1 5 5.3 CC(C)(c1ccccc1)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2n1 10.1021/ml100306h
54576721 76045 0 None -3162 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 474 9 1 6 5.1 CCc1c(CCN2CC(C(=O)O)C2)cccc1-c1nsc(-c2ccc(CC(C)C)c(C#N)c2)n1 10.1021/jm2016107
CHEMBL2057286 76045 0 None -3162 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 474 9 1 6 5.1 CCc1c(CCN2CC(C(=O)O)C2)cccc1-c1nsc(-c2ccc(CC(C)C)c(C#N)c2)n1 10.1021/jm2016107
57522812 76447 0 None -10000 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 505 8 1 6 5.8 CCc1c(CN2CC(C(=O)O)C2)cccc1-c1nsc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1021/jm2016107
CHEMBL2059686 76447 0 None -10000 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 505 8 1 6 5.8 CCc1c(CN2CC(C(=O)O)C2)cccc1-c1nsc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1021/jm2016107
54576288 76448 0 None -25118 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 547 9 1 6 6.6 CCc1c(CCN2CCC(C(=O)O)CC2)cccc1-c1nsc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1021/jm2016107
CHEMBL2059687 76448 0 None -25118 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 547 9 1 6 6.6 CCc1c(CCN2CCC(C(=O)O)CC2)cccc1-c1nsc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1021/jm2016107
107970 1639 83 None -23 4 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2017.12.018
2407 1639 83 None -23 4 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2017.12.018
4167 1639 83 None -23 4 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2017.12.018
CHEMBL314854 1639 83 None -23 4 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2017.12.018
DB08868 1639 83 None -23 4 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2017.12.018
70689433 73175 0 None -10 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assay
ChEMBL 556 11 2 7 4.4 CCCCN(C(=O)c1ccc(C(F)(F)F)cc1)c1nnc(-c2cccc(S(=O)(=O)NCCC(=O)O)c2)s1 10.1016/j.bmcl.2012.02.016
CHEMBL2011735 73175 0 None -10 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assay
ChEMBL 556 11 2 7 4.4 CCCCN(C(=O)c1ccc(C(F)(F)F)cc1)c1nnc(-c2cccc(S(=O)(=O)NCCC(=O)O)c2)s1 10.1016/j.bmcl.2012.02.016
49842175 65957 0 None -19952 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 489 8 2 8 3.2 Cc1c(-c2noc(-c3ccc(OC(C)C)c(C#N)c3)n2)ccc2c1CCN(CC(=O)N[C@@H](C)CO)C2 10.1021/jm200609t
CHEMBL1836171 65957 0 None -19952 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 489 8 2 8 3.2 Cc1c(-c2noc(-c3ccc(OC(C)C)c(C#N)c3)n2)ccc2c1CCN(CC(=O)N[C@@H](C)CO)C2 10.1021/jm200609t
44129145 116387 0 None -398 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 462 8 1 8 4.1 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CN(CCCC(=O)O)CCO4)no2)cc1C#N 10.1021/jm5010336
CHEMBL3359841 116387 0 None -398 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 462 8 1 8 4.1 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CN(CCCC(=O)O)CCO4)no2)cc1C#N 10.1021/jm5010336
42636536 116399 0 None -2511 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 471 8 2 7 5.1 CC(C)Oc1ccc(-c2nc(-c3cccc4c3OCCNC4CCCC(=O)O)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359853 116399 0 None -2511 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 471 8 2 7 5.1 CC(C)Oc1ccc(-c2nc(-c3cccc4c3OCCNC4CCCC(=O)O)no2)cc1Cl 10.1021/jm5010336
76329073 105751 0 None -288 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C4CCCC4)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126596 105751 0 None -288 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C4CCCC4)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
46237047 8894 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 356 3 0 3 5.2 CC(C)/N=C1\S/C(=C\c2ccccc2Cl)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097527 8894 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 356 3 0 3 5.2 CC(C)/N=C1\S/C(=C\c2ccccc2Cl)C(=O)N1c1ccccc1 10.1021/jm100181s
25182909 6031 0 None -21 2 Human 6.6 pEC50 = 6.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 501 10 3 7 2.9 Cc1cc(S(=O)(=O)NCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL1080384 6031 0 None -21 2 Human 6.6 pEC50 = 6.6 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 501 10 3 7 2.9 Cc1cc(S(=O)(=O)NCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
69143673 104442 0 None -446 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 384 7 1 4 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)ccc1OCCO 10.1021/jm4014373
CHEMBL3103667 104442 0 None -446 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 384 7 1 4 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)ccc1OCCO 10.1021/jm4014373
76318055 105529 0 None -5 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 8 1 6 6.3 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OCCC(=O)O 10.1021/jm401456d
CHEMBL3121960 105529 0 None -5 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 8 1 6 6.3 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OCCC(=O)O 10.1021/jm401456d
46846902 139764 0 None -501 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 458 6 1 7 4.9 CC(C)(C)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
CHEMBL3798531 139764 0 None -501 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 458 6 1 7 4.9 CC(C)(C)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
44625753 87588 0 None -1862 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 477 10 2 5 5.7 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cn1 10.1021/ml300396r
CHEMBL2336061 87588 0 None -1862 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 477 10 2 5 5.7 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cn1 10.1021/ml300396r
44439851 145647 0 None -5248 3 Human 5.6 pEC50 = 5.6 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 403 6 1 6 4.6 Cc1cc([C@@H]2C[C@H]2C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL391581 145647 0 None -5248 3 Human 5.6 pEC50 = 5.6 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 403 6 1 6 4.6 Cc1cc([C@@H]2C[C@H]2C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
76310994 105776 0 None -2951 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 496 12 3 8 3.7 CCc1cc(-c2noc(-c3cnc(C(CC)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126621 105776 0 None -2951 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 496 12 3 8 3.7 CCc1cc(-c2noc(-c3cnc(C(CC)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
24956676 8522 0 None -2 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 5 1 4 5.3 CCCC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1094213 8522 0 None -2 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 5 1 4 5.3 CCCC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
44439851 145647 0 None -5248 3 Human 5.6 pEC50 = 5.6 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 403 6 1 6 4.6 Cc1cc([C@@H]2C[C@H]2C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL391581 145647 0 None -5248 3 Human 5.6 pEC50 = 5.6 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 403 6 1 6 4.6 Cc1cc([C@@H]2C[C@H]2C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
57395369 69885 0 None -6 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 485 5 1 6 4.5 CC1(C)SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
CHEMBL1938936 69885 0 None -6 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 485 5 1 6 4.5 CC1(C)SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
11452022 3596 39 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2011.10.085
6996 3596 39 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2011.10.085
CHEMBL366208 3596 39 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2011.10.085
68547259 139976 0 None -89 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 498 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(CC(C)C)nc(OC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3799872 139976 0 None -89 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 498 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(CC(C)C)nc(OC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
11452022 3596 39 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at recombinant human S1P3 receptor expressed in Chem-1 cells assessed as calcium flux measured for 180 secs by FLIPR assayAgonist activity at recombinant human S1P3 receptor expressed in Chem-1 cells assessed as calcium flux measured for 180 secs by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/acsmedchemlett.0c00631
6996 3596 39 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at recombinant human S1P3 receptor expressed in Chem-1 cells assessed as calcium flux measured for 180 secs by FLIPR assayAgonist activity at recombinant human S1P3 receptor expressed in Chem-1 cells assessed as calcium flux measured for 180 secs by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/acsmedchemlett.0c00631
CHEMBL366208 3596 39 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at recombinant human S1P3 receptor expressed in Chem-1 cells assessed as calcium flux measured for 180 secs by FLIPR assayAgonist activity at recombinant human S1P3 receptor expressed in Chem-1 cells assessed as calcium flux measured for 180 secs by FLIPR assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/acsmedchemlett.0c00631
11452022 3596 39 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2010.02.006
6996 3596 39 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2010.02.006
CHEMBL366208 3596 39 None -19 6 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2010.02.006
44422573 85556 0 None -10 4 Human 6.6 pEC50 = 6.6 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 370 12 4 3 3.4 CCCCCCCCc1ccc(NC(=O)[C@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
CHEMBL227851 85556 0 None -10 4 Human 6.6 pEC50 = 6.6 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 370 12 4 3 3.4 CCCCCCCCc1ccc(NC(=O)[C@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
16737679 57362 0 None -70 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4cc(Cc5ccccc5)ccc4o3)c(F)c2)C1 10.1021/ml100227q
CHEMBL1651717 57362 0 None -70 2 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4cc(Cc5ccccc5)ccc4o3)c(F)c2)C1 10.1021/ml100227q
53324301 57995 0 None -1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 4 4.3 O=C(O)C1CN(Cc2ccc(-n3cc4ccc(Cc5ccccc5)cc4n3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672557 57995 0 None -1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 4 4.3 O=C(O)C1CN(Cc2ccc(-n3cc4ccc(Cc5ccccc5)cc4n3)c(F)c2)C1 10.1021/ml100228m
24825339 91766 0 None -6309 3 Human 5.6 pEC50 = 5.6 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 392 7 1 7 3.8 Cc1nc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL241052 91766 0 None -6309 3 Human 5.6 pEC50 = 5.6 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 392 7 1 7 3.8 Cc1nc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C#N)c2)n1 10.1016/j.bmcl.2006.10.057
11567535 104437 0 None -602 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 400 8 1 5 4.5 COc1cc(OCCO)ccc1CCC(=O)c1sc(C)c2c1C[C@@H]1[C@H]2C1(C)C 10.1021/jm4014373
CHEMBL3103662 104437 0 None -602 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 400 8 1 5 4.5 COc1cc(OCCO)ccc1CCC(=O)c1sc(C)c2c1C[C@@H]1[C@H]2C1(C)C 10.1021/jm4014373
44565715 180443 0 None -3 4 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 498 12 4 5 4.5 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL475253 180443 0 None -3 4 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 498 12 4 5 4.5 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
11222939 67575 9 None -4 4 Human 7.5 pEC50 = 7.5 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1021/jm050242f
44438254 67575 9 None -4 4 Human 7.5 pEC50 = 7.5 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1021/jm050242f
CHEMBL190006 67575 9 None -4 4 Human 7.5 pEC50 = 7.5 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1 10.1021/jm050242f
11853338 104721 0 None -263 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 425 8 0 4 5.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCN(C)C 10.1021/jm4014373
CHEMBL3105491 104721 0 None -263 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 425 8 0 4 5.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCN(C)C 10.1021/jm4014373
44565739 178960 0 None -33 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 459 12 4 5 4.2 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
CHEMBL470511 178960 0 None -33 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 459 12 4 5 4.2 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
69263869 104709 0 None -660 4 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 436 6 1 5 6.0 CCc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1CCC(=O)O 10.1021/jm4014373
CHEMBL3105479 104709 0 None -660 4 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 436 6 1 5 6.0 CCc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1CCC(=O)O 10.1021/jm4014373
53318125 57392 0 None -20 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)cnc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651853 57392 0 None -20 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)cnc4s3)c(F)c2)C1 10.1021/ml100306h
68762699 105778 0 None -288 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 496 12 3 8 3.3 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1CC(C)C 10.1021/jm4014696
CHEMBL3126623 105778 0 None -288 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 496 12 3 8 3.3 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1CC(C)C 10.1021/jm4014696
57395262 71496 0 None -1071 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccccc3F)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935578 71496 0 None -1071 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccccc3F)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1962545 71496 0 None -1071 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccccc3F)ccc21 10.1016/j.bmcl.2011.11.048
76318200 105785 0 None -741 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 10 3 8 2.6 CCc1cc(-c2noc(-c3ccc(C(C)C)nc3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126630 105785 0 None -741 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 10 3 8 2.6 CCc1cc(-c2noc(-c3ccc(C(C)C)nc3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
127046095 139788 0 None -9 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.7 CCCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1C 10.1016/j.ejmech.2016.03.048
CHEMBL3798722 139788 0 None -9 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.7 CCCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1C 10.1016/j.ejmech.2016.03.048
57402284 71493 0 None -26915 2 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 437 9 1 3 5.2 CC[C@H](COc1ccc2c(c1)CCC(CN1CC(C(=O)O)C1)=C2C)Cc1ccc(F)cc1 10.1016/j.bmcl.2011.11.048
CHEMBL1935585 71493 0 None -26915 2 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 437 9 1 3 5.2 CC[C@H](COc1ccc2c(c1)CCC(CN1CC(C(=O)O)C1)=C2C)Cc1ccc(F)cc1 10.1016/j.bmcl.2011.11.048
CHEMBL1962534 71493 0 None -26915 2 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 437 9 1 3 5.2 CC[C@H](COc1ccc2c(c1)CCC(CN1CC(C(=O)O)C1)=C2C)Cc1ccc(F)cc1 10.1016/j.bmcl.2011.11.048
118716148 114882 0 None -19 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 443 9 4 7 2.6 N#Cc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341926 114882 0 None -19 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 443 9 4 7 2.6 N#Cc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
11452022 3596 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at SIP3 receptorAgonist activity at SIP3 receptor
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2012.04.095
6996 3596 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at SIP3 receptorAgonist activity at SIP3 receptor
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2012.04.095
CHEMBL366208 3596 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at SIP3 receptorAgonist activity at SIP3 receptor
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2012.04.095
10883396 3649 45 None 1 15 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
5283560 3649 45 None 1 15 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
911 3649 45 None 1 15 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
CHEMBL225155 3649 45 None 1 15 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
11452022 3596 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/jm050242f
6996 3596 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/jm050242f
CHEMBL366208 3596 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligandAgonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/jm050242f
11452022 3596 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS binding
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.ejmech.2012.02.022
6996 3596 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS binding
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.ejmech.2012.02.022
CHEMBL366208 3596 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS binding
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.ejmech.2012.02.022
11452022 3596 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assayAgonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/ml100301k
6996 3596 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assayAgonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/ml100301k
CHEMBL366208 3596 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assayAgonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/ml100301k
44217654 140095 0 None -1 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 552 15 3 8 4.2 CCCc1cc(CN(C)CC(C)C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
CHEMBL3800604 140095 0 None -1 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 552 15 3 8 4.2 CCCc1cc(CN(C)CC(C)C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
2924 1640 43 None -10 7 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor by GTPgammaS binding assayAgonist activity at human S1P3 receptor by GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acsmedchemlett.5b00448
44398069 1640 43 None -10 7 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor by GTPgammaS binding assayAgonist activity at human S1P3 receptor by GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acsmedchemlett.5b00448
9908268 1640 43 None -10 7 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor by GTPgammaS binding assayAgonist activity at human S1P3 receptor by GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acsmedchemlett.5b00448
CHEMBL114606 1640 43 None -10 7 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human S1P3 receptor by GTPgammaS binding assayAgonist activity at human S1P3 receptor by GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acsmedchemlett.5b00448
76314621 105743 0 None -18 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 510 13 3 8 4.0 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C(CC)CC)n1 10.1021/jm4014696
CHEMBL3126587 105743 0 None -18 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 510 13 3 8 4.0 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C(CC)CC)n1 10.1021/jm4014696
2924 1640 43 None -10 7 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting methodAgonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.0c01109
44398069 1640 43 None -10 7 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting methodAgonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.0c01109
9908268 1640 43 None -10 7 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting methodAgonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.0c01109
CHEMBL114606 1640 43 None -10 7 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting methodAgonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.0c01109
76322116 106082 0 None 54 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 421 12 4 4 3.2 CCc1ccc(CCCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
CHEMBL3133607 106082 0 None 54 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 421 12 4 4 3.2 CCc1ccc(CCCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
10883396 3649 45 None 1 15 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation countingAgonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/ml400194r
5283560 3649 45 None 1 15 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation countingAgonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/ml400194r
911 3649 45 None 1 15 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation countingAgonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/ml400194r
CHEMBL225155 3649 45 None 1 15 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation countingAgonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/ml400194r
44218604 105763 0 None -100 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 511 13 3 9 2.9 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1N(CC)CC 10.1021/jm4014696
CHEMBL3126608 105763 0 None -100 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 511 13 3 9 2.9 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cnc1N(CC)CC 10.1021/jm4014696
45377662 84117 0 None -1000 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 468 9 1 6 4.3 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207778 84117 0 None -1000 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 468 9 1 6 4.3 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
58390859 84129 0 None -338 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 484 9 1 6 4.8 CCCCN(C(=O)c1ccccc1Cl)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207791 84129 0 None -338 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 484 9 1 6 4.8 CCCCN(C(=O)c1ccccc1Cl)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
46866185 7332 0 None -15 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 321 12 2 3 4.2 CCCCCCCOc1ccc(CC[C@](C)(N)CC(=O)O)cc1 10.1016/j.bmcl.2010.01.118
CHEMBL1086172 7332 0 None -15 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 321 12 2 3 4.2 CCCCCCCOc1ccc(CC[C@](C)(N)CC(=O)O)cc1 10.1016/j.bmcl.2010.01.118
57394952 70905 0 None -144 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 447 7 1 7 5.1 Cc1cc(-c2nc(-c3csc(CN4CC(C(=O)O)C4)c3)no2)ccc1Oc1ccccc1 10.1016/j.bmcl.2011.12.019
CHEMBL1951158 70905 0 None -144 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 447 7 1 7 5.1 Cc1cc(-c2nc(-c3csc(CN4CC(C(=O)O)C4)c3)no2)ccc1Oc1ccccc1 10.1016/j.bmcl.2011.12.019
23121172 63435 0 None -301 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 367 12 2 3 4.6 C/C(=C\c1ccc(OCCCCc2ccccc2)cc1)CNCCC(=O)O 10.1016/j.bmcl.2011.05.029
CHEMBL1797506 63435 0 None -301 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 367 12 2 3 4.6 C/C(=C\c1ccc(OCCCCc2ccccc2)cc1)CNCCC(=O)O 10.1016/j.bmcl.2011.05.029
57570487 87609 0 None -199 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 460 10 2 5 5.5 C/C(=N\OCc1ccc(-c2ccco2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
CHEMBL2336083 87609 0 None -199 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 460 10 2 5 5.5 C/C(=N\OCc1ccc(-c2ccco2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
118716178 114897 0 None -23 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 448 10 4 8 1.7 COc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3342003 114897 0 None -23 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 448 10 4 8 1.7 COc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
76322119 106087 0 None -4 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 423 12 4 5 3.6 CCCCc1ccc(Oc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
CHEMBL3133612 106087 0 None -4 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 423 12 4 5 3.6 CCCCc1ccc(Oc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
46236272 8598 0 None 1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 398 3 1 4 5.5 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CCCC2)N1c1ccccc1 10.1021/jm100181s
CHEMBL1094834 8598 0 None 1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 398 3 1 4 5.5 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CCCC2)N1c1ccccc1 10.1021/jm100181s
46236517 9015 0 None -1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 1 4 5.5 Cc1cccc(C)c1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1098467 9015 0 None -1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 1 4 5.5 Cc1cccc(C)c1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
25072410 105749 0 None -162 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 495 10 3 9 2.4 CCc1cc(-c2noc(-c3cc(C)nc(N4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126593 105749 0 None -162 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 495 10 3 9 2.4 CCc1cc(-c2noc(-c3cc(C)nc(N4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76329076 105767 0 None -707 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3ccc(CC(C)C)c(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126612 105767 0 None -707 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3ccc(CC(C)C)c(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
11678855 134443 0 None -31 3 Human 7.5 pEC50 = 7.5 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 607 21 4 10 5.9 C[C@@](N)(CCc1ccc(OCCCCCCCCCCCNc2ccc([N+](=O)[O-])c3nonc23)cc1)COP(=O)(O)O 10.1016/j.bmcl.2005.09.038
CHEMBL371758 134443 0 None -31 3 Human 7.5 pEC50 = 7.5 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 607 21 4 10 5.9 C[C@@](N)(CCc1ccc(OCCCCCCCCCCCNc2ccc([N+](=O)[O-])c3nonc23)cc1)COP(=O)(O)O 10.1016/j.bmcl.2005.09.038
46236273 8520 0 None 1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 412 3 1 4 5.9 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CCCCC2)N1c1ccccc1 10.1021/jm100181s
CHEMBL1094193 8520 0 None 1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 412 3 1 4 5.9 O=C1/C(=C/c2ccc(O)c(Cl)c2)S/C(=N\C2CCCCC2)N1c1ccccc1 10.1021/jm100181s
25032056 105736 0 None -776 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.8 CCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1021/jm4014696
CHEMBL3126435 105736 0 None -776 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.8 CCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1021/jm4014696
46195467 149357 0 None -17 2 Human 6.5 pEC50 = 6.5 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 482 12 3 9 3.0 CCCOc1ccc(-c2nc(-c3cccc4c3CCN4CC(N)(CO)CO)no2)cc1OCCC nan
CHEMBL3945262 149357 0 None -17 2 Human 6.5 pEC50 = 6.5 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 482 12 3 9 3.0 CCCOc1ccc(-c2nc(-c3cccc4c3CCN4CC(N)(CO)CO)no2)cc1OCCC nan
46881876 5601 0 None -12 3 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 335 13 2 3 4.6 CCCCCCCOc1ccc(CC[C@](C)(N)CCC(=O)O)cc1 10.1016/j.bmcl.2010.01.118
CHEMBL1077288 5601 0 None -12 3 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 335 13 2 3 4.6 CCCCCCCOc1ccc(CC[C@](C)(N)CCC(=O)O)cc1 10.1016/j.bmcl.2010.01.118
127046992 140036 0 None -61 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 508 11 3 8 3.0 CCc1cc(-c2noc(-c3ccc(CN4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3800230 140036 0 None -61 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 508 11 3 8 3.0 CCc1cc(-c2noc(-c3ccc(CN4CCCC4)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
44547414 68343 0 None -2398 6 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at recombinant human S1P3 receptor expressed in HEK293 cells after 2 hrs by beta-arrestin assayAgonist activity at recombinant human S1P3 receptor expressed in HEK293 cells after 2 hrs by beta-arrestin assay
ChEMBL 499 5 1 5 5.2 O=C(O)CCC(=O)N1CCc2cc(-c3noc(-c4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)ccc21 10.1016/j.bmcl.2011.05.110
CHEMBL1916559 68343 0 None -2398 6 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at recombinant human S1P3 receptor expressed in HEK293 cells after 2 hrs by beta-arrestin assayAgonist activity at recombinant human S1P3 receptor expressed in HEK293 cells after 2 hrs by beta-arrestin assay
ChEMBL 499 5 1 5 5.2 O=C(O)CCC(=O)N1CCc2cc(-c3noc(-c4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)ccc21 10.1016/j.bmcl.2011.05.110
11852848 105567 0 None -186 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 499 9 3 8 3.7 CCc1cc(-c2noc(-c3scc4c3CCC(C)(C)C4)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121999 105567 0 None -186 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 499 9 3 8 3.7 CCc1cc(-c2noc(-c3scc4c3CCC(C)(C)C4)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
54576289 76449 0 None -12589 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 519 9 1 6 5.8 CCc1c(CCN2CC(C(=O)O)C2)cccc1-c1nsc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1021/jm2016107
CHEMBL2059688 76449 0 None -12589 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity against S1P3 receptor by cell based FRET assayAgonist activity against S1P3 receptor by cell based FRET assay
ChEMBL 519 9 1 6 5.8 CCc1c(CCN2CC(C(=O)O)C2)cccc1-c1nsc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1021/jm2016107
57505996 116418 1 None -7943 2 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 360 4 1 6 3.7 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCNC4)no2)cc1C#N 10.1021/jm5010336
CHEMBL3360364 116418 1 None -7943 2 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 360 4 1 6 3.7 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCNC4)no2)cc1C#N 10.1021/jm5010336
46236806 8729 0 None 3 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 322 3 0 3 4.6 CC(C)/N=C1\S/C(=C\c2ccccc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1095987 8729 0 None 3 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 322 3 0 3 4.6 CC(C)/N=C1\S/C(=C\c2ccccc2)C(=O)N1c1ccccc1 10.1021/jm100181s
68763522 105788 0 None -316 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cnc(CC(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126633 105788 0 None -316 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cnc(CC(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
24784418 105781 0 None -446 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 473 11 3 8 3.4 CCc1cc(-c2noc(-c3ccc(CC(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126626 105781 0 None -446 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 473 11 3 8 3.4 CCc1cc(-c2noc(-c3ccc(CC(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
11315809 71657 0 None -3801 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935576 71657 0 None -3801 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1963630 71657 0 None -3801 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
57570476 87597 0 None -1995 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 502 8 1 4 6.5 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CN2CC(C(=O)O)C2)c(C)c1 10.1021/ml300396r
CHEMBL2336070 87597 0 None -1995 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 502 8 1 4 6.5 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CN2CC(C(=O)O)C2)c(C)c1 10.1021/ml300396r
44217170 139748 0 None -446 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 482 11 3 8 2.5 CCc1cc(-c2noc(-c3ccc(CN(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3798420 139748 0 None -446 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 482 11 3 8 2.5 CCc1cc(-c2noc(-c3ccc(CN(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
25182776 147678 0 None -17 2 Human 4.5 pEC50 = 4.5 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 365 4 2 5 3.0 CN(c1cc(C(=O)Nc2ccc3c(c2)CC(=O)N3)ncn1)C1CCCCC1 nan
CHEMBL3931810 147678 0 None -17 2 Human 4.5 pEC50 = 4.5 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 365 4 2 5 3.0 CN(c1cc(C(=O)Nc2ccc3c(c2)CC(=O)N3)ncn1)C1CCCCC1 nan
25182901 6029 0 None -537 2 Human 5.5 pEC50 = 5.5 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 404 6 2 5 4.5 Cc1cc2[nH]ncc2cc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL1080382 6029 0 None -537 2 Human 5.5 pEC50 = 5.5 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 404 6 2 5 4.5 Cc1cc2[nH]ncc2cc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
25182901 6029 0 None -537 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 404 6 2 5 4.5 Cc1cc2[nH]ncc2cc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 10.1016/j.bmcl.2010.01.102
CHEMBL1080382 6029 0 None -537 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 404 6 2 5 4.5 Cc1cc2[nH]ncc2cc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 10.1016/j.bmcl.2010.01.102
68555865 105737 0 None -331 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(C)nc(CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126436 105737 0 None -331 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cc(C)nc(CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
59446971 154066 0 None -173 2 Human 5.5 pEC50 = 5.5 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 501 11 2 7 3.5 COCCNS(=O)(=O)c1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)c(C)c1 nan
CHEMBL3984678 154066 0 None -173 2 Human 5.5 pEC50 = 5.5 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 501 11 2 7 3.5 COCCNS(=O)(=O)c1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)c(C)c1 nan
11313781 58445 0 None -47 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 339 11 2 3 3.8 O=C(O)CCNC/C=C/c1ccc(OCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.01.029
11313781 58445 0 None -47 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 339 11 2 3 3.8 O=C(O)CCNC/C=C/c1ccc(OCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.05.029
CHEMBL1683045 58445 0 None -47 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 339 11 2 3 3.8 O=C(O)CCNC/C=C/c1ccc(OCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.01.029
CHEMBL1683045 58445 0 None -47 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 339 11 2 3 3.8 O=C(O)CCNC/C=C/c1ccc(OCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.05.029
11371585 63433 0 None -77 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 351 9 1 3 3.7 O=C(O)C1CN(C/C=C/c2ccc(OCCCc3ccccc3)cc2)C1 10.1016/j.bmcl.2011.05.029
CHEMBL1797504 63433 0 None -77 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 351 9 1 3 3.7 O=C(O)C1CN(C/C=C/c2ccc(OCCCc3ccccc3)cc2)C1 10.1016/j.bmcl.2011.05.029
46236520 8900 0 None -2 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 4 1 4 5.5 CCc1ccccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1097537 8900 0 None -2 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 4 1 4 5.5 CCc1ccccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
46236810 8974 0 None -1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 368 4 1 5 4.3 COc1cc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)ccc1O 10.1021/jm100181s
CHEMBL1098200 8974 0 None -1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 368 4 1 5 4.3 COc1cc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)ccc1O 10.1021/jm100181s
44412994 78320 0 None -3388 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 499 7 1 6 5.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C(F)(F)F)C(F)(F)F)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL210942 78320 0 None -3388 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 499 7 1 6 5.5 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C(F)(F)F)C(F)(F)F)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
118707198 113045 0 None -154 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 463 12 3 5 4.2 Cc1ccc(CCCC(=O)c2cc(C)c(COC[C@@](C)(N)COP(=O)(O)O)c(C)c2)cc1 10.1016/j.bmc.2014.05.035
CHEMBL3311353 113045 0 None -154 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 463 12 3 5 4.2 Cc1ccc(CCCC(=O)c2cc(C)c(COC[C@@](C)(N)COP(=O)(O)O)c(C)c2)cc1 10.1016/j.bmc.2014.05.035
11854090 104688 0 None -776 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 455 9 2 5 4.3 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(=O)NCCO 10.1021/jm4014373
CHEMBL3105245 104688 0 None -776 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 455 9 2 5 4.3 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(=O)NCCO 10.1021/jm4014373
16737507 57361 0 None -8 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4cc(Cc5ccccc5)ccc4o3)cc2F)C1 10.1021/ml100227q
CHEMBL1651716 57361 0 None -8 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4cc(Cc5ccccc5)ccc4o3)cc2F)C1 10.1021/ml100227q
46224767 199298 0 None -48 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human SIP3 receptor by [35S]GTPgammaS binding assayAgonist activity at human SIP3 receptor by [35S]GTPgammaS binding assay
ChEMBL 293 2 0 4 3.2 Cc1nn(C(=O)/C=C/c2ccncc2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1016/j.bmcl.2009.11.045
CHEMBL590383 199298 0 None -48 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human SIP3 receptor by [35S]GTPgammaS binding assayAgonist activity at human SIP3 receptor by [35S]GTPgammaS binding assay
ChEMBL 293 2 0 4 3.2 Cc1nn(C(=O)/C=C/c2ccncc2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1016/j.bmcl.2009.11.045
53324746 57393 0 None -15 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)cc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1651854 57393 0 None -15 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)cc4s3)c(F)c2)C1 10.1021/ml100228m
51346934 57996 32 None -83 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 450 6 1 4 5.3 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5F)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672558 57996 32 None -83 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 450 6 1 4 5.3 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5F)ccc4s3)c(F)c2)C1 10.1021/ml100228m
53324746 57393 0 None -15 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)cc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651854 57393 0 None -15 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 432 6 1 4 5.2 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)cc4s3)c(F)c2)C1 10.1021/ml100306h
72793790 104710 0 None -100 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 527 13 3 6 5.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNC(CC(=O)O)C(=O)O 10.1021/jm4014373
CHEMBL3105480 104710 0 None -100 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 527 13 3 6 5.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNC(CC(=O)O)C(=O)O 10.1021/jm4014373
76318445 106076 0 None -12 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 496 11 4 7 4.1 CCc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)c(Cl)c3)cc2)co1 10.1039/C3MD00079F
CHEMBL3133601 106076 0 None -12 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 496 11 4 7 4.1 CCc1nc(-c2ccc(Oc3ccc(CCC(N)(CO)COP(=O)(O)O)c(Cl)c3)cc2)co1 10.1039/C3MD00079F
46236932 9053 0 None 5 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 0 4 4.6 COc1cccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)c1 10.1021/jm100181s
CHEMBL1098770 9053 0 None 5 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 0 4 4.6 COc1cccc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)c1 10.1021/jm100181s
2924 1640 43 None -10 7 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.ejmech.2014.07.081
44398069 1640 43 None -10 7 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.ejmech.2014.07.081
9908268 1640 43 None -10 7 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.ejmech.2014.07.081
CHEMBL114606 1640 43 None -10 7 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.ejmech.2014.07.081
11676168 70950 12 None -316 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS binding
ChEMBL 422 11 3 5 3.3 Cc1ccc(CCCC(=O)c2ccc(CC[C@@](C)(N)COP(=O)(O)O)n2C)cc1 10.1016/j.ejmech.2012.02.022
CHEMBL1951588 70950 12 None -316 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO-K1 cells assessed as induction of GTPgammaS binding
ChEMBL 422 11 3 5 3.3 Cc1ccc(CCCC(=O)c2ccc(CC[C@@](C)(N)COP(=O)(O)O)n2C)cc1 10.1016/j.ejmech.2012.02.022
11676168 70950 12 None -316 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assayAgonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assay
ChEMBL 422 11 3 5 3.3 Cc1ccc(CCCC(=O)c2ccc(CC[C@@](C)(N)COP(=O)(O)O)n2C)cc1 10.1021/ml100301k
CHEMBL1951588 70950 12 None -316 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assayAgonist activity at human S1P3R expressed in CHO-K1 cells by [35S]GTPgammaS binding assay
ChEMBL 422 11 3 5 3.3 Cc1ccc(CCCC(=O)c2ccc(CC[C@@](C)(N)COP(=O)(O)O)n2C)cc1 10.1021/ml100301k
46236518 8898 0 None -4 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 1 4 5.5 Cc1cccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c1C 10.1021/jm100181s
CHEMBL1097535 8898 0 None -4 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 1 4 5.5 Cc1cccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c1C 10.1021/jm100181s
44219528 139697 0 None -66 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.7 CCCCN(C)Cc1ccc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1C 10.1016/j.ejmech.2016.03.048
CHEMBL3798068 139697 0 None -66 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.7 CCCCN(C)Cc1ccc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc1C 10.1016/j.ejmech.2016.03.048
25074253 105748 15 None -575 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)nc(N(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3126592 105748 15 None -575 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)nc(N(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
67172039 148990 0 None -3235 2 Human 5.5 pEC50 = 5.5 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 484 6 1 4 5.8 CC(C)Cc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1C(F)(F)F nan
CHEMBL3942289 148990 0 None -3235 2 Human 5.5 pEC50 = 5.5 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 484 6 1 4 5.8 CC(C)Cc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1C(F)(F)F nan
25074253 105748 15 None -575 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)nc(N(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126592 105748 15 None -575 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)nc(N(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
53322715 57989 0 None -1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 416 6 1 4 4.7 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4o3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672550 57989 0 None -1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 416 6 1 4 4.7 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5)ccc4o3)c(F)c2)C1 10.1021/ml100228m
118716143 114877 0 None -32 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 486 9 4 6 3.8 NC(CO)(CCc1ccc(-c2coc(-c3ccc(C(F)(F)F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341921 114877 0 None -32 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 486 9 4 6 3.8 NC(CO)(CCc1ccc(-c2coc(-c3ccc(C(F)(F)F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
127045963 139833 0 None -26 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 13 3 9 3.6 CCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c(C)c1C 10.1016/j.ejmech.2016.03.048
CHEMBL3799029 139833 0 None -26 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 530 13 3 9 3.6 CCCN(C)Cc1sc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c(C)c1C 10.1016/j.ejmech.2016.03.048
76318196 105761 0 None -446 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 12 3 8 3.1 CCc1cc(-c2noc(-c3ccnc(CCC(C)C)c3)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126606 105761 0 None -446 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 12 3 8 3.1 CCc1cc(-c2noc(-c3ccnc(CCC(C)C)c3)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm4014696
127046551 139696 0 None -1 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cnc(C)c(OC4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3798060 139696 0 None -1 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cnc(C)c(OC4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
25192005 7736 0 None -3 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1089004 7736 0 None -3 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
44219370 139729 0 None -93 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.3 CCCN(C)Cc1cc(C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
CHEMBL3798240 139729 0 None -93 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.3 CCCN(C)Cc1cc(C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
73774584 106093 0 None -7 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 443 10 4 5 3.9 NC(CO)(CCc1ccc(Oc2ccc(-c3ccccc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
CHEMBL3133706 106093 0 None -7 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 443 10 4 5 3.9 NC(CO)(CCc1ccc(Oc2ccc(-c3ccccc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
76318057 105544 0 None -190 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 416 9 2 5 4.4 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CCCC2 10.1021/jm401456d
CHEMBL3121976 105544 0 None -190 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 416 9 2 5 4.4 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CCCC2 10.1021/jm401456d
53320107 58006 0 None -79 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 466 6 1 4 5.9 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5cccc(Cl)c5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672568 58006 0 None -79 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 466 6 1 4 5.9 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5cccc(Cl)c5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
46195468 152517 0 None -5 2 Human 7.4 pEC50 = 7.4 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 454 10 3 9 2.2 CCOc1ccc(-c2nc(-c3ccc4c(c3)CN(CC(N)(CO)CO)C4)no2)cc1OCC nan
CHEMBL3971409 152517 0 None -5 2 Human 7.4 pEC50 = 7.4 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 454 10 3 9 2.2 CCOc1ccc(-c2nc(-c3ccc4c(c3)CN(CC(N)(CO)CO)C4)no2)cc1OCC nan
56835182 69883 0 None -30 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 485 6 1 6 4.5 CCC1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
CHEMBL1938934 69883 0 None -30 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 485 6 1 6 4.5 CCC1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
57404009 71663 0 None -977 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3cccc(F)c3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935577 71663 0 None -977 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3cccc(F)c3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1963645 71663 0 None -977 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 409 8 1 3 4.6 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3cccc(F)c3)ccc21 10.1016/j.bmcl.2011.11.048
76318446 106088 0 None -4 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 457 11 4 5 3.8 NC(CO)(CCc1ccc(Oc2ccc(Cc3ccccc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
CHEMBL3133613 106088 0 None -4 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 457 11 4 5 3.8 NC(CO)(CCc1ccc(Oc2ccc(Cc3ccccc3)cc2)cc1)COP(=O)(O)O 10.1039/C3MD00079F
76321773 105566 0 None -3019 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 517 12 3 7 3.8 CCc1cc(CCC(=O)c2sc(OC)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121998 105566 0 None -3019 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 517 12 3 7 3.8 CCc1cc(CCC(=O)c2sc(OC)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
11852952 105557 0 None -776 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 487 10 3 6 3.9 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121989 105557 0 None -776 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 487 10 3 6 3.9 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
76336361 105758 1 None -12882 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 10 3 8 2.6 CCc1cc(-c2noc(-c3ccnc(C(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126603 105758 1 None -12882 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 454 10 3 8 2.6 CCc1cc(-c2noc(-c3ccnc(C(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
66655211 167735 0 None -316 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 451 6 1 4 5.5 O=C(O)CCN1CCC2(CC1)COc1cc(SCc3c(Cl)cccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
CHEMBL4205124 167735 0 None -316 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 451 6 1 4 5.5 O=C(O)CCN1CCC2(CC1)COc1cc(SCc3c(Cl)cccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
CHEMBL4302786 167735 0 None -316 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assayAgonist activity at human S1P3 receptor expressed in CHO cells assessed as increase in calcium flux by aequorin-derived luminescence assay
ChEMBL 451 6 1 4 5.5 O=C(O)CCN1CCC2(CC1)COc1cc(SCc3c(Cl)cccc3Cl)ccc12 10.1016/j.bmcl.2017.12.018
118723864 116388 0 None -630 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 432 7 1 7 3.9 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CCC(=O)O)C4)no2)cc1C#N 10.1021/jm5010336
CHEMBL3359842 116388 0 None -630 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 432 7 1 7 3.9 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CCC(=O)O)C4)no2)cc1C#N 10.1021/jm5010336
46205775 8229 0 None -3 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 475 11 4 5 3.8 NC(CO)(CCc1ccc(-c2ccc(OCc3ccccc3)cc2F)cc1)COP(=O)(O)O 10.1021/jm901776q
CHEMBL1092272 8229 0 None -3 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 475 11 4 5 3.8 NC(CO)(CCc1ccc(-c2ccc(OCc3ccccc3)cc2F)cc1)COP(=O)(O)O 10.1021/jm901776q
46206105 8235 0 None -1 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 477 10 4 5 4.4 NC(CO)(CCc1ccc(-c2ccc(Sc3ccccc3)cc2F)cc1)COP(=O)(O)O 10.1021/jm901776q
CHEMBL1092286 8235 0 None -1 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 477 10 4 5 4.4 NC(CO)(CCc1ccc(-c2ccc(Sc3ccccc3)cc2F)cc1)COP(=O)(O)O 10.1021/jm901776q
11852237 104690 0 None -37 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 6 2 7 4.4 Cc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1OC[C@@H](O)CO 10.1021/jm4014373
CHEMBL3105247 104690 0 None -37 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 6 2 7 4.4 Cc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1OC[C@@H](O)CO 10.1021/jm4014373
70681384 74161 0 None -363 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human S1P3 receptor by [S35]GTPgammaS binding assayAgonist activity at human S1P3 receptor by [S35]GTPgammaS binding assay
ChEMBL 484 10 1 6 6.4 CCCc1cc(-c2cnc(-c3sc(CN4CC(C(=O)O)C4)cc3CC)s2)ccc1OC(C)C 10.1016/j.bmcl.2012.03.067
CHEMBL2022905 74161 0 None -363 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human S1P3 receptor by [S35]GTPgammaS binding assayAgonist activity at human S1P3 receptor by [S35]GTPgammaS binding assay
ChEMBL 484 10 1 6 6.4 CCCc1cc(-c2cnc(-c3sc(CN4CC(C(=O)O)C4)cc3CC)s2)ccc1OC(C)C 10.1016/j.bmcl.2012.03.067
11662328 91765 0 None -1318 3 Human 6.4 pEC50 = 6.4 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 448 7 1 5 5.8 Cc1cc(CC(C)C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
CHEMBL241050 91765 0 None -1318 3 Human 6.4 pEC50 = 6.4 Functional
Displacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cellsDisplacement of [35S]GTP-gamma-S from human S1P3 receptor expressed in CHO cells
ChEMBL 448 7 1 5 5.8 Cc1cc(CC(C)C(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2006.10.057
57570503 87589 0 None -1819 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 482 10 2 5 6.3 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)s1 10.1021/ml300396r
CHEMBL2336062 87589 0 None -1819 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 482 10 2 5 6.3 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)s1 10.1021/ml300396r
67414717 104433 0 None -288 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 397 7 1 4 5.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCN 10.1021/jm4014373
CHEMBL3103658 104433 0 None -288 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 397 7 1 4 5.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCN 10.1021/jm4014373
11501873 140147 0 None -2137 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 384 7 1 5 4.7 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(F)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL380253 140147 0 None -2137 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 384 7 1 5 4.7 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(F)c2)n1 10.1016/j.bmcl.2006.04.084
46846820 140052 0 None -4168 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4noc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
CHEMBL3800349 140052 0 None -4168 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4noc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
25182899 6123 0 None -33 3 Human 6.4 pEC50 = 6.4 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 350 7 2 5 3.2 CCCN(CC1CC1)c1cc(C(=O)Nc2ccc3[nH]ncc3c2)ncn1 nan
CHEMBL1080865 6123 0 None -33 3 Human 6.4 pEC50 = 6.4 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 350 7 2 5 3.2 CCCN(CC1CC1)c1cc(C(=O)Nc2ccc3[nH]ncc3c2)ncn1 nan
25182899 6123 0 None -33 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 350 7 2 5 3.2 CCCN(CC1CC1)c1cc(C(=O)Nc2ccc3[nH]ncc3c2)ncn1 10.1016/j.bmcl.2010.01.102
CHEMBL1080865 6123 0 None -33 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 350 7 2 5 3.2 CCCN(CC1CC1)c1cc(C(=O)Nc2ccc3[nH]ncc3c2)ncn1 10.1016/j.bmcl.2010.01.102
118716145 114879 0 None -16 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341923 114879 0 None -16 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
44565622 179340 0 None -5 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 428 11 4 5 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCC2CCCCC2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473562 179340 0 None -5 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 428 11 4 5 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCC2CCCCC2)cc1 10.1016/j.bmcl.2009.02.073
9969355 58441 0 None -26 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 369 14 2 3 4.5 O=C(O)CCNCCCc1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.01.029
CHEMBL1683041 58441 0 None -26 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 369 14 2 3 4.5 O=C(O)CCNCCCc1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.01.029
67416434 104722 0 None -630 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 411 8 1 4 5.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCN 10.1021/jm4014373
CHEMBL3105492 104722 0 None -630 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 411 8 1 4 5.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCN 10.1021/jm4014373
46236521 8927 0 None -7 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 406 3 1 4 5.6 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1Cl 10.1021/jm100181s
CHEMBL1097807 8927 0 None -7 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 406 3 1 4 5.6 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1Cl 10.1021/jm100181s
44199411 139838 0 None -165 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.7 CCCCN(C)Cc1cc(C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
CHEMBL3799086 139838 0 None -165 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 14 3 8 3.7 CCCCN(C)Cc1cc(C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
11597340 104398 0 None -3890 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 438 7 1 4 5.8 Cc1sc(C(=O)CCc2cc(Cl)c(OCCO)c(Cl)c2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
CHEMBL3102988 104398 0 None -3890 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 438 7 1 4 5.8 Cc1sc(C(=O)CCc2cc(Cl)c(OCCO)c(Cl)c2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
46236660 8963 0 None -3 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 402 4 1 5 4.9 COc1ccccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1098144 8963 0 None -3 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 402 4 1 5 4.9 COc1ccccc1N1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
76325530 105752 0 None -331 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)cc(N(CC)CC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126597 105752 0 None -331 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)cc(N(CC)CC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76336364 105775 0 None -4265 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 10 3 8 2.9 CCc1cc(-c2noc(-c3cnc(C(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126620 105775 0 None -4265 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 10 3 8 2.9 CCc1cc(-c2noc(-c3cnc(C(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
44422601 85581 0 None -11 5 Human 7.4 pEC50 = 7.4 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 398 14 4 3 4.2 CCCCCCCCCCc1ccc(NC(=O)[C@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
CHEMBL228139 85581 0 None -11 5 Human 7.4 pEC50 = 7.4 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 398 14 4 3 4.2 CCCCCCCCCCc1ccc(NC(=O)[C@H](N)CCP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
11854607 104714 0 None -346 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 485 10 3 6 3.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3105484 104714 0 None -346 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 485 10 3 6 3.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
56949140 147260 0 None -83 2 Human 6.4 pEC50 = 6.4 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 367 5 0 4 5.6 Clc1cc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)ccn1 nan
CHEMBL3928616 147260 0 None -83 2 Human 6.4 pEC50 = 6.4 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 367 5 0 4 5.6 Clc1cc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)ccn1 nan
68280743 147921 0 None -11 2 Human 6.4 pEC50 = 6.4 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 348 5 1 5 4.5 Nc1cc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)ccn1 nan
CHEMBL3933624 147921 0 None -11 2 Human 6.4 pEC50 = 6.4 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 348 5 1 5 4.5 Nc1cc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)ccn1 nan
25110406 1296 53 None -2238 4 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 409 9 2 7 3.8 OCCNC1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)OCC)OCC nan
2928 1296 53 None -2238 4 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 409 9 2 7 3.8 OCCNC1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)OCC)OCC nan
CHEMBL3922179 1296 53 None -2238 4 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 409 9 2 7 3.8 OCCNC1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)OCC)OCC nan
57570461 87613 0 None -1659 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 477 10 2 5 5.7 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)nc1 10.1021/ml300396r
CHEMBL2336087 87613 0 None -1659 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 477 10 2 5 5.7 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)nc1 10.1021/ml300396r
44218451 139617 0 None -1230 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 522 12 3 8 3.3 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN1CCCC1 10.1016/j.ejmech.2016.03.048
CHEMBL3797541 139617 0 None -1230 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 522 12 3 8 3.3 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN1CCCC1 10.1016/j.ejmech.2016.03.048
127047780 139706 0 None -14 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.3 CCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1C 10.1016/j.ejmech.2016.03.048
CHEMBL3798148 139706 0 None -14 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.3 CCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1C 10.1016/j.ejmech.2016.03.048
11854607 104714 0 None -346 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 485 10 3 6 3.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm4014373
CHEMBL3105484 104714 0 None -346 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 485 10 3 6 3.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm4014373
2924 1640 43 None -10 7 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1039/C3MD00079F
44398069 1640 43 None -10 7 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1039/C3MD00079F
9908268 1640 43 None -10 7 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1039/C3MD00079F
CHEMBL114606 1640 43 None -10 7 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1039/C3MD00079F
127045962 140015 0 None -676 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 502 11 3 9 2.9 CCc1cc(-c2noc(-c3sc(CN(C)C)c(C)c3C)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3800102 140015 0 None -676 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 502 11 3 9 2.9 CCc1cc(-c2noc(-c3sc(CN(C)C)c(C)c3C)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
52914984 147558 0 None -5011 2 Human 5.4 pEC50 = 5.4 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 nan
CHEMBL3930827 147558 0 None -5011 2 Human 5.4 pEC50 = 5.4 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 nan
11852953 105562 0 None -3630 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 501 11 3 6 4.1 CCc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121994 105562 0 None -3630 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 501 11 3 6 4.1 CCc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
11852049 105572 0 None -234 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 400 7 1 4 5.4 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCCO 10.1021/jm401456d
CHEMBL3122003 105572 0 None -234 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 400 7 1 4 5.4 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCCO 10.1021/jm401456d
11852142 105573 0 None -63 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 414 8 1 4 5.8 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCCCO 10.1021/jm401456d
CHEMBL3122004 105573 0 None -63 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 414 8 1 4 5.8 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCCCO 10.1021/jm401456d
66829275 139632 0 None -147 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 502 12 3 9 2.8 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)sc1CN(C)C 10.1016/j.ejmech.2016.03.048
CHEMBL3797647 139632 0 None -147 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 502 12 3 9 2.8 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)sc1CN(C)C 10.1016/j.ejmech.2016.03.048
11588811 4012 45 None -8 4 Human 6.4 pEC50 = 6.4 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 10.1016/j.bmc.2006.10.060
136212600 4012 45 None -8 4 Human 6.4 pEC50 = 6.4 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 10.1016/j.bmc.2006.10.060
3324 4012 45 None -8 4 Human 6.4 pEC50 = 6.4 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 10.1016/j.bmc.2006.10.060
CHEMBL228102 4012 45 None -8 4 Human 6.4 pEC50 = 6.4 Functional
Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assayActivity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 10.1016/j.bmc.2006.10.060
57391849 70918 0 None -1479 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 8 1 7 5.6 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3C)cc2)n1 10.1016/j.bmcl.2011.12.019
CHEMBL1951312 70918 0 None -1479 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 8 1 7 5.6 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3C)cc2)n1 10.1016/j.bmcl.2011.12.019
58344526 150128 4 None -28183 5 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 404 7 2 7 3.6 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NCCO)no2)cc1C#N nan
CHEMBL3951270 150128 4 None -28183 5 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 404 7 2 7 3.6 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NCCO)no2)cc1C#N nan
58390949 84115 0 None -81 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 442 10 2 6 4.0 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CNCC(=O)O)cc2)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207776 84115 0 None -81 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 442 10 2 6 4.0 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CNCC(=O)O)cc2)s1 10.1016/j.bmcl.2012.09.110
46236519 8899 0 None -2 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 1 4 5.5 Cc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c(C)c1 10.1021/jm100181s
CHEMBL1097536 8899 0 None -2 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 400 3 1 4 5.5 Cc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c(C)c1 10.1021/jm100181s
25031140 105643 0 None -229 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 496 12 3 8 3.7 CCc1cc(-c2noc(-c3cc(C)nc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3124957 105643 0 None -229 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 496 12 3 8 3.7 CCc1cc(-c2noc(-c3cc(C)nc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
11646599 77666 0 None -2290 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 380 7 1 5 4.8 Cc1cc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)ccc1OC(C)C 10.1016/j.bmcl.2006.04.084
CHEMBL208898 77666 0 None -2290 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 380 7 1 5 4.8 Cc1cc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)ccc1OC(C)C 10.1016/j.bmcl.2006.04.084
44412867 79742 0 None -1148 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 420 7 1 5 5.1 CCOc1ccc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)cc1C(F)(F)F 10.1016/j.bmcl.2006.04.084
CHEMBL211689 79742 0 None -1148 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 420 7 1 5 5.1 CCOc1ccc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)cc1C(F)(F)F 10.1016/j.bmcl.2006.04.084
57396699 70899 0 None -537 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 433 7 1 7 4.8 O=C(O)C1CN(Cc2cc(-c3noc(-c4ccc(Oc5ccccc5)cc4)n3)cs2)C1 10.1016/j.bmcl.2011.12.019
CHEMBL1951152 70899 0 None -537 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 433 7 1 7 4.8 O=C(O)C1CN(Cc2cc(-c3noc(-c4ccc(Oc5ccccc5)cc4)n3)cs2)C1 10.1016/j.bmcl.2011.12.019
127046866 139840 0 None -676 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 488 12 3 9 2.6 CCc1cc(-c2noc(-c3ccc(CN(C)CC)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3799109 139840 0 None -676 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 488 12 3 9 2.6 CCc1cc(-c2noc(-c3ccc(CN(C)CC)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
69144360 104443 0 None -478 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 404 7 1 4 5.2 Cc1sc(C(=O)CCc2ccc(OCCO)c(Cl)c2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
CHEMBL3103668 104443 0 None -478 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 404 7 1 4 5.2 Cc1sc(C(=O)CCc2ccc(OCCO)c(Cl)c2)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
67171242 148622 0 None -141 2 Human 5.3 pEC50 = 5.3 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 523 5 1 6 6.1 O=C(O)[C@H]1CCCN(Cc2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 nan
CHEMBL3939314 148622 0 None -141 2 Human 5.3 pEC50 = 5.3 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 523 5 1 6 6.1 O=C(O)[C@H]1CCCN(Cc2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 nan
44600645 57404 0 None -123 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 458 6 1 4 5.7 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)cc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651865 57404 0 None -123 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 458 6 1 4 5.7 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)cc4s3)c(F)c2)C1 10.1021/ml100306h
118716185 114904 0 None -245 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 11 4 7 2.6 CCCc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3342010 114904 0 None -245 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 11 4 7 2.6 CCCc1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
68553624 105741 0 None -234 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)nc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126585 105741 0 None -234 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)nc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
11540052 180567 0 None -33 4 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL475405 180567 0 None -33 4 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
11611053 77943 0 None -524 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 401 7 1 5 4.9 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(C(F)(F)C(C)C)cn2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL209567 77943 0 None -524 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 401 7 1 5 4.9 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(C(F)(F)C(C)C)cn2)n1 10.1016/j.bmcl.2006.04.084
44412936 138766 0 None -6606 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 405 8 1 6 4.8 CC[C@H](C)Oc1ccc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)cc1C#N 10.1016/j.bmcl.2006.04.084
CHEMBL378054 138766 0 None -6606 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 405 8 1 6 4.8 CC[C@H](C)Oc1ccc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)cc1C#N 10.1016/j.bmcl.2006.04.084
25182773 7626 0 None -26915 3 Human 4.3 pEC50 = 4.3 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 443 7 2 6 3.2 Cc1cc(S(N)(=O)=O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL1088177 7626 0 None -26915 3 Human 4.3 pEC50 = 4.3 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 443 7 2 6 3.2 Cc1cc(S(N)(=O)=O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
53322061 57396 0 None -2 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)nc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651857 57396 0 None -2 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)nc4s3)c(F)c2)C1 10.1021/ml100306h
44218131 139986 0 None -371 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN(C)C 10.1016/j.ejmech.2016.03.048
CHEMBL3799916 139986 0 None -371 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.7 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccc1CN(C)C 10.1016/j.ejmech.2016.03.048
16736754 57365 0 None -16 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 395 7 1 4 4.5 O=C(O)C1CN(Cc2ccc(-c3cc4cc(OCC5CC5)ccc4o3)c(F)c2)C1 10.1021/ml100227q
CHEMBL1651720 57365 0 None -16 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 395 7 1 4 4.5 O=C(O)C1CN(Cc2ccc(-c3cc4cc(OCC5CC5)ccc4o3)c(F)c2)C1 10.1021/ml100227q
58390878 84118 0 None -380 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 482 9 1 6 4.7 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CCC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207779 84118 0 None -380 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 482 9 1 6 4.7 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CCC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
53320363 58005 0 None -117 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 466 6 1 4 5.9 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5Cl)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672567 58005 0 None -117 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 466 6 1 4 5.9 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5Cl)ccc4s3)c(F)c2)C1 10.1021/ml100228m
11690483 104431 0 None -346 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 428 8 2 5 4.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OC[C@H](O)CO 10.1021/jm4014373
CHEMBL3103656 104431 0 None -346 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 428 8 2 5 4.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OC[C@H](O)CO 10.1021/jm4014373
118716184 114903 0 None -17 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 10 4 7 2.8 CC(C)c1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3342009 114903 0 None -17 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 10 4 7 2.8 CC(C)c1ccc(-n2cc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)nn2)cc1 10.1016/j.ejmech.2014.07.081
76314622 105744 0 None -50 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 11 3 8 3.3 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C2CCC2)n1 10.1021/jm4014696
CHEMBL3126588 105744 0 None -50 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 11 3 8 3.3 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C2CCC2)n1 10.1021/jm4014696
11452022 3596 39 None -19 6 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/jm200609t
6996 3596 39 None -19 6 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/jm200609t
CHEMBL366208 3596 39 None -19 6 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/jm200609t
44406009 72709 0 None 10 4 Human 8.3 pEC50 = 8.3 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 515 18 5 10 3.4 N[C@@H](COP(=O)(O)O)[C@H](O)/C=C/CCCCCCCCCCNc1ccc([N+](=O)[O-])c2nonc12 10.1016/j.bmcl.2005.09.038
CHEMBL199754 72709 0 None 10 4 Human 8.3 pEC50 = 8.3 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 515 18 5 10 3.4 N[C@@H](COP(=O)(O)O)[C@H](O)/C=C/CCCCCCCCCCNc1ccc([N+](=O)[O-])c2nonc12 10.1016/j.bmcl.2005.09.038
46881847 7058 0 None -6 4 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 373 13 3 4 3.8 CCCCCCCOc1ccc(CC[C@](C)(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.01.118
CHEMBL1084929 7058 0 None -6 4 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 373 13 3 4 3.8 CCCCCCCOc1ccc(CC[C@](C)(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2010.01.118
76336211 105530 0 None -4 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 511 11 2 7 5.9 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OCCNCCC(=O)O 10.1021/jm401456d
CHEMBL3121961 105530 0 None -4 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 511 11 2 7 5.9 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OCCNCCC(=O)O 10.1021/jm401456d
46236809 8731 0 None -1 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 3 1 4 4.6 Cc1cc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)ccc1O 10.1021/jm100181s
CHEMBL1095995 8731 0 None -1 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 3 1 4 4.6 Cc1cc(/C=C2\S/C(=N\C(C)C)N(c3ccccc3)C2=O)ccc1O 10.1021/jm100181s
127046743 139824 0 None -45 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 524 12 3 9 3.4 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(OC2CCCC2)n1 10.1016/j.ejmech.2016.03.020
CHEMBL3798969 139824 0 None -45 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 524 12 3 9 3.4 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(OC2CCCC2)n1 10.1016/j.ejmech.2016.03.020
44412971 138934 0 None -16595 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 445 7 1 6 4.9 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C(F)(F)F)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL378436 138934 0 None -16595 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 445 7 1 6 4.9 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C(F)(F)F)c(C#N)c2)n1 10.1016/j.bmcl.2006.04.084
57398802 71491 0 None -1659 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 391 8 1 3 4.4 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935575 71491 0 None -1659 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 391 8 1 3 4.4 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1962532 71491 0 None -1659 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 391 8 1 3 4.4 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OCCCc3ccccc3)ccc21 10.1016/j.bmcl.2011.11.048
44599207 3609 43 None -724 5 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 10.1021/ml300396r
5326 3609 43 None -724 5 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 10.1021/ml300396r
9289 3609 43 None -724 5 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 10.1021/ml300396r
CHEMBL2336071 3609 43 None -724 5 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 10.1021/ml300396r
DB12371 3609 43 None -724 5 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 10.1021/ml300396r
57404344 73176 0 None -398 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assay
ChEMBL 556 11 2 7 4.4 CCCCN(C(=O)c1ccc(C(F)(F)F)cc1)c1nnc(-c2ccc(S(=O)(=O)NCCC(=O)O)cc2)s1 10.1016/j.bmcl.2012.02.016
CHEMBL2011736 73176 0 None -398 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in HEK293T cells by Ca(2+) mobilization assay
ChEMBL 556 11 2 7 4.4 CCCCN(C(=O)c1ccc(C(F)(F)F)cc1)c1nnc(-c2ccc(S(=O)(=O)NCCC(=O)O)cc2)s1 10.1016/j.bmcl.2012.02.016
70681688 74981 0 None -3162 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 494 6 1 4 6.5 O=C(O)C1CCN(CCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
CHEMBL2032436 74981 0 None -3162 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 494 6 1 4 6.5 O=C(O)C1CCN(CCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
70685939 74982 0 None -630 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 508 7 1 4 6.9 O=C(O)C1CCN(CCCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
CHEMBL2032437 74982 0 None -630 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 508 7 1 4 6.9 O=C(O)C1CCN(CCCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)CC1 10.1016/j.bmcl.2012.04.095
44129298 116394 0 None -251 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 427 6 2 6 4.5 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNC4CC(=O)O)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359848 116394 0 None -251 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 427 6 2 6 4.5 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNC4CC(=O)O)no2)cc1Cl 10.1021/jm5010336
72793788 104723 0 None -741 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 425 9 1 4 5.8 CNCCCOc1c(C)cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc1C 10.1021/jm4014373
CHEMBL3105493 104723 0 None -741 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 425 9 1 4 5.8 CNCCCOc1c(C)cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc1C 10.1021/jm4014373
76329311 106086 0 None 1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 415 12 4 5 3.1 CCCCCCC1CCc2cc(CCC(N)(CO)COP(=O)(O)O)ccc2O1 10.1039/C3MD00079F
CHEMBL3133611 106086 0 None 1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 415 12 4 5 3.1 CCCCCCC1CCc2cc(CCC(N)(CO)COP(=O)(O)O)ccc2O1 10.1039/C3MD00079F
11697911 14219 0 None -97 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 441 12 4 5 3.4 CCCCOc1ccc(-c2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)c(F)c1 10.1021/jm901776q
CHEMBL1089557 14219 0 None -97 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 441 12 4 5 3.4 CCCCOc1ccc(-c2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)c(F)c1 10.1021/jm901776q
CHEMBL1199009 14219 0 None -97 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 441 12 4 5 3.4 CCCCOc1ccc(-c2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)c(F)c1 10.1021/jm901776q
127045708 140080 0 None -3981 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 444 7 1 7 4.7 CC(C)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
CHEMBL3800513 140080 0 None -3981 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 444 7 1 7 4.7 CC(C)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
46236661 8576 0 None -1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 402 4 1 5 4.9 COc1cccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c1 10.1021/jm100181s
CHEMBL1094699 8576 0 None -1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 402 4 1 5 4.9 COc1cccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c1 10.1021/jm100181s
24851766 105789 0 None -269 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cnc(CC(C)C)c(C)c3)n2)cc(C)c1OC[C@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126634 105789 0 None -269 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 482 11 3 8 3.0 CCc1cc(-c2noc(-c3cnc(CC(C)C)c(C)c3)n2)cc(C)c1OC[C@H](O)CNC(=O)CO 10.1021/jm4014696
44218479 140001 0 None -436 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 512 13 3 9 3.4 CCc1cc(-c2noc(-c3cc(OC)cc(C(CC)CC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800001 140001 0 None -436 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 512 13 3 9 3.4 CCc1cc(-c2noc(-c3cc(OC)cc(C(CC)CC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
11495124 104438 0 None -812 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 404 7 1 4 5.2 Cc1sc(C(=O)CCc2ccc(OCCO)cc2Cl)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
CHEMBL3103663 104438 0 None -812 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 404 7 1 4 5.2 Cc1sc(C(=O)CCc2ccc(OCCO)cc2Cl)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1021/jm4014373
59593534 104716 0 None -295 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 410 7 1 3 5.8 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1CCC(=O)O 10.1021/jm4014373
CHEMBL3105486 104716 0 None -295 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 410 7 1 3 5.8 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1CCC(=O)O 10.1021/jm4014373
25182754 152222 0 None -4 2 Human 5.3 pEC50 = 5.3 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 347 4 2 5 4.0 O=C(Nc1ccnc2ccccc12)c1cc(NC2CCCCC2)ncn1 nan
CHEMBL3968786 152222 0 None -4 2 Human 5.3 pEC50 = 5.3 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 347 4 2 5 4.0 O=C(Nc1ccnc2ccccc12)c1cc(NC2CCCCC2)ncn1 nan
76310993 105753 0 None -97 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(N(CC)CC)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126598 105753 0 None -97 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(N(CC)CC)cc(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
46236663 8526 0 None 1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 432 5 1 6 4.9 COc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c(OC)c1 10.1021/jm100181s
CHEMBL1094246 8526 0 None 1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 432 5 1 6 4.9 COc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)c(OC)c1 10.1021/jm100181s
67351486 105531 0 None -1949 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 475 12 3 6 3.8 Cc1cc(CCC(=O)c2sc(C)c(CC(C)C)c2C)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121962 105531 0 None -1949 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 475 12 3 6 3.8 Cc1cc(CCC(=O)c2sc(C)c(CC(C)C)c2C)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
76336213 105561 0 None -1096 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 487 11 3 6 3.8 CCc1cc(CCC(=O)c2scc3c2CCC(C)(C)C3)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121993 105561 0 None -1096 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 487 11 3 6 3.8 CCc1cc(CCC(=O)c2scc3c2CCC(C)(C)C3)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
25110382 146109 0 None -33113 5 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 366 6 1 6 4.2 CCOc1ccc(-c2nc(-c3cccc4c3CCC4O)no2)cc1OCC nan
CHEMBL3919445 146109 0 None -33113 5 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 366 6 1 6 4.2 CCOc1ccc(-c2nc(-c3cccc4c3CCC4O)no2)cc1OCC nan
23729229 105536 0 None -346 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 473 10 3 8 3.4 Cc1cc(-c2noc(-c3scc(CC(C)C)c3C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121967 105536 0 None -346 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 473 10 3 8 3.4 Cc1cc(-c2noc(-c3scc(CC(C)C)c3C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
46237177 8923 0 None 2 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 382 6 1 5 3.9 CC(C)/N=C1\S/C(=C\c2cccc(OCCO)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097802 8923 0 None 2 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 382 6 1 5 3.9 CC(C)/N=C1\S/C(=C\c2cccc(OCCO)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
46237051 8921 0 None 1 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 380 6 1 4 4.5 CC(C)/N=C1\S/C(=C\c2ccc(CCCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097800 8921 0 None 1 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 380 6 1 4 4.5 CC(C)/N=C1\S/C(=C\c2ccc(CCCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
44565716 179743 0 None -25 4 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 493 10 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
CHEMBL474418 179743 0 None -25 4 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 493 10 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
44565717 189530 0 None -7 4 Human 7.3 pEC50 = 7.3 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 479 9 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2010.02.098
CHEMBL514170 189530 0 None -7 4 Human 7.3 pEC50 = 7.3 Functional
Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation countingAntagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL 479 9 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2010.02.098
53317713 57993 0 None -5 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 416 6 1 4 4.7 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)cc4o3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672555 57993 0 None -5 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 416 6 1 4 4.7 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(Cc5ccccc5)cc4o3)c(F)c2)C1 10.1021/ml100228m
53326037 57395 0 None -1 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4cnc(Cc5ccccc5)cc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651856 57395 0 None -1 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 433 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3nc4cnc(Cc5ccccc5)cc4s3)c(F)c2)C1 10.1021/ml100306h
127046742 139927 0 None -50 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 12 3 9 3.0 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(OC2CCC2)n1 10.1016/j.ejmech.2016.03.020
CHEMBL3799580 139927 0 None -50 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 12 3 9 3.0 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(OC2CCC2)n1 10.1016/j.ejmech.2016.03.020
56949141 148136 0 None -48 2 Human 6.3 pEC50 = 6.3 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 348 5 1 5 4.5 Nc1ncccc1-c1noc(CCC2(c3ccccc3)CCCCC2)n1 nan
CHEMBL3935426 148136 0 None -48 2 Human 6.3 pEC50 = 6.3 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 348 5 1 5 4.5 Nc1ncccc1-c1noc(CCC2(c3ccccc3)CCCCC2)n1 nan
127046323 140014 0 None -79 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 11 3 8 2.8 CCc1cc(-c2noc(-c3cc(C)c(CN(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3800093 140014 0 None -79 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 11 3 8 2.8 CCc1cc(-c2noc(-c3cc(C)c(CN(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
11854857 104713 0 None -616 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 469 10 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNC(=O)CO 10.1021/jm4014373
CHEMBL3105483 104713 0 None -616 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 469 10 2 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNC(=O)CO 10.1021/jm4014373
57394329 70696 0 None -295 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 461 7 2 5 5.4 O=C(O)CCC(=O)Nc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
CHEMBL1950567 70696 0 None -295 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 461 7 2 5 5.4 O=C(O)CCC(=O)Nc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
66931911 139600 0 None -56 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.3 CCc1cc(-c2noc(-c3ccc(CN(CC)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3797436 139600 0 None -56 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 510 13 3 8 3.3 CCc1cc(-c2noc(-c3ccc(CN(CC)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
127048142 139832 0 None -173 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 525 13 3 9 2.9 CCc1cc(-c2noc(-c3cc(C)nc(CN(C)CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3799026 139832 0 None -173 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 525 13 3 9 2.9 CCc1cc(-c2noc(-c3cc(C)nc(CN(C)CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
70681813 75272 0 None -69 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 451 4 2 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cccc(CN)c21 10.1021/ml200252b
CHEMBL2037122 75272 0 None -69 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 451 4 2 4 4.9 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2cccc(CN)c21 10.1021/ml200252b
46881537 7325 0 None -169 2 Human 5.3 pEC50 = 5.3 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 475 12 3 7 2.4 CCCN(CC1CC1)c1cc(C(=O)Nc2ccc(S(=O)(=O)NCCC(=O)O)cc2C)ncn1 nan
CHEMBL1086157 7325 0 None -169 2 Human 5.3 pEC50 = 5.3 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 475 12 3 7 2.4 CCCN(CC1CC1)c1cc(C(=O)Nc2ccc(S(=O)(=O)NCCC(=O)O)cc2C)ncn1 nan
11854356 104689 0 None -169 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 475 9 1 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCNS(C)(=O)=O 10.1021/jm4014373
CHEMBL3105246 104689 0 None -169 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 475 9 1 5 4.7 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCNS(C)(=O)=O 10.1021/jm4014373
118716142 114876 0 None -61 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 452 9 4 6 3.4 NC(CO)(CCc1ccc(-c2coc(-c3ccc(Cl)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341920 114876 0 None -61 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 452 9 4 6 3.4 NC(CO)(CCc1ccc(-c2coc(-c3ccc(Cl)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
11852233 105558 0 None -467 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 501 12 3 6 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNCCC(=O)O 10.1021/jm401456d
CHEMBL3121990 105558 0 None -467 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 501 12 3 6 4.8 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCC(O)CNCCC(=O)O 10.1021/jm401456d
44217169 139867 0 None -44 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 13 3 8 3.5 CCc1cc(-c2noc(-c3ccc(CN(C)CC(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3799260 139867 0 None -44 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 524 13 3 8 3.5 CCc1cc(-c2noc(-c3ccc(CN(C)CC(C)C)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
76321897 105783 0 None -64 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccc(CC(C)C)nc3)n2)cc(C)c1OC[C@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126628 105783 0 None -64 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccc(CC(C)C)nc3)n2)cc(C)c1OC[C@H](O)CNC(=O)CO 10.1021/jm4014696
46237046 8893 0 None 1 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 336 3 0 3 4.9 Cc1ccccc1/C=C1\S/C(=N\C(C)C)N(c2ccccc2)C1=O 10.1021/jm100181s
CHEMBL1097526 8893 0 None 1 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 336 3 0 3 4.9 Cc1ccccc1/C=C1\S/C(=N\C(C)C)N(c2ccccc2)C1=O 10.1021/jm100181s
46237050 8934 0 None 1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 366 5 1 4 4.1 CC(C)/N=C1\S/C(=C\c2ccc(CCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097843 8934 0 None 1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 366 5 1 4 4.1 CC(C)/N=C1\S/C(=C\c2ccc(CCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
46236268 9008 0 None 1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 4 1 4 5.3 CCC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098447 9008 0 None 1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 4 1 4 5.3 CCC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
59202018 105532 0 None -75 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 447 12 3 6 3.2 Cc1cc(CCC(=O)c2ccc(CC(C)C)s2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121963 105532 0 None -75 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 447 12 3 6 3.2 Cc1cc(CCC(=O)c2ccc(CC(C)C)s2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
57570497 87594 0 None -2951 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 490 10 2 4 6.6 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(C)c1 10.1021/ml300396r
CHEMBL2336067 87594 0 None -2951 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 490 10 2 4 6.6 C/C(=N\OCc1ccc(C2CCCCC2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)c(C)c1 10.1021/ml300396r
44625666 87610 0 None -331 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 476 10 2 5 5.9 C/C(=N\OCc1ccc(-c2cccs2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
CHEMBL2336084 87610 0 None -331 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 476 10 2 5 5.9 C/C(=N\OCc1ccc(-c2cccs2)c(C(F)(F)F)c1)c1ccc(CNCCC(=O)O)cc1 10.1021/ml300396r
56948781 145651 0 None -17 2 Human 5.2 pEC50 = 5.2 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 368 5 0 3 5.9 Fc1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)cc1F nan
CHEMBL3915834 145651 0 None -17 2 Human 5.2 pEC50 = 5.2 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 368 5 0 3 5.9 Fc1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)cc1F nan
76336363 105771 0 None -630 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3ccc(N(CC)CC)c(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126616 105771 0 None -630 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3ccc(N(CC)CC)c(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
11853834 104711 0 None -398 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 485 11 3 6 4.2 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNCC(=O)O 10.1021/jm4014373
CHEMBL3105481 104711 0 None -398 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 485 11 3 6 4.2 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNCC(=O)O 10.1021/jm4014373
57508868 105549 0 None -380 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 430 9 2 5 4.6 CCc1sc(C(=O)CCc2cc(C)c(OCC(O)CO)c(C)c2)c2c1CC(C)CC2 10.1021/jm401456d
CHEMBL3121981 105549 0 None -380 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 430 9 2 5 4.6 CCc1sc(C(=O)CCc2cc(C)c(OCC(O)CO)c(C)c2)c2c1CC(C)CC2 10.1021/jm401456d
10904818 303 0 None -2 4 Human 8.2 pEC50 = 8.2 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 373 13 3 4 3.8 CCCCCCCOc1ccc(cc1)CC[C@](COP(=O)(O)O)(N)C 10.1016/j.bmcl.2005.09.038
2937 303 0 None -2 4 Human 8.2 pEC50 = 8.2 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 373 13 3 4 3.8 CCCCCCCOc1ccc(cc1)CC[C@](COP(=O)(O)O)(N)C 10.1016/j.bmcl.2005.09.038
CHEMBL382739 303 0 None -2 4 Human 8.2 pEC50 = 8.2 Functional
Binding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assayBinding potency at human S1P3 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 373 13 3 4 3.8 CCCCCCCOc1ccc(cc1)CC[C@](COP(=O)(O)O)(N)C 10.1016/j.bmcl.2005.09.038
118707195 113042 0 None -21 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 453 12 3 5 3.7 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)c(F)c2)cc1 10.1016/j.bmc.2014.05.035
CHEMBL3311350 113042 0 None -21 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in CHOK1 cell membranes by [35S]GTPgammaS binding assay
ChEMBL 453 12 3 5 3.7 Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(O)O)c(F)c2)cc1 10.1016/j.bmc.2014.05.035
57400521 70925 0 None -794 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 8 1 7 5.6 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3)c(C)c2)n1 10.1016/j.bmcl.2011.12.019
CHEMBL1951319 70925 0 None -794 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 475 8 1 7 5.6 CCc1cc(CN2CC(C(=O)O)C2)sc1-c1noc(-c2ccc(Oc3ccccc3)c(C)c2)n1 10.1016/j.bmcl.2011.12.019
53318790 57994 0 None -8 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 4 4.2 O=C(O)C1CN(Cc2ccc(-c3cn4ccc(Cc5ccccc5)cc4n3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672556 57994 0 None -8 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 4 4.2 O=C(O)C1CN(Cc2ccc(-c3cn4ccc(Cc5ccccc5)cc4n3)c(F)c2)C1 10.1021/ml100228m
118716181 114900 0 None -28 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 486 9 4 7 2.7 NC(CO)(CCc1ccc(-c2cn(-c3ccc(C(F)(F)F)cc3)nn2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3342006 114900 0 None -28 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 486 9 4 7 2.7 NC(CO)(CCc1ccc(-c2cn(-c3ccc(C(F)(F)F)cc3)nn2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
44199450 105780 1 None -295 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cnc(N(CC)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126625 105780 1 None -295 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cnc(N(CC)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76318198 105770 0 None -3090 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)c(N(CC)CC)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126615 105770 0 None -3090 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 12 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)c(N(CC)CC)cn3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
25154344 6540 0 None -20 3 Human 7.2 pEC50 = 7.2 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 515 11 3 7 3.3 Cc1cc(S(=O)(=O)NCCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
CHEMBL1082869 6540 0 None -20 3 Human 7.2 pEC50 = 7.2 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 515 11 3 7 3.3 Cc1cc(S(=O)(=O)NCCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 nan
25154344 6540 0 None -20 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 515 11 3 7 3.3 Cc1cc(S(=O)(=O)NCCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 10.1016/j.bmcl.2010.01.102
CHEMBL1082869 6540 0 None -20 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assayAgonist activity at S1P3 receptor expressed in CHO cells after 60 mins by [35S]-GTPgammaS binding assay
ChEMBL 515 11 3 7 3.3 Cc1cc(S(=O)(=O)NCCC(=O)O)ccc1NC(=O)c1cc(N(CC2CC2)C2CCCCC2)ncn1 10.1016/j.bmcl.2010.01.102
76325392 105548 0 None -154 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 470 9 2 5 5.5 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC1(CCCC1)CC2 10.1021/jm401456d
CHEMBL3121980 105548 0 None -154 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 470 9 2 5 5.5 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC1(CCCC1)CC2 10.1021/jm401456d
11682696 79945 0 None -562 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 396 8 1 6 4.5 COc1cc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)ccc1OC(C)C 10.1016/j.bmcl.2006.04.084
CHEMBL212580 79945 0 None -562 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 396 8 1 6 4.5 COc1cc(-c2nc(-c3ccc(CCC(=O)O)cc3C)no2)ccc1OC(C)C 10.1016/j.bmcl.2006.04.084
46846915 140013 0 None -15848 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 450 7 1 7 4.1 CC(C)Cc1onc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)c1C(F)(F)F 10.1021/acs.jmedchem.6b00089
CHEMBL3800091 140013 0 None -15848 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 450 7 1 7 4.1 CC(C)Cc1onc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)c1C(F)(F)F 10.1021/acs.jmedchem.6b00089
11568129 104403 0 None -776 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 428 8 2 5 4.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OC[C@@H](O)CO 10.1021/jm4014373
CHEMBL3102993 104403 0 None -776 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 428 8 2 5 4.5 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OC[C@@H](O)CO 10.1021/jm4014373
56835182 69883 0 None -30 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 485 6 1 6 4.5 CCC1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
CHEMBL1938934 69883 0 None -30 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 485 6 1 6 4.5 CCC1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
44565597 179287 0 None -6 4 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 436 12 4 5 3.2 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473156 179287 0 None -6 4 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 436 12 4 5 3.2 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
56948659 154070 0 None -30 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cell membranes after 45 mins by [35S] GTPgammaS binding based scintillation counting analysisAgonist activity at human S1P3 receptor expressed in CHO cell membranes after 45 mins by [35S] GTPgammaS binding based scintillation counting analysis
ChEMBL 332 5 0 3 5.6 c1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL3984700 154070 0 None -30 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cell membranes after 45 mins by [35S] GTPgammaS binding based scintillation counting analysisAgonist activity at human S1P3 receptor expressed in CHO cell membranes after 45 mins by [35S] GTPgammaS binding based scintillation counting analysis
ChEMBL 332 5 0 3 5.6 c1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)cc1 10.1021/acs.jmedchem.6b01575
56948659 154070 0 None -30 2 Human 6.2 pEC50 = 6.2 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 332 5 0 3 5.6 c1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)cc1 nan
CHEMBL3984700 154070 0 None -30 2 Human 6.2 pEC50 = 6.2 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with MULTIDROP. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the VELOCITY11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 ul) was added to each well.
ChEMBL 332 5 0 3 5.6 c1ccc(-c2noc(CCC3(c4ccccc4)CCCCC3)n2)cc1 nan
127046130 139915 0 None -144 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 402 6 1 7 3.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)on4)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
CHEMBL3799501 139915 0 None -144 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 402 6 1 7 3.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)on4)n3)cc2)C1 10.1021/acs.jmedchem.6b00089
54756908 65965 0 None -794 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 434 7 2 8 2.8 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(C(CO)CO)C4)no2)cc1C#N 10.1021/jm200609t
CHEMBL1836214 65965 0 None -794 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assayAgonist activity at human S1P3 receptor expressed in RBL cells assessed as [35S]GTPgammaS binding after 3 hrs by radiometric assay
ChEMBL 434 7 2 8 2.8 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(C(CO)CO)C4)no2)cc1C#N 10.1021/jm200609t
44129140 116422 0 None -251 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 376 4 1 7 3.5 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNCCO4)no2)cc1C#N 10.1021/jm5010336
CHEMBL3360368 116422 0 None -251 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 376 4 1 7 3.5 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNCCO4)no2)cc1C#N 10.1021/jm5010336
46881877 7105 0 None -9 4 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 359 13 2 5 3.8 CCCCCCCOc1ccc(CC[C@](C)(N)CCc2nnn[nH]2)cc1 10.1016/j.bmcl.2010.01.118
CHEMBL1085191 7105 0 None -9 4 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS bindingAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of [S35]GTPgammaS binding
ChEMBL 359 13 2 5 3.8 CCCCCCCOc1ccc(CC[C@](C)(N)CCc2nnn[nH]2)cc1 10.1016/j.bmcl.2010.01.118
72793811 104692 0 None -93 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 6 2 7 4.4 Cc1cc(-c2nnc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)o2)cc(C)c1OCC(O)CO 10.1021/jm4014373
CHEMBL3105249 104692 0 None -93 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 6 2 7 4.4 Cc1cc(-c2nnc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)o2)cc(C)c1OCC(O)CO 10.1021/jm4014373
72793822 104708 0 None -15 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 8 3 8 3.5 Cc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3105478 104708 0 None -15 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 8 3 8 3.5 Cc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
66829256 140012 0 None -741 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 488 11 3 9 2.6 CCc1cc(-c2noc(-c3cc(C)c(CN(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3800086 140012 0 None -741 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 488 11 3 9 2.6 CCc1cc(-c2noc(-c3cc(C)c(CN(C)C)s3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
25182913 148299 0 None -34 2 Human 6.2 pEC50 = 6.2 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 378 6 2 5 4.0 CC(C)CN(c1cc(C(=O)Nc2ccc3[nH]ncc3c2)ncn1)C1CCCC1 nan
CHEMBL3936796 148299 0 None -34 2 Human 6.2 pEC50 = 6.2 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 378 6 2 5 4.0 CC(C)CN(c1cc(C(=O)Nc2ccc3[nH]ncc3c2)ncn1)C1CCCC1 nan
46237048 8895 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 0 4 4.6 COc1ccccc1/C=C1\S/C(=N\C(C)C)N(c2ccccc2)C1=O 10.1021/jm100181s
CHEMBL1097528 8895 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 0 4 4.6 COc1ccccc1/C=C1\S/C(=N\C(C)C)N(c2ccccc2)C1=O 10.1021/jm100181s
11405953 63428 0 None -44 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 367 13 2 3 4.6 O=C(O)CCNC/C=C/c1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.05.029
CHEMBL1797499 63428 0 None -44 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 367 13 2 3 4.6 O=C(O)CCNC/C=C/c1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.05.029
76336569 106081 0 None -9 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 435 13 4 4 3.5 CCCCc1ccc(CCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
CHEMBL3133606 106081 0 None -9 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay
ChEMBL 435 13 4 4 3.5 CCCCc1ccc(CCc2ccc(CCC(N)(CO)COP(=O)(O)O)cc2)cc1 10.1039/C3MD00079F
46236665 8528 0 None -1 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 4 1 4 4.9 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1Cc1ccccc1 10.1021/jm100181s
CHEMBL1094248 8528 0 None -1 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 4 1 4 4.9 CC(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1Cc1ccccc1 10.1021/jm100181s
53320088 57992 0 None -52 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4ccc(Cc5ccccc5)cc4o3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672554 57992 0 None -52 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 415 6 1 3 5.3 O=C(O)C1CN(Cc2ccc(-c3cc4ccc(Cc5ccccc5)cc4o3)c(F)c2)C1 10.1021/ml100228m
46237052 8798 0 None -1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 396 7 1 5 4.3 CC(C)/N=C1\S/C(=C\c2ccc(OCCCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1096676 8798 0 None -1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 396 7 1 5 4.3 CC(C)/N=C1\S/C(=C\c2ccc(OCCCO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
46846899 139946 0 None -2511 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 458 9 1 7 4.9 CCCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
CHEMBL3799701 139946 0 None -2511 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 458 9 1 7 4.9 CCCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
53322735 57997 0 None -33 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 450 6 1 4 5.3 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5cccc(F)c5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672559 57997 0 None -33 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 450 6 1 4 5.3 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5cccc(F)c5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
49872066 139810 0 None -95 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 524 11 3 9 3.6 CCc1cc(-c2noc(-c3cc(OC)nc(C4CCCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3798839 139810 0 None -95 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 524 11 3 9 3.6 CCc1cc(-c2noc(-c3cc(OC)nc(C4CCCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
72793822 104708 0 None -15 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 8 3 8 3.5 Cc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm4014373
CHEMBL3105478 104708 0 None -15 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 497 8 3 8 3.5 Cc1cc(-c2noc(-c3sc(C)c4c3C[C@@H]3[C@H]4C3(C)C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm4014373
45377797 84116 0 None -288 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 456 11 2 6 4.4 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CNCCC(=O)O)cc2)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207777 84116 0 None -288 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 456 11 2 6 4.4 CCCCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CNCCC(=O)O)cc2)s1 10.1016/j.bmcl.2012.09.110
76329075 105759 0 None -380 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 12 3 8 2.9 CCCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/jm4014696
CHEMBL3126604 105759 0 None -380 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 12 3 8 2.9 CCCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/jm4014696
127046548 139603 0 None -234 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cnc(C4CCCC4)c(OC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3797447 139603 0 None -234 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cnc(C4CCCC4)c(OC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
49872065 139630 0 None -117 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)nc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3797626 139630 0 None -117 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)nc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
44599687 70691 0 None -194 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 447 8 2 5 5.9 O=C(O)CCCNc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
CHEMBL1950562 70691 0 None -194 2 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 447 8 2 5 5.9 O=C(O)CCCNc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
23121435 63430 0 None -301 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 387 12 2 3 4.8 O=C(O)CCNC/C=C/c1ccc(OCCCCc2ccccc2)cc1Cl 10.1016/j.bmcl.2011.05.029
CHEMBL1797501 63430 0 None -301 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 387 12 2 3 4.8 O=C(O)CCNC/C=C/c1ccc(OCCCCc2ccccc2)cc1Cl 10.1016/j.bmcl.2011.05.029
11397995 87595 0 None -10232 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 504 11 2 4 6.8 CCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CNCCC(=O)O 10.1021/ml300396r
CHEMBL2336068 87595 0 None -10232 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assayAgonist activity at human S1P3 receptor transfected in CHO cells incubated for 10 to 15 mins prior to GTPgamma35S addition measured after 120 mins by GTPgamma35S binding assay
ChEMBL 504 11 2 4 6.8 CCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CNCCC(=O)O 10.1021/ml300396r
46846900 139595 0 None -1288 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 458 8 1 7 4.8 CC(C)Cc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
CHEMBL3797415 139595 0 None -1288 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 458 8 1 7 4.8 CC(C)Cc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccc1 10.1021/acs.jmedchem.6b00089
76325522 105734 0 None -7413 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 480 10 3 8 3.2 CCc1cc(-c2noc(-c3ccnc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126433 105734 0 None -7413 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 480 10 3 8 3.2 CCc1cc(-c2noc(-c3ccnc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
16657820 105535 0 None -147 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 487 10 3 8 3.7 Cc1cc(-c2noc(-c3sc(C)c(CC(C)C)c3C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121966 105535 0 None -147 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 487 10 3 8 3.7 Cc1cc(-c2noc(-c3sc(C)c(CC(C)C)c3C)n2)cc(C)c1OCC(O)CNC(=O)CO 10.1021/jm401456d
57390144 69881 0 None -2 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 457 5 1 6 3.8 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C(=O)N5CCSC5)cc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.10.069
CHEMBL1938932 69881 0 None -2 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 457 5 1 6 3.8 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C(=O)N5CCSC5)cc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.10.069
11853832 104394 0 None -1548 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 471 11 3 6 4.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNCCO 10.1021/jm4014373
CHEMBL3102984 104394 0 None -1548 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 471 11 3 6 4.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(O)CNCCO 10.1021/jm4014373
76325532 105760 0 None -3801 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccnc(CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126605 105760 0 None -3801 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccnc(CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
25182920 144228 0 None -16 2 Human 6.1 pEC50 = 6.1 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 465 11 2 7 3.9 COC(=O)CCNCc1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)cc1 nan
CHEMBL3904549 144228 0 None -16 2 Human 6.1 pEC50 = 6.1 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 465 11 2 7 3.9 COC(=O)CCNCc1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)cc1 nan
11853337 104719 0 None -301 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 411 8 1 4 5.4 CNCCOc1c(C)cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc1C 10.1021/jm4014373
CHEMBL3105489 104719 0 None -301 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 411 8 1 4 5.4 CNCCOc1c(C)cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc1C 10.1021/jm4014373
23121338 63436 0 None -134 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 379 11 2 3 4.5 O=C(O)CCNCC1=Cc2ccc(OCCCCc3ccccc3)cc2CC1 10.1016/j.bmcl.2011.05.029
CHEMBL1797507 63436 0 None -134 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 379 11 2 3 4.5 O=C(O)CCNCC1=Cc2ccc(OCCCCc3ccccc3)cc2CC1 10.1016/j.bmcl.2011.05.029
44125588 116396 0 None -158 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 429 5 2 7 3.8 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNC(C(=O)O)CO4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3359850 116396 0 None -158 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 429 5 2 7 3.8 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CNC(C(=O)O)CO4)no2)cc1Cl 10.1021/jm5010336
70694328 74985 0 None -1995 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 466 6 1 4 5.7 O=C(O)C1CN(CCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
CHEMBL2032440 74985 0 None -1995 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assayAgonist activity at human SIP3 receptor assessed as calcium mobilization by GeneBLAzer assay
ChEMBL 466 6 1 4 5.7 O=C(O)C1CN(CCc2ccc3oc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)nc3c2)C1 10.1016/j.bmcl.2012.04.095
44128987 116393 0 None -1000 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 460 8 1 7 4.3 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CCCC(=O)O)CC4)no2)cc1C#N 10.1021/jm5010336
CHEMBL3359847 116393 0 None -1000 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 460 8 1 7 4.3 CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(CCCC(=O)O)CC4)no2)cc1C#N 10.1021/jm5010336
44128745 116417 0 None -3981 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 374 4 1 6 3.8 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNCC4)no2)cc1C#N 10.1021/jm5010336
CHEMBL3360363 116417 0 None -3981 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 374 4 1 6 3.8 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CCNCC4)no2)cc1C#N 10.1021/jm5010336
44125469 116430 0 None -25 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 427 7 1 6 4.6 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CN(CCC(=O)O)C4)no2)cc1Cl 10.1021/jm5010336
CHEMBL3360376 116430 0 None -25 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 minsAgonist activity at human S1P3R expressed in RBL membranes assessed as [35S]GTPgammaS binding after 30 mins
ChEMBL 427 7 1 6 4.6 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CN(CCC(=O)O)C4)no2)cc1Cl 10.1021/jm5010336
44217502 139978 0 None -7 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 538 14 3 8 3.8 CCc1cc(CN(C)CC(C)C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
CHEMBL3799888 139978 0 None -7 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 538 14 3 8 3.8 CCc1cc(CN(C)CC(C)C)cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)c1 10.1016/j.ejmech.2016.03.048
76314474 105570 0 None -1 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 527 10 3 8 4.3 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3122001 105570 0 None -1 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 527 10 3 8 4.3 CCc1cc(-c2noc(-c3sc(CC)c4c3CCC(C)(C)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
45376041 84124 0 None -36 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 482 9 1 6 4.6 CC(C)CCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207785 84124 0 None -36 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 482 9 1 6 4.6 CC(C)CCN(C(=O)c1ccccc1F)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2)s1 10.1016/j.bmcl.2012.09.110
57398468 70895 0 None -123 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 491 6 1 7 5.7 O=C(O)C1CN(Cc2cc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cs2)C1 10.1016/j.bmcl.2011.12.019
CHEMBL1951147 70895 0 None -123 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 491 6 1 7 5.7 O=C(O)C1CN(Cc2cc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cs2)C1 10.1016/j.bmcl.2011.12.019
127046399 139643 0 None -1122 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)cc(C4CCCC4)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3797747 139643 0 None -1122 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3cc(OC)cc(C4CCCC4)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
24957029 8827 0 None -2 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 4 1 4 5.2 CCC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
CHEMBL1096872 8827 0 None -2 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 4 1 4 5.2 CCC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
127048102 139913 0 None -181 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 511 13 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)nc(CN(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3799493 139913 0 None -181 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 511 13 3 9 2.7 CCc1cc(-c2noc(-c3cc(C)nc(CN(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
76314473 105547 0 None -741 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 442 9 2 5 4.7 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC1(CC2)CC1 10.1021/jm401456d
CHEMBL3121979 105547 0 None -741 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 442 9 2 5 4.7 CCc1sc(C(=O)CCc2cc(C)c(OC[C@@H](O)CO)c(C)c2)c2c1CC1(CC2)CC1 10.1021/jm401456d
56835064 71495 0 None -14791 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 439 8 1 3 5.3 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@@H](C)Cc3ccc(Cl)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935587 71495 0 None -14791 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 439 8 1 3 5.3 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@@H](C)Cc3ccc(Cl)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1962536 71495 0 None -14791 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 439 8 1 3 5.3 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@@H](C)Cc3ccc(Cl)cc3)ccc21 10.1016/j.bmcl.2011.11.048
53235405 145094 0 None -6760 2 Human 5.1 pEC50 = 5.1 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 404 6 1 5 4.4 CCCc1ccc(-c2onc3c2COc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1 nan
CHEMBL3911661 145094 0 None -6760 2 Human 5.1 pEC50 = 5.1 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 404 6 1 5 4.4 CCCc1ccc(-c2onc3c2COc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1 nan
46236402 8597 0 None -14 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 336 4 1 4 3.9 C=CCN1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
CHEMBL1094831 8597 0 None -14 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 336 4 1 4 3.9 C=CCN1C(=O)/C(=C/c2ccc(O)c(Cl)c2)S/C1=N\C(C)C 10.1021/jm100181s
118716153 114888 0 None -15 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 450 10 4 6 2.8 NC(CO)(CCc1ccc(-c2coc(Cc3ccc(F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341931 114888 0 None -15 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 450 10 4 6 2.8 NC(CO)(CCc1ccc(-c2coc(Cc3ccc(F)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
46886019 8233 0 None -45 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 457 10 4 5 4.2 Cc1ccc(Oc2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)cc1 10.1021/jm901776q
CHEMBL1092284 8233 0 None -45 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilizationAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization
ChEMBL 457 10 4 5 4.2 Cc1ccc(Oc2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)cc1 10.1021/jm901776q
76314472 105543 0 None -45 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 529 10 3 9 3.7 CCc1cc(-c2noc(-c3sc(OC)c4c3CCC(C)(C)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
CHEMBL3121975 105543 0 None -45 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 529 10 3 9 3.7 CCc1cc(-c2noc(-c3sc(OC)c4c3CCC(C)(C)C4)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm401456d
57399546 70697 0 None -1380 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 476 7 3 6 4.3 N[C@H](CC(=O)O)C(=O)Nc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
CHEMBL1950568 70697 0 None -1380 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 476 7 3 6 4.3 N[C@H](CC(=O)O)C(=O)Nc1ccc(-c2nc3ccc(C4(c5ccccc5)CC4)nc3s2)c(F)c1 10.1016/j.bmcl.2011.12.073
44600643 57403 0 None -25 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 501 6 1 5 6.3 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CCCCC5)nc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651864 57403 0 None -25 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 501 6 1 5 6.3 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CCCCC5)nc4s3)c(F)c2)C1 10.1021/ml100306h
11853579 104393 0 None -616 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 455 11 2 5 5.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNCCO 10.1021/jm4014373
CHEMBL3102983 104393 0 None -616 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 455 11 2 5 5.1 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCCNCCO 10.1021/jm4014373
118716147 114881 0 None -19 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 11 4 6 3.7 CCCc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341925 114881 0 None -19 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 460 11 4 6 3.7 CCCc1ccc(-c2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
59446831 145344 0 None -2 2 Human 7.1 pEC50 = 7.1 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 500 11 2 7 3.9 O=C(O)CCCS(=O)(=O)c1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)cc1 nan
CHEMBL3913491 145344 0 None -2 2 Human 7.1 pEC50 = 7.1 Functional
35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).35S-GTPgammaS Binding: Measurements of 35S-GTPgammaS Binding: Membranes (1 to 10 ug protein) prepared as described above, were incubated in 96-well Scintiplates (PerkinElmer) with test compounds diluted in DMSO, in 180 ul of 20 mM HEPES, pH 7.4, 10 mM MgCl2, 2 ug/well Saponin, 0.2% fatty acid free BSA (Assay buffer), 140 mM NaCl and 1.7 uM GDP. The assay was initiated with the addition of 20 ul of 1.5 nM [35S]-GTPgammaS (1100 Ci/mmol; GE Healthcare) in assay buffer. After 60 min incubation at 30° C. on a shaker, plates were centrifuged for 10 min at 2000 RPM. Supernatant was discarded and membrane bound radioactivity was measured on a PerkinElmer 1450 MicroBeta counter. Triplicate samples were averaged and expressed as % response relative to S1P activation in absence of compound (n=2).
ChEMBL 500 11 2 7 3.9 O=C(O)CCCS(=O)(=O)c1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)cc1 nan
46846913 139679 0 None -2818 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 424 9 1 7 4.1 CCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1CC(C)C 10.1021/acs.jmedchem.6b00089
CHEMBL3797951 139679 0 None -2818 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 424 9 1 7 4.1 CCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1CC(C)C 10.1021/acs.jmedchem.6b00089
67168742 144761 0 None -3235 2 Human 5.1 pEC50 = 5.1 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 520 5 2 7 5.0 N#CC1(NC(=O)C(O)c2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)CC1 nan
CHEMBL3909064 144761 0 None -3235 2 Human 5.1 pEC50 = 5.1 Functional
GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.GTPgammaS Binding Assay: Compounds were loaded in a 384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Membranes prepared from S1P1/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 ul/well, final protein 3 ug/well) with multidrop. [35S]GTP (1250 Ci/mmol, Perkin Elmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl2, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 uM GDP, 0.1% fatty acid free BSA, and 10 ug/ml Saponin to 0.4 nM. 40 ul of the [35S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to Millipore 384-well FB filter plates via the Velocity11 Vprep liquid handler. The filter plate was washed with water 4 times by using the manifold Embla plate washer and dried at 60° C. for 45 min. MicroScint 20 scintillation fluid (30 u) was added to each well.
ChEMBL 520 5 2 7 5.0 N#CC1(NC(=O)C(O)c2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)CC1 nan
11852636 105576 0 None -1380 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 399 7 1 4 5.3 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCCN 10.1021/jm401456d
CHEMBL3122007 105576 0 None -1380 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as membrane-bound 35S-GTPgammaS incubated 30 mins prior to substrate addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 399 7 1 4 5.3 Cc1cc(CCC(=O)c2sc(C)c3c2CCC(C)(C)C3)cc(C)c1OCCN 10.1021/jm401456d
46237049 8896 0 None 4 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 1 4 4.1 CC(C)/N=C1\S/C(=C\c2ccc(CO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1097529 8896 0 None 4 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 352 4 1 4 4.1 CC(C)/N=C1\S/C(=C\c2ccc(CO)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
76336362 105769 0 None -1071 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3ccc(C4CCCC4)c(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126614 105769 0 None -1071 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3ccc(C4CCCC4)c(C)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76314624 105774 0 None -4365 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)cc(C4CCCC4)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
CHEMBL3126619 105774 0 None -4365 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 494 10 3 8 3.5 CCc1cc(-c2noc(-c3cc(C)cc(C4CCCC4)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/jm4014696
76314623 105747 0 None -2187 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 469 11 4 9 2.3 CCNc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1021/jm4014696
CHEMBL3126591 105747 0 None -2187 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 469 11 4 9 2.3 CCNc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1021/jm4014696
118716150 114884 0 None -17 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 424 9 4 7 2.8 NC(CO)(CCc1ccc(-c2coc(-c3cccs3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341928 114884 0 None -17 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 424 9 4 7 2.8 NC(CO)(CCc1ccc(-c2coc(-c3cccs3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
72793791 104718 0 None -257 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 425 7 1 4 4.9 CNC(=O)COc1c(C)cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc1C 10.1021/jm4014373
CHEMBL3105488 104718 0 None -257 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 425 7 1 4 4.9 CNC(=O)COc1c(C)cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc1C 10.1021/jm4014373
127048141 139785 0 None -102 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 511 13 3 9 2.7 CCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1016/j.ejmech.2016.03.048
CHEMBL3798697 139785 0 None -102 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 511 13 3 9 2.7 CCCN(C)Cc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)cc(C)n1 10.1016/j.ejmech.2016.03.048
11853836 104717 0 None -1445 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 411 7 1 4 4.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(N)=O 10.1021/jm4014373
CHEMBL3105487 104717 0 None -1445 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 411 7 1 4 4.6 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCC(N)=O 10.1021/jm4014373
53319458 57397 0 None -25 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 447 6 1 5 5.2 C[C@@H](c1ccccc1)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2n1 10.1021/ml100306h
CHEMBL1651858 57397 0 None -25 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 447 6 1 5 5.2 C[C@@H](c1ccccc1)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2n1 10.1021/ml100306h
11589375 104397 0 None -338 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 398 7 1 4 5.2 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCO 10.1021/jm4014373
CHEMBL3102987 104397 0 None -338 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 398 7 1 4 5.2 Cc1cc(CCC(=O)c2sc(C)c3c2C[C@@H]2[C@H]3C2(C)C)cc(C)c1OCCO 10.1021/jm4014373
46236404 8961 0 None -1 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 3 1 4 5.2 Cc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)cc1 10.1021/jm100181s
CHEMBL1098142 8961 0 None -1 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 3 1 4 5.2 Cc1ccc(N2C(=O)/C(=C/c3ccc(O)c(Cl)c3)S/C2=N\C(C)C)cc1 10.1021/jm100181s
46238365 8815 0 None -8 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 344 2 1 4 4.2 C/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1096787 8815 0 None -8 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 344 2 1 4 4.2 C/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
58344592 154566 0 None -69183 4 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 445 7 1 7 3.7 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NCC(=O)N(C)C)no2)cc1C#N nan
CHEMBL3921214 154566 0 None -69183 4 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 445 7 1 7 3.7 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NCC(=O)N(C)C)no2)cc1C#N nan
CHEMBL3991184 154566 0 None -69183 4 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 445 7 1 7 3.7 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NCC(=O)N(C)C)no2)cc1C#N nan
44600476 57400 7 None -446 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 459 6 1 5 5.1 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)nc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.10.069
CHEMBL1651861 57400 7 None -446 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 459 6 1 5 5.1 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)nc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.10.069
44600476 57400 7 None -446 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 459 6 1 5 5.1 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)nc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.12.073
CHEMBL1651861 57400 7 None -446 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing chimeric Gq/i5 G-protein assessed as Ca2+ release by FLIPR assay
ChEMBL 459 6 1 5 5.1 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)nc4s3)c(F)c2)C1 10.1016/j.bmcl.2011.12.073
44600476 57400 7 None -446 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 459 6 1 5 5.1 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)nc4s3)c(F)c2)C1 10.1021/ml100306h
CHEMBL1651861 57400 7 None -446 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 459 6 1 5 5.1 O=C(O)C1CN(Cc2ccc(-c3nc4ccc(C5(c6ccccc6)CC5)nc4s3)c(F)c2)C1 10.1021/ml100306h
52938426 3376 12 None -38904 5 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 360 4 1 6 4.0 N#Cc1cc(ccc1OC(C)C)c1onc(n1)c1cccc2c1CC[C@@H]2N nan
9889 3376 12 None -38904 5 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 360 4 1 6 4.0 N#Cc1cc(ccc1OC(C)C)c1onc(n1)c1cccc2c1CC[C@@H]2N nan
CHEMBL3899384 3376 12 None -38904 5 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 360 4 1 6 4.0 N#Cc1cc(ccc1OC(C)C)c1onc(n1)c1cccc2c1CC[C@@H]2N nan
58344778 154537 0 None -52480 5 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 360 4 1 6 4.0 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4N)no2)cc1C#N nan
CHEMBL3902160 154537 0 None -52480 5 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 360 4 1 6 4.0 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4N)no2)cc1C#N nan
CHEMBL3990889 154537 0 None -52480 5 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 360 4 1 6 4.0 CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4N)no2)cc1C#N nan
118716152 114887 0 None -34 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 462 11 4 7 2.7 COc1ccc(Cc2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341930 114887 0 None -34 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 462 11 4 7 2.7 COc1ccc(Cc2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
44591264 179979 0 None -7 4 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)c(F)c1 10.1016/j.bmcl.2008.11.072
CHEMBL474688 179979 0 None -7 4 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgammaS binding
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)c(F)c1 10.1016/j.bmcl.2008.11.072
11977818 70901 0 None -891 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 433 7 1 7 4.8 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(Oc5ccccc5)cc4)n3)s2)C1 10.1016/j.bmcl.2011.12.019
CHEMBL1951154 70901 0 None -891 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma bindingAgonist activity at human S1P3 receptor assessed as stimulation of [35S]GTPgamma binding
ChEMBL 433 7 1 7 4.8 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(Oc5ccccc5)cc4)n3)s2)C1 10.1016/j.bmcl.2011.12.019
57397196 69884 0 None -18 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 499 6 1 6 4.8 CC(C)C1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
CHEMBL1938935 69884 0 None -18 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 499 6 1 6 4.8 CC(C)C1SCCN1C(=O)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1 10.1016/j.bmcl.2011.10.069
11484624 58442 0 None -3 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 341 12 2 3 3.7 O=C(O)CCNCCCc1ccc(OCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.01.029
CHEMBL1683042 58442 0 None -3 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levelsAgonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium levels
ChEMBL 341 12 2 3 3.7 O=C(O)CCNCCCc1ccc(OCCCc2ccccc2)cc1 10.1016/j.bmcl.2011.01.029
127047779 139700 0 None -30 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.9 CCc1cc(-c2noc(-c3ccc(C)c(CN(C)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3798098 139700 0 None -30 2 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.9 CCc1cc(-c2noc(-c3ccc(C)c(CN(C)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
44217168 139817 0 None -64 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.9 CCc1cc(-c2noc(-c3ccc(CN(C)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
CHEMBL3798876 139817 0 None -64 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysisAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes assessed as [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount analysis
ChEMBL 496 12 3 8 2.9 CCc1cc(-c2noc(-c3ccc(CN(C)CC)c(C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.048
127047084 139784 0 None -645 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3ccc(C4CCCC4)c(OC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3798690 139784 0 None -645 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.2 CCc1cc(-c2noc(-c3ccc(C4CCCC4)c(OC)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
58537193 139873 0 None -5370 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 416 6 1 7 3.9 Cc1c(-c2ccccc2)noc1-c1nc(-c2ccc(CN3CC(C(=O)O)C3)cc2)no1 10.1021/acs.jmedchem.6b00089
CHEMBL3799276 139873 0 None -5370 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assayAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes after 45 mins by [35S]-GTPgammaS binding assay
ChEMBL 416 6 1 7 3.9 Cc1c(-c2ccccc2)noc1-c1nc(-c2ccc(CN3CC(C(=O)O)C3)cc2)no1 10.1021/acs.jmedchem.6b00089
46883880 8018 0 None -67 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@H]([C@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1090758 8018 0 None -67 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@H]([C@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
118716156 114891 0 None -6 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 474 11 4 6 3.8 CC(C)c1ccc(Cc2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
CHEMBL3341934 114891 0 None -6 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 474 11 4 6 3.8 CC(C)c1ccc(Cc2nc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)co2)cc1 10.1016/j.ejmech.2014.07.081
127046567 140003 0 None -933 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cc(C)cc(OC4CCCC4)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800028 140003 0 None -933 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 510 11 3 9 3.1 CCc1cc(-c2noc(-c3cc(C)cc(OC4CCCC4)n3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
11603726 76830 0 None -6760 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S bindingAgonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S binding
ChEMBL 400 7 1 5 5.2 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.064
CHEMBL206940 76830 0 None -6760 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S bindingAgonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S binding
ChEMBL 400 7 1 5 5.2 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2ccc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.064
70686052 75278 0 None -234 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 494 6 2 4 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccc(CCC(=O)O)cc21 10.1021/ml200252b
CHEMBL2037128 75278 0 None -234 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay
ChEMBL 494 6 2 4 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccc(CCC(=O)O)cc21 10.1021/ml200252b
57402282 71661 0 None -25118 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 423 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@@H](C)Cc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1935584 71661 0 None -25118 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 423 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@@H](C)Cc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
CHEMBL1963634 71661 0 None -25118 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium levelAgonist activity at human S1P3 receptor expressed in CHO cells assessed as induction of intracellular calcium level
ChEMBL 423 8 1 3 4.8 CC1=C(CN2CC(C(=O)O)C2)CCc2cc(OC[C@@H](C)Cc3ccc(F)cc3)ccc21 10.1016/j.bmcl.2011.11.048
46236807 9060 0 None 1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 338 3 1 4 4.3 CC(C)/N=C1\S/C(=C\c2ccc(O)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098811 9060 0 None 1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 338 3 1 4 4.3 CC(C)/N=C1\S/C(=C\c2ccc(O)cc2)C(=O)N1c1ccccc1 10.1021/jm100181s
127046184 139880 0 None -478 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 484 11 3 9 2.6 CCc1cc(-c2noc(-c3cc(C)nc(OC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3799305 139880 0 None -478 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 484 11 3 9 2.6 CCc1cc(-c2noc(-c3cc(C)nc(OC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
11697013 78263 0 None -1318 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S bindingAgonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S binding
ChEMBL 401 7 1 6 4.6 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2cnc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.064
CHEMBL210695 78263 0 None -1318 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S bindingAgonist activity at S1P3 receptor assessed as induction of [35S]GTP-gamma-S binding
ChEMBL 401 7 1 6 4.6 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2cnc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.064
58390929 84130 0 None -870 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 498 9 1 6 5.1 CCCCN(C(=O)c1ccccc1Cl)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2C)s1 10.1016/j.bmcl.2012.09.110
CHEMBL2207792 84130 0 None -870 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor by [35S]GTPgammaS binding assayAgonist activity at S1P3 receptor by [35S]GTPgammaS binding assay
ChEMBL 498 9 1 6 5.1 CCCCN(C(=O)c1ccccc1Cl)c1nnc(-c2ccc(CN3CC(C(=O)O)C3)cc2C)s1 10.1016/j.bmcl.2012.09.110
11697013 78263 0 None -1318 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 401 7 1 6 4.6 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2cnc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.084
CHEMBL210695 78263 0 None -1318 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptakeAgonist activity at S1P3 receptor expressed in CHO cells measured as S1P-induced [35S]GTP-gamma-S uptake
ChEMBL 401 7 1 6 4.6 Cc1cc(CCC(=O)O)ccc1-c1noc(-c2cnc(OC(C)C)c(Cl)c2)n1 10.1016/j.bmcl.2006.04.084
46236269 9009 0 None 1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 2 1 4 5.3 CC(C)(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1098448 9009 0 None 1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 386 2 1 4 5.3 CC(C)(C)/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
49871977 140050 0 None -239 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 512 13 3 9 3.4 CCc1cc(-c2noc(-c3cc(OC)nc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
CHEMBL3800336 140050 0 None -239 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDPAgonist activity at human recombinant S1PR3 expressed in CHO cell membranes incubated for 30 mins by [35S]GTPgammaS binding assay in presence of GDP
ChEMBL 512 13 3 9 3.4 CCc1cc(-c2noc(-c3cc(OC)nc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1016/j.ejmech.2016.03.020
46195606 149311 0 None -40 2 Human 7.0 pEC50 = 7.0 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 450 10 3 7 3.4 CCCc1ccc(-c2nc(-c3cccc4c3CCN4CC(N)(CO)CO)no2)cc1CCC nan
CHEMBL3944892 149311 0 None -40 2 Human 7.0 pEC50 = 7.0 Functional
Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.Calcium Mobilization Assay: Selected Compounds of the Examples were evaluated at Millipore Corporation, USA, using S1P1 receptor; [35S]-GTPgamaS binding assay. A [35S]-GTPgamaS binding assay at Millipore was conducted by GPCR Profiler Custom Service Laboratory, Temecula, Calif., Millipore, Inc. to monitor dose-dependent agonist selectivity for selected Examples against the S1P1 receptors. The assay was completed with sample compounds subjected to an eight-point, four-fold dose response curve with starting concentration of 10 uM. Selectivity was determined upon initial addition of compounds followed by a 30 minute incubation at 30° C. Following compound incubation, bounded [35S]-GTPgamaS was determined by filtration and scintillation counting. Independently, selected compounds were evaluated for S1P1 and S1P3 agonistic activity. The S1P1 assay system was GTPgama-S35 binding in membranes from CHO K1 cells, expressing S1P1 human receptor. The S1P3 assay system was calcium mobilization in CHO K1 cells expression.
ChEMBL 450 10 3 7 3.4 CCCc1ccc(-c2nc(-c3cccc4c3CCN4CC(N)(CO)CO)no2)cc1CCC nan
53326886 58001 0 None -32 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 468 6 1 4 5.5 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccc(F)c(F)c5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
CHEMBL1672563 58001 0 None -32 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assayAgonist activity at human S1P3 receptor expressed in CHO-K1 cells co-expressing Gq/i5 G-protein assessed as calcium mobilization by FLIPR assay
ChEMBL 468 6 1 4 5.5 O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccc(F)c(F)c5)ccc4s3)c(F)c2)C1 10.1021/ml100228m
46884020 8440 0 None -30 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
CHEMBL1093686 8440 0 None -30 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assayAgonist activity at human S1P3 receptor assessed as effect on calcium mobilization by Gq dependent whole cell assay
ChEMBL 397 11 3 3 4.5 CCCCCCCCc1ccc2c(c1)CC[C@H]([C@@](C)(N)COP(=O)(O)O)C2 10.1016/j.bmcl.2010.02.006
2924 1640 43 None -10 7 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader methodAgonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.1c01979
44398069 1640 43 None -10 7 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader methodAgonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.1c01979
9908268 1640 43 None -10 7 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader methodAgonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.1c01979
CHEMBL114606 1640 43 None -10 7 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader methodAgonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader method
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.1c01979
118716154 114889 0 None -54 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 466 10 4 6 3.3 NC(CO)(CCc1ccc(-c2coc(Cc3ccc(Cl)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
CHEMBL3341932 114889 0 None -54 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assayAgonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay
ChEMBL 466 10 4 6 3.3 NC(CO)(CCc1ccc(-c2coc(Cc3ccc(Cl)cc3)n2)cc1)COP(=O)(O)O 10.1016/j.ejmech.2014.07.081
57402358 69877 0 None -19 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 461 7 1 5 5.6 CCC(c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1)c1ccccn1 10.1016/j.bmcl.2011.10.069
CHEMBL1938927 69877 0 None -19 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assayAgonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq/i5 protein by calcium flux assay
ChEMBL 461 7 1 5 5.6 CCC(c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2c1)c1ccccn1 10.1016/j.bmcl.2011.10.069
46236808 8607 0 None 2 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 356 3 1 4 4.4 CC(C)/N=C1\S/C(=C\c2ccc(O)c(F)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
CHEMBL1094885 8607 0 None 2 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells by GTPgammaS binding assay
ChEMBL 356 3 1 4 4.4 CC(C)/N=C1\S/C(=C\c2ccc(O)c(F)c2)C(=O)N1c1ccccc1 10.1021/jm100181s
52938427 2984 55 None -1659 5 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C nan
5383 2984 55 None -1659 5 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C nan
8709 2984 55 None -1659 5 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C nan
CHEMBL3707247 2984 55 None -1659 5 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C nan
DB12612 2984 55 None -1659 5 Human 5.0 pEC50 = 5 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
ChEMBL 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C nan
46224769 200842 0 None -501 4 Human 6.0 pEC50 = 6 Functional
Agonist activity at human SIP3 receptor by [35S]GTPgammaS binding assayAgonist activity at human SIP3 receptor by [35S]GTPgammaS binding assay
ChEMBL 331 2 1 3 4.3 Cc1nn(C(=O)/C=C/c2cccc3[nH]ccc23)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1016/j.bmcl.2009.11.045
CHEMBL601062 200842 0 None -501 4 Human 6.0 pEC50 = 6 Functional
Agonist activity at human SIP3 receptor by [35S]GTPgammaS binding assayAgonist activity at human SIP3 receptor by [35S]GTPgammaS binding assay
ChEMBL 331 2 1 3 4.3 Cc1nn(C(=O)/C=C/c2cccc3[nH]ccc23)c2c1[C@H]1[C@@H](C2)C1(C)C 10.1016/j.bmcl.2009.11.045
76318195 105756 0 None -4786 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 10 3 8 2.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/jm4014696
CHEMBL3126601 105756 0 None -4786 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysisAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to [35S]-GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis
ChEMBL 440 10 3 8 2.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/jm4014696
53323420 57398 0 None -26 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 447 6 1 5 5.2 C[C@H](c1ccccc1)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2n1 10.1021/ml100306h
CHEMBL1651859 57398 0 None -26 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assayAgonist activity at human S1P3R expressed in CHO cells by Ca(2+) mobilization assay
ChEMBL 447 6 1 5 5.2 C[C@H](c1ccccc1)c1ccc2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3F)sc2n1 10.1021/ml100306h
44607576 48108 0 None -25 3 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 391 5 1 4 5.5 COc1cccc(OC)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
CHEMBL1550998 48108 0 None -25 3 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 391 5 1 4 5.5 COc1cccc(OC)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
5038554 46187 5 None 1 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 318 4 1 3 4.3 Cc1ccc(NC(=O)C(C)c2ccc([N+](=O)[O-])cc2)cc1Cl nan
CHEMBL1534431 46187 5 None 1 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 318 4 1 3 4.3 Cc1ccc(NC(=O)C(C)c2ccc([N+](=O)[O-])cc2)cc1Cl nan
16105531 169366 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 582 16 3 7 5.6 CCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
CHEMBL442040 169366 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 582 16 3 7 5.6 CCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
2727678 84517 36 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 287 11 2 3 4.0 CCCCCCCCCCCC1N[C@H](C(=O)O)CS1 10.1021/jm060834d
CHEMBL222029 84517 36 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 287 11 2 3 4.0 CCCCCCCCCCCC1N[C@H](C(=O)O)CS1 10.1021/jm060834d
3893874 33957 4 None 1 2 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 397 5 1 4 5.4 Cc1cc(C(=O)OC(C(=O)Nc2ccc(C)c(Cl)c2)c2ccccc2)c(C)o1 nan
CHEMBL1424117 33957 4 None 1 2 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 397 5 1 4 5.4 Cc1cc(C(=O)OC(C(=O)Nc2ccc(C)c(Cl)c2)c2ccccc2)c(C)o1 nan
3247435 46143 3 None 2 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 347 7 1 2 5.7 CCCC[C@@H]1C[C@H]1[C@@H](NC(=O)c1cccs1)c1ccc(Cl)cc1 nan
CHEMBL1533923 46143 3 None 2 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 347 7 1 2 5.7 CCCC[C@@H]1C[C@H]1[C@@H](NC(=O)c1cccs1)c1ccc(Cl)cc1 nan
44437393 14706 0 None -29 4 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assayAntagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assay
ChEMBL 608 17 2 5 9.5 CCCCCCCCCCC#CC(O)c1ccccc1-c1ccc(Sc2ccc(OCCCC)cc2)c(S(=O)(=O)O)c1 10.1016/j.bmc.2007.02.048
CHEMBL1206181 14706 0 None -29 4 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assayAntagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assay
ChEMBL 608 17 2 5 9.5 CCCCCCCCCCC#CC(O)c1ccccc1-c1ccc(Sc2ccc(OCCCC)cc2)c(S(=O)(=O)O)c1 10.1016/j.bmc.2007.02.048
CHEMBL239659 14706 0 None -29 4 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assayAntagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assay
ChEMBL 608 17 2 5 9.5 CCCCCCCCCCC#CC(O)c1ccccc1-c1ccc(Sc2ccc(OCCCC)cc2)c(S(=O)(=O)O)c1 10.1016/j.bmc.2007.02.048
10086559 119269 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 307 8 2 3 4.0 CCCCCCCc1ccc(C2N[C@H](C(=O)O)CS2)cc1 10.1021/jm060834d
CHEMBL343684 119269 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 307 8 2 3 4.0 CCCCCCCc1ccc(C2N[C@H](C(=O)O)CS2)cc1 10.1021/jm060834d
16105532 84069 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 582 16 3 7 5.6 CCCCCCCCOc1ccc(/C(=N\NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
CHEMBL220756 84069 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 582 16 3 7 5.6 CCCCCCCCOc1ccc(/C(=N\NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
1810026 20029 20 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 365 4 1 1 5.2 O=C(Nc1ccc(Br)cc1)C(c1ccccc1)c1ccccc1 nan
CHEMBL1303503 20029 20 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 365 4 1 1 5.2 O=C(Nc1ccc(Br)cc1)C(c1ccccc1)c1ccccc1 nan
2727676 83174 4 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 273 10 2 3 3.6 CCCCCCCCCCC1N[C@H](C(=O)O)CS1 10.1021/jm060834d
CHEMBL218352 83174 4 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 273 10 2 3 3.6 CCCCCCCCCCC1N[C@H](C(=O)O)CS1 10.1021/jm060834d
44607582 35267 0 None -52 3 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 437 4 1 4 5.5 Cc1ccc(S(C)(=O)=O)c(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
CHEMBL1436066 35267 0 None -52 3 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 437 4 1 4 5.5 Cc1ccc(S(C)(=O)=O)c(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
2328694 53728 3 None -11 5 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 408 6 2 3 5.2 O=C(Nc1ccccc1)Nc1cc(OCC(F)(F)F)cc(OCC(F)(F)F)c1 nan
CHEMBL1603615 53728 3 None -11 5 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 408 6 2 3 5.2 O=C(Nc1ccccc1)Nc1cc(OCC(F)(F)F)cc(OCC(F)(F)F)c1 nan
4492589 30908 6 None -251 4 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 359 3 1 2 6.1 Cc1cccc(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
CHEMBL1397874 30908 6 None -251 4 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 359 3 1 2 6.1 Cc1cccc(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
2971621 43725 9 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 390 8 1 5 5.3 COc1ccc(C(CC(=O)c2ccc(C)cc2)Nc2ccc([N+](=O)[O-])cc2)cc1 nan
CHEMBL1510469 43725 9 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 390 8 1 5 5.3 COc1ccc(C(CC(=O)c2ccc(C)cc2)Nc2ccc([N+](=O)[O-])cc2)cc1 nan
3827421 33447 7 None -1 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 329 4 1 1 5.8 O=C(Nc1ccc2ccccc2c1)C(c1ccccc1)C1CCCC1 nan
CHEMBL1419954 33447 7 None -1 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 329 4 1 1 5.8 O=C(Nc1ccc2ccccc2c1)C(c1ccccc1)C1CCCC1 nan
11452022 3596 39 None -19 6 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human S1P3 expressed in CHO cells after 60 mins by [35S]GTPgammaS binding assayAgonist activity at human S1P3 expressed in CHO cells after 60 mins by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2011.10.088
6996 3596 39 None -19 6 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human S1P3 expressed in CHO cells after 60 mins by [35S]GTPgammaS binding assayAgonist activity at human S1P3 expressed in CHO cells after 60 mins by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2011.10.088
CHEMBL366208 3596 39 None -19 6 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human S1P3 expressed in CHO cells after 60 mins by [35S]GTPgammaS binding assayAgonist activity at human S1P3 expressed in CHO cells after 60 mins by [35S]GTPgammaS binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2011.10.088
3730347 42941 7 None 2 2 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 293 4 1 1 4.9 Cc1ccc(NC(=O)C(c2ccccc2)C2CCCC2)cc1 nan
CHEMBL1503503 42941 7 None 2 2 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 293 4 1 1 4.9 Cc1ccc(NC(=O)C(c2ccccc2)C2CCCC2)cc1 nan
1363299 32943 10 None -100 5 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 359 3 1 2 6.1 Cc1cccc(C)c1NC(=O)c1ccc(-c2ccc(Cl)cc2Cl)o1 nan
CHEMBL1415555 32943 10 None -100 5 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 359 3 1 2 6.1 Cc1cccc(C)c1NC(=O)c1ccc(-c2ccc(Cl)cc2Cl)o1 nan
16105530 83191 0 None 2 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 694 24 3 7 8.7 CCCCCCCCCCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
CHEMBL218445 83191 0 None 2 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 694 24 3 7 8.7 CCCCCCCCCCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
6890484 72889 7 None -1 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 375 6 1 5 4.1 O=C(N/N=C/c1ccc(-c2ccc([N+](=O)[O-])cc2)o1)[C@H]1C[C@@H]1c1ccccc1 nan
CHEMBL2003667 72889 7 None -1 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 375 6 1 5 4.1 O=C(N/N=C/c1ccc(-c2ccc([N+](=O)[O-])cc2)o1)[C@H]1C[C@@H]1c1ccccc1 nan
2101118 40215 7 None - 1 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 386 4 2 1 6.2 FC(F)(F)c1cccc(NC(S)=NC(c2ccccc2)c2ccccc2)c1 nan
CHEMBL1480424 40215 7 None - 1 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 386 4 2 1 6.2 FC(F)(F)c1cccc(NC(S)=NC(c2ccccc2)c2ccccc2)c1 nan
6056442 79106 5 None 1 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 701 23 3 7 8.1 CCCCCCCCCCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)N2CCCCC2)cc1OC 10.1021/jm060834d
CHEMBL2113260 79106 5 None 1 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 701 23 3 7 8.1 CCCCCCCCCCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)N2CCCCC2)cc1OC 10.1021/jm060834d
16105541 83192 0 None 1 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 694 24 3 7 8.7 CCCCCCCCCCCCCCCCOc1ccc(/C(=N\NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
CHEMBL218446 83192 0 None 1 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 694 24 3 7 8.7 CCCCCCCCCCCCCCCCOc1ccc(/C(=N\NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1OC 10.1021/jm060834d
44419095 96666 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 743 27 4 7 10.2 CCCCCCCCCCCCCCCCCC(=O)Nc1ccc(C(=O)CC(=O)Cc2cc(C(=O)O)ccc2Oc2cc(C(=O)O)cc(C(=O)O)c2)cc1 10.1021/jm060834d
CHEMBL263827 96666 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 743 27 4 7 10.2 CCCCCCCCCCCCCCCCCC(=O)Nc1ccc(C(=O)CC(=O)Cc2cc(C(=O)O)ccc2Oc2cc(C(=O)O)cc(C(=O)O)c2)cc1 10.1021/jm060834d
564008 45247 13 None -1 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 333 4 0 5 4.5 O=[N+]([O-])c1ccc(C2=NN(c3ccccc3)C(c3ccco3)C2)cc1 nan
CHEMBL1526126 45247 13 None -1 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 333 4 0 5 4.5 O=[N+]([O-])c1ccc(C2=NN(c3ccccc3)C(c3ccco3)C2)cc1 nan
2353214 29068 6 None -3 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 387 6 1 2 5.7 O=C(Nc1ccc(OC(F)F)c(Cl)c1)C(c1ccccc1)c1ccccc1 nan
CHEMBL1380914 29068 6 None -3 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 387 6 1 2 5.7 O=C(Nc1ccc(OC(F)F)c(Cl)c1)C(c1ccccc1)c1ccccc1 nan
2727242 39965 5 None - 1 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 428 4 1 3 6.1 O=C(Nc1ccc(F)cc1F)c1c(C(F)(F)F)ccnc1Oc1ccc(Cl)cc1 nan
CHEMBL1478342 39965 5 None - 1 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 428 4 1 3 6.1 O=C(Nc1ccc(F)cc1F)c1c(C(F)(F)F)ccnc1Oc1ccc(Cl)cc1 nan
44419094 97256 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 715 27 4 7 10.2 CCCCCCCCCCCCCCCCCNc1ccc(C(=O)CC(=O)Cc2cc(C(=O)O)ccc2Oc2cc(C(=O)O)cc(C(=O)O)c2)cc1 10.1021/jm060834d
CHEMBL268805 97256 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 715 27 4 7 10.2 CCCCCCCCCCCCCCCCCNc1ccc(C(=O)CC(=O)Cc2cc(C(=O)O)ccc2Oc2cc(C(=O)O)cc(C(=O)O)c2)cc1 10.1021/jm060834d
6217704 32583 3 None -14 6 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 490 7 0 8 5.2 CCOC(=O)/C(=C\c1ccc(OC(F)F)cc1)C1=Nn2c(nnc2-c2ccc(Cl)cc2)SC1 nan
CHEMBL1412583 32583 3 None -14 6 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 490 7 0 8 5.2 CCOC(=O)/C(=C\c1ccc(OC(F)F)cc1)C1=Nn2c(nnc2-c2ccc(Cl)cc2)SC1 nan
44437418 14829 0 None -39 4 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assayAntagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assay
ChEMBL 612 17 3 7 6.9 CCCCOc1ccc(Sc2ccc(-c3ccccc3C(O)C#CCOCCCCCCCO)cc2S(=O)(=O)O)cc1 10.1016/j.bmc.2007.02.048
CHEMBL1207343 14829 0 None -39 4 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assayAntagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assay
ChEMBL 612 17 3 7 6.9 CCCCOc1ccc(Sc2ccc(-c3ccccc3C(O)C#CCOCCCCCCCO)cc2S(=O)(=O)O)cc1 10.1016/j.bmc.2007.02.048
CHEMBL397081 14829 0 None -39 4 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assayAntagonist activity at human S1P3 receptor expressed in CHO cell membrane by FLIPR assay
ChEMBL 612 17 3 7 6.9 CCCCOc1ccc(Sc2ccc(-c3ccccc3C(O)C#CCOCCCCCCCO)cc2S(=O)(=O)O)cc1 10.1016/j.bmc.2007.02.048
2233014 38965 9 None -3 5 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 429 7 1 6 4.9 COc1ccc(CC(=O)Nc2cccc(-c3nnc(-c4cccc(C)c4)o3)c2)cc1OC nan
CHEMBL1467999 38965 9 None -3 5 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 429 7 1 6 4.9 COc1ccc(CC(=O)Nc2cccc(-c3nnc(-c4cccc(C)c4)o3)c2)cc1OC nan
2810094 29583 3 None -1 3 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 365 4 1 3 4.9 Cc1cccc(Cn2nc(C(C)(C)C)cc2C(=O)Nc2ccc(F)cc2)c1 nan
CHEMBL1385499 29583 3 None -1 3 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 365 4 1 3 4.9 Cc1cccc(Cn2nc(C(C)(C)C)cc2C(=O)Nc2ccc(F)cc2)c1 nan
4841482 46080 5 None 2 2 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 397 5 1 3 5.3 Cc1ccc(NC(=O)C(OC(=O)c2ccc(F)cc2)c2ccccc2)cc1Cl nan
CHEMBL1533427 46080 5 None 2 2 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 397 5 1 3 5.3 Cc1ccc(NC(=O)C(OC(=O)c2ccc(F)cc2)c2ccccc2)cc1Cl nan
2794045 31569 9 None 1 2 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 279 4 1 1 4.6 O=C(Nc1ccccc1)C(c1ccccc1)C1CCCC1 nan
CHEMBL1404080 31569 9 None 1 2 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 279 4 1 1 4.6 O=C(Nc1ccccc1)C(c1ccccc1)C1CCCC1 nan
969623 201404 10 None 1 3 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 324 4 1 3 4.4 Cc1ccc(NC(=O)C2(c3ccc([N+](=O)[O-])cc3)CCCC2)cc1 nan
CHEMBL604664 201404 10 None 1 3 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 324 4 1 3 4.4 Cc1ccc(NC(=O)C2(c3ccc([N+](=O)[O-])cc3)CCCC2)cc1 nan
4168101 20867 4 None 1 2 Human 5.1 pIC50 = 5.1 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 405 5 1 3 5.5 O=C(OC(C(=O)Nc1cccc(C(F)(F)F)c1)c1ccccc1)C1CCCCC1 nan
CHEMBL1310437 20867 4 None 1 2 Human 5.1 pIC50 = 5.1 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 405 5 1 3 5.5 O=C(OC(C(=O)Nc1cccc(C(F)(F)F)c1)c1ccccc1)C1CCCCC1 nan
71450073 82589 0 None -234 4 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human S1P3R receptor expressed in CHO cell membranes by [35S]GTPgamma binding assayAntagonist activity at human S1P3R receptor expressed in CHO cell membranes by [35S]GTPgamma binding assay
ChEMBL 585 10 2 5 5.5 Cc1cc(S(=O)(=O)Nc2cccc(-c3cc(C)c(C(=O)N(C)[C@@H](CCN(C)C)C(=O)O)c(C)c3)c2)c(C)cc1Cl 10.1021/jm3009508
CHEMBL2178814 82589 0 None -234 4 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human S1P3R receptor expressed in CHO cell membranes by [35S]GTPgamma binding assayAntagonist activity at human S1P3R receptor expressed in CHO cell membranes by [35S]GTPgamma binding assay
ChEMBL 585 10 2 5 5.5 Cc1cc(S(=O)(=O)Nc2cccc(-c3cc(C)c(C(=O)N(C)[C@@H](CCN(C)C)C(=O)O)c(C)c3)c2)c(C)cc1Cl 10.1021/jm3009508
4460714 141960 10 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 442 18 2 4 6.5 CCCCCCCCCCCCCCCCOc1ccc(S(=O)(=O)O)cc1C(=O)O 10.1021/jm060834d
CHEMBL387252 141960 10 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 442 18 2 4 6.5 CCCCCCCCCCCCCCCCOc1ccc(S(=O)(=O)O)cc1C(=O)O 10.1021/jm060834d
3513763 23133 5 None -1 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 413 5 1 3 5.8 Cc1ccc(NC(=O)C(OC(=O)c2ccccc2Cl)c2ccccc2)cc1Cl nan
CHEMBL1330917 23133 5 None -1 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]
ChEMBL 413 5 1 3 5.8 Cc1ccc(NC(=O)C(OC(=O)c2ccccc2Cl)c2ccccc2)cc1Cl nan
9883039 31624 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 307 8 2 3 4.0 CCCCCCCc1cccc(C2N[C@H](C(=O)O)CS2)c1 10.1021/jm060834d
CHEMBL140460 31624 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 307 8 2 3 4.0 CCCCCCCc1cccc(C2N[C@H](C(=O)O)CS2)c1 10.1021/jm060834d
16105533 83193 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 664 23 3 6 8.7 CCCCCCCCCCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1 10.1021/jm060834d
CHEMBL218447 83193 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cellsAntagonist activity against human S1P3 receptor assessed as inhibition of S1P-induced intracellular calcium mobilization in CHO-K1 cells
ChEMBL 664 23 3 6 8.7 CCCCCCCCCCCCCCCCOc1ccc(/C(=N/NS(=O)(=O)c2cc(C(=O)O)cc(C(=O)O)c2)c2ccccc2)cc1 10.1021/jm060834d
44607575 52547 0 None -60 5 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 375 4 1 3 5.8 COc1cccc(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
CHEMBL1592119 52547 0 None -60 5 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]PUBCHEM_BIOASSAY: Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1510, AID1524, AID1692, AID1853, AID2332, AID489009, AID489017]
ChEMBL 375 4 1 3 5.8 COc1cccc(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 nan
17253208 1299 51 None 1819 2 Human 8.5 pA2 = 8.5 Functional
In a β-arrestin assay.In a β-arrestin assay.
Guide to Pharmacology 316 4 0 3 4.7 O=C(N(C1CCCCC1)C1CCCCC1)c1noc(c1)C1CC1 26494861
9494 1299 51 None 1819 2 Human 8.5 pA2 = 8.5 Functional
In a β-arrestin assay.In a β-arrestin assay.
Guide to Pharmacology 316 4 0 3 4.7 O=C(N(C1CCCCC1)C1CCCCC1)c1noc(c1)C1CC1 26494861
CHEMBL1970071 1299 51 None 1819 2 Human 8.5 pA2 = 8.5 Functional
In a β-arrestin assay.In a β-arrestin assay.
Guide to Pharmacology 316 4 0 3 4.7 O=C(N(C1CCCCC1)C1CCCCC1)c1noc(c1)C1CC1 26494861
49869062 3657 0 None 28 2 Human 9.3 pA2 = 9.3 Functional
In a β-arrestin assay.In a β-arrestin assay.
Guide to Pharmacology 513 10 4 5 5.8 CCC[C@@](COP(=O)(O)O)(CCc1ccc(cc1Cl)Sc1cc(ccc1O)C(F)(F)F)N 26494861
9493 3657 0 None 28 2 Human 9.3 pA2 = 9.3 Functional
In a β-arrestin assay.In a β-arrestin assay.
Guide to Pharmacology 513 10 4 5 5.8 CCC[C@@](COP(=O)(O)O)(CCc1ccc(cc1Cl)Sc1cc(ccc1O)C(F)(F)F)N 26494861
44599207 3609 43 None -724 5 Human 8.5 pEC50 = 8.5 Functional
NoneNone
Drug Central 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C None
5326 3609 43 None -724 5 Human 8.5 pEC50 = 8.5 Functional
NoneNone
Drug Central 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C None
9289 3609 43 None -724 5 Human 8.5 pEC50 = 8.5 Functional
NoneNone
Drug Central 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C None
CHEMBL2336071 3609 43 None -724 5 Human 8.5 pEC50 = 8.5 Functional
NoneNone
Drug Central 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C None
DB12371 3609 43 None -724 5 Human 8.5 pEC50 = 8.5 Functional
NoneNone
Drug Central 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C None
52938427 2984 55 None -1659 5 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
Drug Central 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C None
5383 2984 55 None -1659 5 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
Drug Central 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C None
8709 2984 55 None -1659 5 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
Drug Central 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C None
CHEMBL3707247 2984 55 None -1659 5 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
Drug Central 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C None
DB12612 2984 55 None -1659 5 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrsAgonist activity at human S1P3 Galpha5 expressed in NFAT-bla HEK293T cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs
Drug Central 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C None
11363176 3149 47 None -12 4 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C None
5446 3149 47 None -12 4 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C None
9320 3149 47 None -12 4 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C None
CHEMBL1096146 3149 47 None -12 4 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C None
107970 1639 83 None -23 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
Drug Central 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N None
2407 1639 83 None -23 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
Drug Central 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N None
4167 1639 83 None -23 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
Drug Central 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N None
CHEMBL314854 1639 83 None -23 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
Drug Central 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N None
DB08868 1639 83 None -23 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
Drug Central 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N None
49848557 1098 0 None -3162 5 Human 5.1 pEC50 = 5.1 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 461 7 1 8 4.0 OC(=O)CCN1CCc2c(C1)c(C)n(n2)c1nnc(s1)c1ccc(c(c1)Cl)OC(C)C 26751273
9492 1098 0 None -3162 5 Human 5.1 pEC50 = 5.1 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 461 7 1 8 4.0 OC(=O)CCN1CCc2c(C1)c(C)n(n2)c1nnc(s1)c1ccc(c(c1)Cl)OC(C)C 26751273
CHEMBL3769933 1098 0 None -3162 5 Human 5.1 pEC50 = 5.1 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 461 7 1 8 4.0 OC(=O)CCN1CCc2c(C1)c(C)n(n2)c1nnc(s1)c1ccc(c(c1)Cl)OC(C)C 26751273
44599207 3609 43 None -724 5 Human 5.3 pEC50 = 5.3 Functional
In a GTPγS binding assayIn a GTPγS binding assay
Guide to Pharmacology 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 24900670
5326 3609 43 None -724 5 Human 5.3 pEC50 = 5.3 Functional
In a GTPγS binding assayIn a GTPγS binding assay
Guide to Pharmacology 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 24900670
9289 3609 43 None -724 5 Human 5.3 pEC50 = 5.3 Functional
In a GTPγS binding assayIn a GTPγS binding assay
Guide to Pharmacology 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 24900670
CHEMBL2336071 3609 43 None -724 5 Human 5.3 pEC50 = 5.3 Functional
In a GTPγS binding assayIn a GTPγS binding assay
Guide to Pharmacology 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 24900670
DB12371 3609 43 None -724 5 Human 5.3 pEC50 = 5.3 Functional
In a GTPγS binding assayIn a GTPγS binding assay
Guide to Pharmacology 516 9 1 4 6.8 CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C 24900670
16755143 502 0 None -123 4 Human 6.0 pEC50 = 6.0 Functional
In a GTPγS binding assay.In a GTPγS binding assay.
Guide to Pharmacology 442 4 1 5 5.6 C[C@@H](C(F)(F)F)Oc1ccc(cc1C(F)(F)F)c1onc(n1)c1ccc2c(c1)nc[nH]2 25347187
9569 502 0 None -123 4 Human 6.0 pEC50 = 6.0 Functional
In a GTPγS binding assay.In a GTPγS binding assay.
Guide to Pharmacology 442 4 1 5 5.6 C[C@@H](C(F)(F)F)Oc1ccc(cc1C(F)(F)F)c1onc(n1)c1ccc2c(c1)nc[nH]2 25347187
CHEMBL4297350 502 0 None -123 4 Human 6.0 pEC50 = 6.0 Functional
In a GTPγS binding assay.In a GTPγS binding assay.
Guide to Pharmacology 442 4 1 5 5.6 C[C@@H](C(F)(F)F)Oc1ccc(cc1C(F)(F)F)c1onc(n1)c1ccc2c(c1)nc[nH]2 25347187
DB11819 502 0 None -123 4 Human 6.0 pEC50 = 6.0 Functional
In a GTPγS binding assay.In a GTPγS binding assay.
Guide to Pharmacology 442 4 1 5 5.6 C[C@@H](C(F)(F)F)Oc1ccc(cc1C(F)(F)F)c1onc(n1)c1ccc2c(c1)nc[nH]2 25347187
11259583 524 17 None -1318 7 Mouse 5.9 pEC50 = 5.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 455 7 2 3 6.8 OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1 17113298
11259583 524 17 None -1318 7 Mouse 5.9 pEC50 = 5.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 455 7 2 3 6.8 OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1 17114004
2925 524 17 None -1318 7 Mouse 5.9 pEC50 = 5.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 455 7 2 3 6.8 OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1 17113298
2925 524 17 None -1318 7 Mouse 5.9 pEC50 = 5.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 455 7 2 3 6.8 OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1 17114004
CHEMBL4579553 524 17 None -1318 7 Mouse 5.9 pEC50 = 5.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 455 7 2 3 6.8 OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1 17113298
CHEMBL4579553 524 17 None -1318 7 Mouse 5.9 pEC50 = 5.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 455 7 2 3 6.8 OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1 17114004
11452022 3596 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 17114004
6996 3596 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 17114004
CHEMBL366208 3596 39 None -19 6 Human 8.5 pEC50 = 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 17114004
10904818 303 0 None -2 4 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 373 13 3 4 3.8 CCCCCCCOc1ccc(cc1)CC[C@](COP(=O)(O)O)(N)C 11967257
2937 303 0 None -2 4 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 373 13 3 4 3.8 CCCCCCCOc1ccc(cc1)CC[C@](COP(=O)(O)O)(N)C 11967257
CHEMBL382739 303 0 None -2 4 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 373 13 3 4 3.8 CCCCCCCOc1ccc(cc1)CC[C@](COP(=O)(O)O)(N)C 11967257
2924 1640 43 None -10 7 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
2924 1640 43 None -10 7 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
44398069 1640 43 None -10 7 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
44398069 1640 43 None -10 7 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
9908268 1640 43 None -10 7 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
9908268 1640 43 None -10 7 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
CHEMBL114606 1640 43 None -10 7 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
CHEMBL114606 1640 43 None -10 7 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
10883396 3649 45 None -2 15 Mouse 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 14732717
5283560 3649 45 None -2 15 Mouse 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 14732717
911 3649 45 None -2 15 Mouse 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 14732717
CHEMBL225155 3649 45 None -2 15 Mouse 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 14732717
10883396 3649 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11705398
10883396 3649 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11967257
10883396 3649 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17114004
5283560 3649 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11705398
5283560 3649 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11967257
5283560 3649 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17114004
911 3649 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11705398
911 3649 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11967257
911 3649 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17114004
CHEMBL225155 3649 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11705398
CHEMBL225155 3649 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 11967257
CHEMBL225155 3649 45 None 1 15 Human 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17114004
52938427 2984 55 None -1659 5 Human 5.0 pEC50 > 5 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C 26990079
5383 2984 55 None -1659 5 Human 5.0 pEC50 > 5 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C 26990079
8709 2984 55 None -1659 5 Human 5.0 pEC50 > 5 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C 26990079
CHEMBL3707247 2984 55 None -1659 5 Human 5.0 pEC50 > 5 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C 26990079
DB12612 2984 55 None -1659 5 Human 5.0 pEC50 > 5 Functional
In a GTPγS assay.In a GTPγS assay.
Guide to Pharmacology 404 7 2 7 3.6 OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C 26990079
10282223 4010 4 None 5 3 Human 6.5 pEC50 None 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 601 24 3 4 8.4 CCCCCCCC/C=C\CCCCCCCC(=O)N[C@H](Cc1ccc(cc1)OCc1ccccc1)COP(=O)(O)O 17113298
2909 4010 4 None 5 3 Human 6.5 pEC50 None 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 601 24 3 4 8.4 CCCCCCCC/C=C\CCCCCCCC(=O)N[C@H](Cc1ccc(cc1)OCc1ccccc1)COP(=O)(O)O 17113298
CHEMBL327240 4010 4 None 5 3 Human 6.5 pEC50 None 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 601 24 3 4 8.4 CCCCCCCC/C=C\CCCCCCCC(=O)N[C@H](Cc1ccc(cc1)OCc1ccccc1)COP(=O)(O)O 17113298
2924 1640 43 None -10 7 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
2924 1640 43 None -10 7 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
44398069 1640 43 None -10 7 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
44398069 1640 43 None -10 7 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
9908268 1640 43 None -10 7 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
9908268 1640 43 None -10 7 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
CHEMBL114606 1640 43 None -10 7 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 11967257
CHEMBL114606 1640 43 None -10 7 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 14747617
10430549 1048 39 None -20417 4 Human 4.9 pIC50 None 4.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 16190743
2929 1048 39 None -20417 4 Human 4.9 pIC50 None 4.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 16190743
CHEMBL194419 1048 39 None -20417 4 Human 4.9 pIC50 None 4.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 16190743




Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Similar-
ity
Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
Assay
Type
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

10883396 3649 45 None -1 4 Human 9.7 pEC50 = 9.7 Binding
Displacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation countingDisplacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
5283560 3649 45 None -1 4 Human 9.7 pEC50 = 9.7 Binding
Displacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation countingDisplacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
911 3649 45 None -1 4 Human 9.7 pEC50 = 9.7 Binding
Displacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation countingDisplacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
CHEMBL225155 3649 45 None -1 4 Human 9.7 pEC50 = 9.7 Binding
Displacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation countingDisplacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm100181s
10883396 3649 45 None -1 4 Human 9.0 pEC50 = 9.0 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
5283560 3649 45 None -1 4 Human 9.0 pEC50 = 9.0 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
911 3649 45 None -1 4 Human 9.0 pEC50 = 9.0 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
CHEMBL225155 3649 45 None -1 4 Human 9.0 pEC50 = 9.0 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
10883396 3649 45 None -1 4 Human 8.9 pEC50 = 8.9 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.07.030
5283560 3649 45 None -1 4 Human 8.9 pEC50 = 8.9 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.07.030
911 3649 45 None -1 4 Human 8.9 pEC50 = 8.9 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.07.030
CHEMBL225155 3649 45 None -1 4 Human 8.9 pEC50 = 8.9 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.07.030
49839234 117951 1 None - 0 Human 5.0 pEC50 = 5 Binding
Agonist activity at human S1P3 receptor by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor by beta-arrestin recruitment assay
ChEMBL 472 6 3 3 6.1 O=C(O)CC1NCCc2c1[nH]c1ccc(OCc3ccc(C4CCCC4)c(C(F)(F)F)c3)cc21 10.1016/j.bmcl.2014.11.089
CHEMBL3403619 117951 1 None - 0 Human 5.0 pEC50 = 5 Binding
Agonist activity at human S1P3 receptor by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor by beta-arrestin recruitment assay
ChEMBL 472 6 3 3 6.1 O=C(O)CC1NCCc2c1[nH]c1ccc(OCc3ccc(C4CCCC4)c(C(F)(F)F)c3)cc21 10.1016/j.bmcl.2014.11.089
25110488 71985 0 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 352 4 0 3 5.4 O=C(c1cc(-c2ccccc2)on1)N(C1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1973788 71985 0 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 352 4 0 3 5.4 O=C(c1cc(-c2ccccc2)on1)N(C1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
17253208 1299 51 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 316 4 0 3 4.7 O=C(N(C1CCCCC1)C1CCCCC1)c1noc(c1)C1CC1 10.1016/j.bmcl.2013.09.075
9494 1299 51 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 316 4 0 3 4.7 O=C(N(C1CCCCC1)C1CCCCC1)c1noc(c1)C1CC1 10.1016/j.bmcl.2013.09.075
CHEMBL1970071 1299 51 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 316 4 0 3 4.7 O=C(N(C1CCCCC1)C1CCCCC1)c1noc(c1)C1CC1 10.1016/j.bmcl.2013.09.075
127031187 138882 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmc.2016.03.059
CHEMBL3781008 138882 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmc.2016.03.059
CHEMBL3782062 138882 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmc.2016.03.059
67169586 182338 0 None - 0 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 486 6 1 5 5.4 CC(C)Oc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)c(C(F)(F)F)c1 10.1021/acs.jmedchem.6b01099
CHEMBL4784466 182338 0 None - 0 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 486 6 1 5 5.4 CC(C)Oc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)c(C(F)(F)F)c1 10.1021/acs.jmedchem.6b01099
76325531 105757 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 454 11 3 8 2.5 CCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/ml500484v
CHEMBL3126602 105757 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 454 11 3 8 2.5 CCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/ml500484v
67168053 180847 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 497 5 1 7 5.1 O=C(O)C1CN(Cc2ccc3c(c2)OCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4757149 180847 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 497 5 1 7 5.1 O=C(O)C1CN(Cc2ccc3c(c2)OCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
67169634 180993 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 509 5 1 6 5.6 Cc1cc2c(cc1CN1CC(C(=O)O)C1)CCc1c-2noc1-c1noc(-c2ccccc2)c1C(F)(F)F 10.1021/acs.jmedchem.6b01099
CHEMBL4758827 180993 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 509 5 1 6 5.6 Cc1cc2c(cc1CN1CC(C(=O)O)C1)CCc1c-2noc1-c1noc(-c2ccccc2)c1C(F)(F)F 10.1021/acs.jmedchem.6b01099
67170332 180673 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 6 5.8 O=C(O)C1CN(Cc2ccc3c(c2)CCc2nc(-c4onc(-c5ccccc5)c4C(F)(F)F)sc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4755286 180673 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 6 5.8 O=C(O)C1CN(Cc2ccc3c(c2)CCc2nc(-c4onc(-c5ccccc5)c4C(F)(F)F)sc2-3)C1 10.1021/acs.jmedchem.6b01099
162673462 183191 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 509 5 1 6 5.7 O=C(O)C1CN(Cc2ccc3c(c2)CCCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4795734 183191 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 509 5 1 6 5.7 O=C(O)C1CN(Cc2ccc3c(c2)CCCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
2924 1640 43 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2020.127141
44398069 1640 43 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2020.127141
9908268 1640 43 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2020.127141
CHEMBL114606 1640 43 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2020.127141
53235408 180875 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 473 5 1 6 4.7 CC1(c2onc(-c3onc4c3CCc3cc(CN5CC(C(=O)O)C5)ccc3-4)c2C(F)(F)F)CC1 10.1021/acs.jmedchem.6b01099
CHEMBL4757437 180875 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 473 5 1 6 4.7 CC1(c2onc(-c3onc4c3CCc3cc(CN5CC(C(=O)O)C5)ccc3-4)c2C(F)(F)F)CC1 10.1021/acs.jmedchem.6b01099
67171369 181691 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 496 5 1 7 4.7 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2onc(-c3ccccn3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4776597 181691 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 496 5 1 7 4.7 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2onc(-c3ccccn3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
162660222 181229 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 553 6 2 7 5.6 O=C(O)[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4761456 181229 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 553 6 2 7 5.6 O=C(O)[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
76321895 105762 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 482 12 3 8 3.4 CCc1cc(-c2noc(-c3ccnc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
CHEMBL3126607 105762 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 482 12 3 8 3.4 CCc1cc(-c2noc(-c3ccnc(C(CC)CC)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
25110485 72763 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 332 5 0 3 5.0 CC(C)Cc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
CHEMBL1999116 72763 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 332 5 0 3 5.0 CC(C)Cc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
67169708 182324 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 6 5.8 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2nsc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4784344 182324 0 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 6 5.8 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2nsc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
68182170 183031 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 448 8 1 6 4.4 CCOc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1OCC 10.1021/acs.jmedchem.6b01099
CHEMBL4793933 183031 0 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 448 8 1 6 4.4 CCOc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1OCC 10.1021/acs.jmedchem.6b01099
57391920 69886 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at S1P3 (unknown origin)Agonist activity at S1P3 (unknown origin)
ChEMBL 422 3 1 3 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1021/acs.jmedchem.9b02092
CHEMBL1938937 69886 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at S1P3 (unknown origin)Agonist activity at S1P3 (unknown origin)
ChEMBL 422 3 1 3 5.5 Cn1cc(C(=O)Nc2ccc(-c3ccccc3)c(C(F)(F)F)c2)c(=O)c2ccccc21 10.1021/acs.jmedchem.9b02092
44342468 12118 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
In vitro binding affinity towards human S1P3 receptor expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human S1P3 receptor expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL1184089 12118 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
In vitro binding affinity towards human S1P3 receptor expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human S1P3 receptor expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL332050 12118 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
In vitro binding affinity towards human S1P3 receptor expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human S1P3 receptor expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
162662293 181446 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 513 5 1 6 5.4 O=C(O)C1CN(Cc2cc3c(cc2F)-c2noc(-c4noc(-c5ccccc5)c4C(F)(F)F)c2CC3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4764300 181446 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 513 5 1 6 5.4 O=C(O)C1CN(Cc2cc3c(cc2F)-c2noc(-c4noc(-c5ccccc5)c4C(F)(F)F)c2CC3)C1 10.1021/acs.jmedchem.6b01099
46835922 139455 13 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1021/acs.jmedchem.6b01099
CHEMBL3794064 139455 13 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1021/acs.jmedchem.6b01099
68192004 183413 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 7 5.1 O=C(O)C1CN(Cc2ccc3c(c2)OCCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4798447 183413 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 7 5.1 O=C(O)C1CN(Cc2ccc3c(c2)OCCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
46835922 139455 13 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1016/j.bmcl.2016.03.105
CHEMBL3794064 139455 13 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 470 6 1 7 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1 10.1016/j.bmcl.2016.03.105
44398012 12264 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 425 12 4 4 4.4 CCCCCCCCc1ccc(-c2c[nH]c(C(C)(N)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1184707 12264 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 425 12 4 4 4.4 CCCCCCCCc1ccc(-c2c[nH]c(C(C)(N)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL364950 12264 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 425 12 4 4 4.4 CCCCCCCCc1ccc(-c2c[nH]c(C(C)(N)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
162660222 181229 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 553 6 2 7 5.6 O=C(O)[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4761456 181229 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 553 6 2 7 5.6 O=C(O)[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
25110492 71925 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 302 4 0 3 4.3 O=C(c1cc(C2CC2)on1)N(C1CCCCC1)C1CCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1972130 71925 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 302 4 0 3 4.3 O=C(c1cc(C2CC2)on1)N(C1CCCCC1)C1CCCC1 10.1016/j.bmcl.2013.09.075
162671724 182963 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 567 7 2 7 6.0 O=C(O)C[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4792990 182963 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 567 7 2 7 6.0 O=C(O)C[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
44398058 11766 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 395 12 4 4 4.1 CCCCCCCCc1ccc(-c2c[nH]c([C@H](N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1181660 11766 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 395 12 4 4 4.1 CCCCCCCCc1ccc(-c2c[nH]c([C@H](N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL187712 11766 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 395 12 4 4 4.1 CCCCCCCCc1ccc(-c2c[nH]c([C@H](N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
25110510 72667 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 316 4 0 3 4.5 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1995815 72667 0 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 316 4 0 3 4.5 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCC1 10.1016/j.bmcl.2013.09.075
162656217 180967 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 561 7 2 8 4.0 CS(=O)(=O)CCNC(=O)C(O)c1ccc2c(c1)CCc1c(-c3noc(-c4ccccc4)c3C(F)(F)F)noc1-2 10.1021/acs.jmedchem.6b01099
CHEMBL4758481 180967 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 561 7 2 8 4.0 CS(=O)(=O)CCNC(=O)C(O)c1ccc2c(c1)CCc1c(-c3noc(-c4ccccc4)c3C(F)(F)F)noc1-2 10.1021/acs.jmedchem.6b01099
52914984 147558 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
CHEMBL3930827 147558 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
46847147 139327 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 431 7 1 8 3.5 CCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccn1 10.1016/j.bmcl.2016.03.105
CHEMBL3792704 139327 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 431 7 1 8 3.5 CCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccn1 10.1016/j.bmcl.2016.03.105
127027154 138320 0 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assayAgonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assay
ChEMBL 330 4 0 4 5.3 CC(C)Oc1ccc(-c2nnc(-c3ccccc3)s2)cc1Cl 10.1021/acs.jmedchem.5b01512
CHEMBL3771092 138320 0 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assayAgonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assay
ChEMBL 330 4 0 4 5.3 CC(C)Oc1ccc(-c2nnc(-c3ccccc3)s2)cc1Cl 10.1021/acs.jmedchem.5b01512
2924 1640 43 None - 0 Human 8.7 pEC50 = 8.7 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2005.05.097
44398069 1640 43 None - 0 Human 8.7 pEC50 = 8.7 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2005.05.097
9908268 1640 43 None - 0 Human 8.7 pEC50 = 8.7 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2005.05.097
CHEMBL114606 1640 43 None - 0 Human 8.7 pEC50 = 8.7 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2005.05.097
25110496 71839 0 None - 0 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 344 4 0 3 5.2 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCCC1C 10.1016/j.bmcl.2013.09.075
CHEMBL1969371 71839 0 None - 0 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 344 4 0 3 5.2 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCCC1C 10.1016/j.bmcl.2013.09.075
77050638 140310 9 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to controlAgonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to control
ChEMBL 329 7 2 2 4.7 CCCCCC[C@@H]1CCc2cc([C@H]3CC[C@](N)(CO)C3)ccc2C1 10.1021/acs.jmedchem.6b01433
CHEMBL3806158 140310 9 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to controlAgonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to control
ChEMBL 329 7 2 2 4.7 CCCCCC[C@@H]1CCc2cc([C@H]3CC[C@](N)(CO)C3)ccc2C1 10.1021/acs.jmedchem.6b01433
67170391 180304 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 510 5 1 4 6.7 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2ccc(C3CCCCC3)c(C(F)(F)F)c2)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4750972 180304 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 510 5 1 4 6.7 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2ccc(C3CCCCC3)c(C(F)(F)F)c2)C1 10.1021/acs.jmedchem.6b01099
46847145 139383 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 445 8 1 8 3.9 CCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccn1 10.1016/j.bmcl.2016.03.105
CHEMBL3793185 139383 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 445 8 1 8 3.9 CCCc1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccn1 10.1016/j.bmcl.2016.03.105
162657458 181038 0 None - 0 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 535 4 2 7 4.2 O=C1NC(=O)C2(CN(Cc3ccc4c(c3)CCc3c(-c5noc(-c6ccccc6)c5C(F)(F)F)noc3-4)C2)N1 10.1021/acs.jmedchem.6b01099
CHEMBL4759408 181038 0 None - 0 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 535 4 2 7 4.2 O=C1NC(=O)C2(CN(Cc3ccc4c(c3)CCc3c(-c5noc(-c6ccccc6)c5C(F)(F)F)noc3-4)C2)N1 10.1021/acs.jmedchem.6b01099
86299710 118876 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 482 12 3 8 3.1 CCc1cc(-c2noc(-c3ccnc(CCC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
CHEMBL3422425 118876 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 482 12 3 8 3.1 CCc1cc(-c2noc(-c3ccnc(CCC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
53234380 152414 0 None - 0 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 486 6 1 5 5.4 CC(C)Oc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1C(F)(F)F 10.1021/acs.jmedchem.6b01099
CHEMBL3970572 152414 0 None - 0 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 486 6 1 5 5.4 CC(C)Oc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1C(F)(F)F 10.1021/acs.jmedchem.6b01099
44398172 11779 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 315 10 3 3 4.0 CCCCCCCCc1ccc(-c2c[nH]c([C@H](N)CO)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1181739 11779 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 315 10 3 3 4.0 CCCCCCCCc1ccc(-c2c[nH]c([C@H](N)CO)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL190529 11779 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 315 10 3 3 4.0 CCCCCCCCc1ccc(-c2c[nH]c([C@H](N)CO)n2)cc1 10.1016/j.bmcl.2005.05.097
25110511 72048 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 316 4 0 3 4.7 O=C(c1cc(C2CC2)on1)N(C1CCCCCC1)C1CCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1976353 72048 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 316 4 0 3 4.7 O=C(c1cc(C2CC2)on1)N(C1CCCCCC1)C1CCCC1 10.1016/j.bmcl.2013.09.075
67172039 148990 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 484 6 1 4 5.8 CC(C)Cc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1C(F)(F)F 10.1021/acs.jmedchem.6b01099
CHEMBL3942289 148990 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 484 6 1 4 5.8 CC(C)Cc1ccc(-c2onc3c2CCc2cc(CN4CC(C(=O)O)C4)ccc2-3)cc1C(F)(F)F 10.1021/acs.jmedchem.6b01099
25110501 72175 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 332 4 0 4 3.8 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCOCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1979798 72175 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 332 4 0 4 3.8 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCOCC1 10.1016/j.bmcl.2013.09.075
46835914 139459 0 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 471 6 1 8 4.0 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccn5)c4C(F)(F)F)n3)cc2)C1 10.1016/j.bmcl.2016.03.105
CHEMBL3794145 139459 0 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 471 6 1 8 4.0 O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccn5)c4C(F)(F)F)n3)cc2)C1 10.1016/j.bmcl.2016.03.105
107970 1639 83 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2013.09.058
2407 1639 83 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2013.09.058
4167 1639 83 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2013.09.058
CHEMBL314854 1639 83 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2013.09.058
DB08868 1639 83 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at S1P3 receptor (unknown origin)Agonist activity at S1P3 receptor (unknown origin)
ChEMBL 307 12 3 3 3.2 CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N 10.1016/j.bmcl.2013.09.058
67171285 183301 0 None - 0 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 481 5 1 6 5.1 O=C(O)C1CN(Cc2ccc3c(c2)Cc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4797042 183301 0 None - 0 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 481 5 1 6 5.1 O=C(O)C1CN(Cc2ccc3c(c2)Cc2c-3noc2-c2noc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
25110484 72339 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 382 5 0 4 5.5 COc1ccc(-c2cc(C(=O)N(C3CCCCC3)C3CCCCC3)no2)cc1 10.1016/j.bmcl.2013.09.075
CHEMBL1984536 72339 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 382 5 0 4 5.5 COc1ccc(-c2cc(C(=O)N(C3CCCCC3)C3CCCCC3)no2)cc1 10.1016/j.bmcl.2013.09.075
11682677 11782 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 395 12 4 4 4.1 CCCCCCCCc1ccc(-c2c[nH]c([C@@H](N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1181748 11782 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 395 12 4 4 4.1 CCCCCCCCc1ccc(-c2c[nH]c([C@@H](N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL190865 11782 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 395 12 4 4 4.1 CCCCCCCCc1ccc(-c2c[nH]c([C@@H](N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
25110498 72925 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 330 4 0 3 4.9 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL2004782 72925 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 330 4 0 3 4.9 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
56955982 103746 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 344 4 0 3 5.4 O=C(c1cc(C2CCCC2)on1)N(C1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL3088204 103746 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 344 4 0 3 5.4 O=C(c1cc(C2CCCC2)on1)N(C1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
25110494 72021 0 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 330 5 0 3 4.9 O=C(c1cc(C2CC2)on1)N(CC1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1975200 72021 0 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 330 5 0 3 4.9 O=C(c1cc(C2CC2)on1)N(CC1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
25110500 71802 0 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 4 0 4 3.5 O=C(c1cc(C2CC2)on1)N(C1CCCCC1)C1CCOCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1967913 71802 0 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 4 0 4 3.5 O=C(c1cc(C2CC2)on1)N(C1CCCCC1)C1CCOCC1 10.1016/j.bmcl.2013.09.075
156016628 177691 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CC[C@](N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmcl.2020.127141
CHEMBL4641924 177691 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CC[C@](N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmcl.2020.127141
118717778 115172 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 525 7 2 8 3.3 N[C@@H](CO)COc1cc(Cl)c(-c2nnc(N3CCN(C(=O)c4cccc(Cl)c4)CC3)s2)cc1F 10.1016/j.bmcl.2014.09.003
CHEMBL3344420 115172 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 525 7 2 8 3.3 N[C@@H](CO)COc1cc(Cl)c(-c2nnc(N3CCN(C(=O)c4cccc(Cl)c4)CC3)s2)cc1F 10.1016/j.bmcl.2014.09.003
76336361 105758 1 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 454 10 3 8 2.6 CCc1cc(-c2noc(-c3ccnc(C(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
CHEMBL3126603 105758 1 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 454 10 3 8 2.6 CCc1cc(-c2noc(-c3ccnc(C(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
118717777 115171 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 483 7 2 8 2.5 N[C@@H](CO)COc1cc(Cl)c(-c2nnc(N3CCN(C(=O)C4CCCC4)CC3)s2)cc1F 10.1016/j.bmcl.2014.09.003
CHEMBL3344419 115171 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 483 7 2 8 2.5 N[C@@H](CO)COc1cc(Cl)c(-c2nnc(N3CCN(C(=O)C4CCCC4)CC3)s2)cc1F 10.1016/j.bmcl.2014.09.003
5309153 37498 10 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 5 0 3 4.7 CCCc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
CHEMBL1455786 37498 10 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 5 0 3 4.7 CCCc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
53235481 151142 0 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2onc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
CHEMBL3959509 151142 0 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2onc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
67170089 180047 0 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c(-c4onc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4747682 180047 0 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c(-c4onc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
118717764 115157 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 481 7 2 8 2.3 CC1(C)CC(C(=O)N2CCN(c3noc(-c4cc(F)c(OC[C@@H](N)CO)cc4Cl)n3)CC2)C1 10.1016/j.bmcl.2014.09.003
CHEMBL3344405 115157 0 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 481 7 2 8 2.3 CC1(C)CC(C(=O)N2CCN(c3noc(-c4cc(F)c(OC[C@@H](N)CO)cc4Cl)n3)CC2)C1 10.1016/j.bmcl.2014.09.003
44342175 85520 0 None -10 2 Human 6.4 pEC50 = 6.4 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL227371 85520 0 None -10 2 Human 6.4 pEC50 = 6.4 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL422074 85520 0 None -10 2 Human 6.4 pEC50 = 6.4 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
67167161 182196 0 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 6 5.8 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2snc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4782854 182196 0 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 511 5 1 6 5.8 O=C(O)C1CN(Cc2ccc3c(c2)CCc2c-3noc2-c2snc(-c3ccccc3)c2C(F)(F)F)C1 10.1021/acs.jmedchem.6b01099
118717771 115165 0 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 509 7 2 8 2.5 CC(C)(C(=O)N1CCN(c2noc(-c3cc(F)c(OC[C@@H](N)CO)cc3Cl)n2)CC1)C(F)(F)F 10.1016/j.bmcl.2014.09.003
CHEMBL3344413 115165 0 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 509 7 2 8 2.5 CC(C)(C(=O)N1CCN(c2noc(-c3cc(F)c(OC[C@@H](N)CO)cc3Cl)n2)CC1)C(F)(F)F 10.1016/j.bmcl.2014.09.003
76311231 106078 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assay
ChEMBL 460 11 4 6 3.7 CCCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmc.2016.03.059
CHEMBL3133603 106078 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assay
ChEMBL 460 11 4 6 3.7 CCCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmc.2016.03.059
CHEMBL3780292 106078 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assayAgonist activity at S1P3 receptor (unknown origin) expressed in CHO cells incubated for 2 hrs by HTRF-IP1 assay
ChEMBL 460 11 4 6 3.7 CCCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmc.2016.03.059
11452022 3596 39 None - 0 Human 8.3 pEC50 = 8.3 Binding
Agonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assayAgonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.5b01512
6996 3596 39 None - 0 Human 8.3 pEC50 = 8.3 Binding
Agonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assayAgonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.5b01512
CHEMBL366208 3596 39 None - 0 Human 8.3 pEC50 = 8.3 Binding
Agonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assayAgonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/acs.jmedchem.5b01512
44392705 66666 0 None - 0 Human 7.3 pEC50 = 7.3 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 380 17 4 4 3.2 CCCCCCCCCCCCCCNC(=O)[C@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
9821227 66666 0 None - 0 Human 7.3 pEC50 = 7.3 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 380 17 4 4 3.2 CCCCCCCCCCCCCCNC(=O)[C@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL185389 66666 0 None - 0 Human 7.3 pEC50 = 7.3 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 380 17 4 4 3.2 CCCCCCCCCCCCCCNC(=O)[C@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL332472 66666 0 None - 0 Human 7.3 pEC50 = 7.3 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 380 17 4 4 3.2 CCCCCCCCCCCCCCNC(=O)[C@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
127031187 138882 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmcl.2020.127141
CHEMBL3781008 138882 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmcl.2020.127141
CHEMBL3782062 138882 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CCC(N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmcl.2020.127141
25110499 71697 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 344 4 0 3 5.3 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL1965004 71697 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 344 4 0 3 5.3 CC1CCCCC1N(C(=O)c1cc(C2CC2)on1)C1CCCCCC1 10.1016/j.bmcl.2013.09.075
56955980 103745 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 358 4 0 3 5.8 O=C(c1cc(C2CCCCC2)on1)N(C1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
CHEMBL3088203 103745 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 358 4 0 3 5.8 O=C(c1cc(C2CCCCC2)on1)N(C1CCCCC1)C1CCCCC1 10.1016/j.bmcl.2013.09.075
44342246 11412 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 396 18 4 5 3.2 CCCCCCCCCCCCCCONC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL115505 11412 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 396 18 4 5 3.2 CCCCCCCCCCCCCCONC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL1180159 11412 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 396 18 4 5 3.2 CCCCCCCCCCCCCCONC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
162656217 180967 0 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 561 7 2 8 4.0 CS(=O)(=O)CCNC(=O)C(O)c1ccc2c(c1)CCc1c(-c3noc(-c4ccccc4)c3C(F)(F)F)noc1-2 10.1021/acs.jmedchem.6b01099
CHEMBL4758481 180967 0 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 561 7 2 8 4.0 CS(=O)(=O)CCNC(=O)C(O)c1ccc2c(c1)CCc1c(-c3noc(-c4ccccc4)c3C(F)(F)F)noc1-2 10.1021/acs.jmedchem.6b01099
46847148 139378 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 445 8 1 8 3.9 CCCc1c(-c2ccccn2)noc1-c1nc(-c2ccc(CN3CC(C(=O)O)C3)cc2)no1 10.1016/j.bmcl.2016.03.105
CHEMBL3793145 139378 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 445 8 1 8 3.9 CCCc1c(-c2ccccn2)noc1-c1nc(-c2ccc(CN3CC(C(=O)O)C3)cc2)no1 10.1016/j.bmcl.2016.03.105
44398076 12900 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 425 13 5 5 3.2 CCCCCCCCc1ccc(-c2c[nH]c(C(N)(CO)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1188968 12900 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 425 13 5 5 3.2 CCCCCCCCc1ccc(-c2c[nH]c(C(N)(CO)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL537849 12900 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 425 13 5 5 3.2 CCCCCCCCc1ccc(-c2c[nH]c(C(N)(CO)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
25110212 103744 0 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 319 5 0 4 3.8 O=C(c1cc(C2CC2)on1)N(Cc1ccccc1)c1ccccn1 10.1016/j.bmcl.2013.09.075
CHEMBL3088201 103744 0 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 319 5 0 4 3.8 O=C(c1cc(C2CC2)on1)N(Cc1ccccc1)c1ccccn1 10.1016/j.bmcl.2013.09.075
3245758 27631 7 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 290 3 0 3 4.1 Cc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
CHEMBL1369793 27631 7 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 290 3 0 3 4.1 Cc1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
44398170 11772 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 411 12 4 4 4.2 CCCCCCCCc1ccc(-c2c[nH]c([C@@H](N)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1181688 11772 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 411 12 4 4 4.2 CCCCCCCCc1ccc(-c2c[nH]c([C@@H](N)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL188826 11772 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 411 12 4 4 4.2 CCCCCCCCc1ccc(-c2c[nH]c([C@@H](N)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
76329075 105759 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 468 12 3 8 2.9 CCCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/ml500484v
CHEMBL3126604 105759 0 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 468 12 3 8 2.9 CCCCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/ml500484v
25110210 103688 0 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 5 0 3 4.4 O=C(c1cc(C2CC2)on1)N(Cc1ccccc1)c1ccccc1 10.1016/j.bmcl.2013.09.075
CHEMBL3087666 103688 0 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 5 0 3 4.4 O=C(c1cc(C2CC2)on1)N(Cc1ccccc1)c1ccccc1 10.1016/j.bmcl.2013.09.075
156013851 177195 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmcl.2020.127141
CHEMBL4635110 177195 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at S1PR3 (unknown origin) by HTRF assayAgonist activity at S1PR3 (unknown origin) by HTRF assay
ChEMBL 446 10 4 6 3.3 CCc1nc(-c2ccc(-c3ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc3)cc2)co1 10.1016/j.bmcl.2020.127141
76325522 105734 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 480 10 3 8 3.2 CCc1cc(-c2noc(-c3ccnc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
CHEMBL3126433 105734 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 480 10 3 8 3.2 CCc1cc(-c2noc(-c3ccnc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
44342331 11416 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 428 16 4 4 4.5 CCCCCCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL116953 11416 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 428 16 4 4 4.5 CCCCCCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL1180214 11416 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 428 16 4 4 4.5 CCCCCCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
162671724 182963 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 567 7 2 7 6.0 O=C(O)C[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4792990 182963 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 567 7 2 7 6.0 O=C(O)C[C@H]1CCCN(CC(O)c2ccc3c(c2)CCc2c(-c4noc(-c5ccccc5)c4C(F)(F)F)noc2-3)C1 10.1021/acs.jmedchem.6b01099
76325532 105760 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccnc(CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
CHEMBL3126605 105760 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 468 11 3 8 2.7 CCc1cc(-c2noc(-c3ccnc(CC(C)C)c3)n2)cc(C)c1OC[C@@H](O)CNC(=O)CO 10.1021/ml500484v
11675907 11776 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 409 12 4 4 4.3 CCCCCCCCc1ccc(-c2c[nH]c(C(C)(N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1181694 11776 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 409 12 4 4 4.3 CCCCCCCCc1ccc(-c2c[nH]c(C(C)(N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL188881 11776 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 409 12 4 4 4.3 CCCCCCCCc1ccc(-c2c[nH]c(C(C)(N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2005.05.097
10883396 3649 45 None -1 4 Human 7.1 pEC50 = 7.1 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2015.11.090
5283560 3649 45 None -1 4 Human 7.1 pEC50 = 7.1 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2015.11.090
911 3649 45 None -1 4 Human 7.1 pEC50 = 7.1 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2015.11.090
CHEMBL225155 3649 45 None -1 4 Human 7.1 pEC50 = 7.1 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2015.11.090
44398049 13178 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 441 13 5 5 3.4 CCCCCCCCc1ccc(-c2c[nH]c(C(N)(CO)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL1190950 13178 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 441 13 5 5 3.4 CCCCCCCCc1ccc(-c2c[nH]c(C(N)(CO)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
CHEMBL541890 13178 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 441 13 5 5 3.4 CCCCCCCCc1ccc(-c2c[nH]c(C(N)(CO)COP(O)(O)=S)n2)cc1 10.1016/j.bmcl.2005.05.097
162652005 180301 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to controlAgonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to control
ChEMBL 361 12 3 3 4.2 CCCCCCCCC1CCc2cc(CCC(N)(CO)CO)ccc2C1 10.1021/acs.jmedchem.6b01433
CHEMBL4750944 180301 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to controlAgonist activity at human S1P3 expressed in EDG3-Ga15-bla HEK293T cells incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay relative to control
ChEMBL 361 12 3 3 4.2 CCCCCCCCC1CCc2cc(CCC(N)(CO)CO)ccc2C1 10.1021/acs.jmedchem.6b01433
25110489 72032 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 304 5 0 3 4.3 CCCc1cc(C(=O)N(C2CCCCC2)C2CCCC2)no1 10.1016/j.bmcl.2013.09.075
CHEMBL1975908 72032 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 304 5 0 3 4.3 CCCc1cc(C(=O)N(C2CCCCC2)C2CCCC2)no1 10.1016/j.bmcl.2013.09.075
10883396 3649 45 None -1 4 Human 8.1 pEC50 = 8.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2005.05.097
5283560 3649 45 None -1 4 Human 8.1 pEC50 = 8.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2005.05.097
911 3649 45 None -1 4 Human 8.1 pEC50 = 8.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2005.05.097
CHEMBL225155 3649 45 None -1 4 Human 8.1 pEC50 = 8.1 Binding
Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assayEffective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2005.05.097
10883396 3649 45 None -1 4 Human 8.1 pEC50 = 8.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
5283560 3649 45 None -1 4 Human 8.1 pEC50 = 8.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
911 3649 45 None -1 4 Human 8.1 pEC50 = 8.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
CHEMBL225155 3649 45 None -1 4 Human 8.1 pEC50 = 8.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/s0960-894x(03)00812-6
72546270 103747 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 440 8 0 5 6.2 CCOc1ccc(-c2cc(C(=O)N(C3CCCCC3)C3CCCCC3)no2)cc1OCC 10.1016/j.bmcl.2013.09.075
CHEMBL3088205 103747 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 440 8 0 5 6.2 CCOc1ccc(-c2cc(C(=O)N(C3CCCCC3)C3CCCCC3)no2)cc1OCC 10.1016/j.bmcl.2013.09.075
46847146 139400 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 445 7 1 8 4.1 CC(C)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccn1 10.1016/j.bmcl.2016.03.105
CHEMBL3793394 139400 0 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 receptor expressed in EDG3-Ga15-bla HEK293T cell membranes assessed as stimulation of [35S]GTPgamma binding incubated for 45 mins by liquid scintillation counting method
ChEMBL 445 7 1 8 4.1 CC(C)c1c(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)noc1-c1ccccn1 10.1016/j.bmcl.2016.03.105
44342221 12093 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 352 15 4 4 2.5 CCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL1183918 12093 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 352 15 4 4 2.5 CCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL324358 12093 0 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 352 15 4 4 2.5 CCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
44342244 64876 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 380 17 4 4 3.2 CCCCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL182164 64876 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 380 17 4 4 3.2 CCCCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL423691 64876 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 380 17 4 4 3.2 CCCCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
44342231 12100 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 408 19 4 4 4.0 CCCCCCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL1183950 12100 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 408 19 4 4 4.0 CCCCCCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
CHEMBL325408 12100 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 408 19 4 4 4.0 CCCCCCCCCCCCCCCCNC(=O)[C@@H](N)COP(=O)(O)O 10.1016/s0960-894x(03)00812-6
10023913 12133 0 None - 0 Human 7.1 pEC50 = 7.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 400 14 4 4 3.7 CCCCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL1184130 12133 0 None - 0 Human 7.1 pEC50 = 7.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 400 14 4 4 3.7 CCCCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
CHEMBL334038 12133 0 None - 0 Human 7.1 pEC50 = 7.1 Binding
In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligandIn vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL 400 14 4 4 3.7 CCCCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/s0960-894x(03)00812-6
67172256 181174 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2nc(-c4onc(-c5ccccc5)c4C(F)(F)F)oc2-3)C1 10.1021/acs.jmedchem.6b01099
CHEMBL4760972 181174 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting methodAgonist activity at human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method
ChEMBL 495 5 1 6 5.3 O=C(O)C1CN(Cc2ccc3c(c2)CCc2nc(-c4onc(-c5ccccc5)c4C(F)(F)F)oc2-3)C1 10.1021/acs.jmedchem.6b01099
11452022 3596 39 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2015.11.090
6996 3596 39 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2015.11.090
CHEMBL366208 3596 39 None - 0 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2015.11.090
118717795 114834 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 547 9 3 9 2.2 N[C@H](COc1cc(Cl)c(-c2nc(N3CCN(C(=O)C4CCCC4)CC3)no2)cc1F)COP(=O)(O)O 10.1016/j.bmcl.2014.09.003
CHEMBL3341785 114834 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assayAgonist activity at human S1P3 receptor expressed in human EDG3-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay
ChEMBL 547 9 3 9 2.2 N[C@H](COc1cc(Cl)c(-c2nc(N3CCN(C(=O)C4CCCC4)CC3)no2)cc1F)COP(=O)(O)O 10.1016/j.bmcl.2014.09.003
17253281 71826 9 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 4 0 3 4.9 CC(C)c1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
CHEMBL1968913 71826 9 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assayAgonist activity at human S1P3 receptor expressed in CHO cells after 4 hrs by fluorescence assay
ChEMBL 318 4 0 3 4.9 CC(C)c1cc(C(=O)N(C2CCCCC2)C2CCCCC2)no1 10.1016/j.bmcl.2013.09.075
76318195 105756 0 None - 0 Human 5.0 pEC50 = 5 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 440 10 3 8 2.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/ml500484v
CHEMBL3126601 105756 0 None - 0 Human 5.0 pEC50 = 5 Binding
Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assayAgonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay
ChEMBL 440 10 3 8 2.1 CCc1cc(-c2nc(-c3cc(C)c(OC[C@@H](O)CNC(=O)CO)c(CC)c3)no2)ccn1 10.1021/ml500484v
10883396 3649 45 None -1 4 Human 10.4 pIC50 = 10.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.02.106
5283560 3649 45 None -1 4 Human 10.4 pIC50 = 10.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.02.106
911 3649 45 None -1 4 Human 10.4 pIC50 = 10.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.02.106
CHEMBL225155 3649 45 None -1 4 Human 10.4 pIC50 = 10.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2004.02.106
10883396 3649 45 None -1 4 Human 9.6 pIC50 = 9.6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm0492507
5283560 3649 45 None -1 4 Human 9.6 pIC50 = 9.6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm0492507
911 3649 45 None -1 4 Human 9.6 pIC50 = 9.6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm0492507
CHEMBL225155 3649 45 None -1 4 Human 9.6 pIC50 = 9.6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1021/jm0492507
44565597 179287 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 436 12 4 5 3.2 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473156 179287 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 436 12 4 5 3.2 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
10883396 3649 45 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counterDisplacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counter
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1039/d1md00357g
5283560 3649 45 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counterDisplacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counter
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1039/d1md00357g
911 3649 45 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counterDisplacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counter
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1039/d1md00357g
CHEMBL225155 3649 45 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counterDisplacement of [32P]S1P from human recombinant S1PR3 incubated for 60 mins by competitive binding assay based scintillation counter
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1039/d1md00357g
10883396 3649 45 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting methodDisplacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting method
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2017.12.010
5283560 3649 45 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting methodDisplacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting method
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2017.12.010
911 3649 45 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting methodDisplacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting method
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2017.12.010
CHEMBL225155 3649 45 None -1 4 Human 9.4 pIC50 = 9.4 Binding
Displacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting methodDisplacement of [32P]S1P from recombinant human S1PR3 expressed in Chem1 cell membranes co-expressing Galpha15 pretreated for 30 mins followed by [32P]S1P addition measured after 60 mins by scintillation counting method
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2017.12.010
10883396 3649 45 None -1 4 Human 9.2 pIC50 = 9.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
5283560 3649 45 None -1 4 Human 9.2 pIC50 = 9.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
911 3649 45 None -1 4 Human 9.2 pIC50 = 9.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
CHEMBL225155 3649 45 None -1 4 Human 9.2 pIC50 = 9.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2008.11.072
10150171 168009 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 357 13 3 3 4.0 CCCCCCCCc1ccc(CCC(N)COP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL432067 168009 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 357 13 3 3 4.0 CCCCCCCCc1ccc(CCC(N)COP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
10150171 168009 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 357 13 3 3 4.0 CCCCCCCCc1ccc(CCC(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL432067 168009 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 357 13 3 3 4.0 CCCCCCCCc1ccc(CCC(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
44159280 126931 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 4 6.2 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655496 126931 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 4 6.2 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
44344390 13497 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 15 3 2 4.5 O=P(O)(O)CCCNCCCCCCCCCCc1ccccc1 10.1016/j.bmcl.2004.04.069
CHEMBL119349 13497 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 15 3 2 4.5 O=P(O)(O)CCCNCCCCCCCCCCc1ccccc1 10.1016/j.bmcl.2004.04.069
10883396 3649 45 None -1 4 Human 9.0 pIC50 = 9.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
5283560 3649 45 None -1 4 Human 9.0 pIC50 = 9.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
911 3649 45 None -1 4 Human 9.0 pIC50 = 9.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
CHEMBL225155 3649 45 None -1 4 Human 9.0 pIC50 = 9.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10.1016/j.bmcl.2010.02.098
10172546 114444 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 15 3 3 4.5 CCCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL333335 114444 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 15 3 3 4.5 CCCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
10193915 14185 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 375 14 3 3 4.2 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1F 10.1016/j.bmcl.2004.04.070
CHEMBL119873 14185 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 375 14 3 3 4.2 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1F 10.1016/j.bmcl.2004.04.070
25059746 126842 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 9 1 3 7.1 CC(C)COc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655408 126842 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 9 1 3 7.1 CC(C)COc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
10215138 14081 0 None - 0 Human 8.0 pIC50 = 8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 321 15 3 2 4.6 CCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL119760 14081 0 None - 0 Human 8.0 pIC50 = 8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 321 15 3 2 4.6 CCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
44159280 126931 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 4 6.2 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655496 126931 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 4 6.2 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
59762369 126937 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 493 8 1 5 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ncco1 nan
CHEMBL3655502 126937 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 493 8 1 5 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ncco1 nan
59762343 126946 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 512 8 1 5 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3cccnc3)cc2n1Cc1ccccn1 nan
CHEMBL3655510 126946 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 512 8 1 5 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3cccnc3)cc2n1Cc1ccccn1 nan
44565715 180443 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 498 12 4 5 4.5 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL475253 180443 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 498 12 4 5 4.5 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
137651211 157325 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 339 13 2 2 5.0 CCCCCCCCc1ccc(CNCCCP(C)(=O)O)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL4077381 157325 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 339 13 2 2 5.0 CCCCCCCCc1ccc(CNCCCP(C)(=O)O)cc1 10.1021/acs.jmedchem.6b01575
44565596 189546 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 422 11 4 5 2.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL514302 189546 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 422 11 4 5 2.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2ccccc2)cc1 10.1016/j.bmcl.2009.02.073
11510741 189770 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 452 12 4 6 2.9 COc1ccc(CCCCOc2ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL516035 189770 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 452 12 4 6 2.9 COc1ccc(CCCCOc2ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc2)cc1 10.1016/j.bmcl.2009.02.073
44344360 10246 0 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 339 14 3 3 4.8 CCCCCCCCCc1ccc(CNCCCP(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL1160958 10246 0 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 339 14 3 3 4.8 CCCCCCCCCc1ccc(CNCCCP(O)O)cc1 10.1016/j.bmcl.2004.04.069
44344338 13382 0 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 369 15 3 2 4.7 CCCCCCCc1ccc(CCCCNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL119257 13382 0 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 369 15 3 2 4.7 CCCCCCCc1ccc(CCCCNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
10173002 168105 0 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 401 15 3 4 4.4 CCCCCCCCOc1c(C)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL432813 168105 0 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 401 15 3 4 4.4 CCCCCCCCOc1c(C)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
10195325 85120 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 461 7 1 4 5.9 O=C(O)C1CCN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1021/jm0492507
CHEMBL224799 85120 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 461 7 1 4 5.9 O=C(O)C1CCN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1021/jm0492507
10174255 85217 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 485 6 1 6 5.7 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)C1 10.1021/jm0492507
CHEMBL225575 85217 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 485 6 1 6 5.7 O=C(O)C1CN(Cc2ccc(-c3noc(-c4cc(-c5ccccc5)c(C(F)(F)F)s4)n3)cc2)C1 10.1021/jm0492507
46885744 7761 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 548 10 4 5 4.5 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(Br)c1 10.1016/j.bmcl.2010.02.098
CHEMBL1089127 7761 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 548 10 4 5 4.5 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(Br)c1 10.1016/j.bmcl.2010.02.098
138377599 181439 15 None - 0 Human 6.0 pIC50 = 6 Binding
Immunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assayImmunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assay
ChEMBL 408 5 0 5 5.1 CCC/N=C1\S/C(=C\c2ccc(OC(C)=O)c(C)c2)C(=O)N1c1ccccc1C 10.1021/acsmedchemlett.8b00616
CHEMBL4764124 181439 15 None - 0 Human 6.0 pIC50 = 6 Binding
Immunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assayImmunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assay
ChEMBL 408 5 0 5 5.1 CCC/N=C1\S/C(=C\c2ccc(OC(C)=O)c(C)c2)C(=O)N1c1ccccc1C 10.1021/acsmedchemlett.8b00616
44412232 166320 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 391 6 2 5 4.5 CC(C)Cc1ccc(-c2nc(-c3ccc([C@@H]4CC[C@@H](C(=O)O)N4)cc3)no2)cc1 10.1016/j.bmcl.2006.03.038
CHEMBL427221 166320 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 391 6 2 5 4.5 CC(C)Cc1ccc(-c2nc(-c3ccc([C@@H]4CC[C@@H](C(=O)O)N4)cc3)no2)cc1 10.1016/j.bmcl.2006.03.038
58907658 86570 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 350 13 3 4 3.6 CCCCCCCCOc1ccc(NC(=O)[C@@H](N)CCC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
CHEMBL2315815 86570 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 350 13 3 4 3.6 CCCCCCCCOc1ccc(NC(=O)[C@@H](N)CCC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
58907531 86571 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 364 13 3 4 3.9 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)CCC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
CHEMBL2315816 86571 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 364 13 3 4 3.9 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)CCC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
11501417 86572 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 362 12 3 4 3.7 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)/C=C/C(=O)O)cc1 10.1016/j.bmcl.2012.11.053
CHEMBL2315817 86572 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 362 12 3 4 3.7 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)/C=C/C(=O)O)cc1 10.1016/j.bmcl.2012.11.053
11408903 85126 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 475 7 1 4 6.1 Cc1cc(CN2CC(C(=O)O)C2)cc(C)c1OCc1cc(-c2ccccc2)c(C(F)(F)F)s1 10.1021/jm0492507
CHEMBL224853 85126 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 475 7 1 4 6.1 Cc1cc(CN2CC(C(=O)O)C2)cc(C)c1OCc1cc(-c2ccccc2)c(C(F)(F)F)s1 10.1021/jm0492507
11705484 179296 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2cccc(-c3ccccc3)c2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473237 179296 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2cccc(-c3ccccc3)c2)cc1 10.1016/j.bmcl.2009.02.073
44565713 180438 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 495 10 4 6 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3C#N)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL475247 180438 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 495 10 4 6 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3C#N)cc2)cc1 10.1016/j.bmcl.2009.02.073
58907649 86569 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 336 12 3 4 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@H](N)CC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
CHEMBL2315814 86569 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysisDisplacement of [33P]S1P from human S1P3 receptor expressed in HEK293T cells after 1 hr by liquid scintillation counting analysis
ChEMBL 336 12 3 4 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@H](N)CC(=O)O)cc1 10.1016/j.bmcl.2012.11.053
10287091 10601 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 14 4 3 4.1 CCCCCCCCC(O)c1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL117007 10601 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 14 4 3 4.1 CCCCCCCCC(O)c1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
10309271 13358 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 373 14 4 4 3.8 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1O 10.1016/j.bmcl.2004.04.070
CHEMBL119239 13358 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 373 14 4 4 3.8 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1O 10.1016/j.bmcl.2004.04.070
44413349 77639 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 453 6 2 5 5.4 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
CHEMBL208838 77639 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 453 6 2 5 5.4 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
44217417 126430 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 411 9 3 4 4.0 CCc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccncc2)cc1 nan
CHEMBL3651719 126430 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 411 9 3 4 4.0 CCc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccncc2)cc1 nan
59762441 126918 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 9 1 5 5.7 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(CN3CCCC3)n(Cc3ccccn3)c2c1 nan
CHEMBL3655482 126918 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 9 1 5 5.7 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(CN3CCCC3)n(Cc3ccccn3)c2c1 nan
59762392 126885 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 7 1 4 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=NCC(C)(C)O3)cc2n1Cc1ccccc1 nan
CHEMBL3655450 126885 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 7 1 4 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=NCC(C)(C)O3)cc2n1Cc1ccccc1 nan
25060001 126949 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 7 1 4 5.8 COC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655513 126949 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 7 1 4 5.8 COC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59504175 126960 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 9 1 4 6.8 CC(C)COC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655525 126960 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 9 1 4 6.8 CC(C)COC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44565621 179314 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 428 11 4 6 2.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2cccs2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473360 179314 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 428 11 4 6 2.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCc2cccs2)cc1 10.1016/j.bmcl.2009.02.073
59762314 126922 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 488 7 1 4 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N3CCCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655487 126922 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 488 7 1 4 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N3CCCC3)cc2n1Cc1ccccn1 nan
10236683 168091 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 319 14 2 2 4.9 CCCCCCCCCc1ccc(CNCCCC(=O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL432632 168091 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 319 14 2 2 4.9 CCCCCCCCCc1ccc(CNCCCC(=O)O)cc1 10.1016/j.bmcl.2004.04.069
137638716 156974 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 305 13 2 2 4.5 CCCCCCCCc1ccc(CNCCCC(=O)O)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL4072987 156974 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 305 13 2 2 4.5 CCCCCCCCc1ccc(CNCCCC(=O)O)cc1 10.1021/acs.jmedchem.6b01575
44233260 126969 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 442 9 1 5 5.3 CCCOc1ccc2c(C(=O)NCc3cccnc3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655534 126969 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 442 9 1 5 5.3 CCCOc1ccc2c(C(=O)NCc3cccnc3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
44394117 66341 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 17 2 2 6.1 CCCCCCCCCCCCCCC1CCCN1CCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
CHEMBL185066 66341 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 17 2 2 6.1 CCCCCCCCCCCCCCC1CCCN1CCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
10430549 1048 39 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 10.1021/jm0503244
2929 1048 39 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 10.1021/jm0503244
CHEMBL194419 1048 39 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 10.1021/jm0503244
10249887 70928 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 391 5 1 5 4.2 CC(C)(C)c1ccc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)cc1 10.1021/jm0503244
CHEMBL195141 70928 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 391 5 1 5 4.2 CC(C)(C)c1ccc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)cc1 10.1021/jm0503244
9979368 71706 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 417 6 1 5 5.0 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(C5CCCCC5)cc4)n3)cc2)C1 10.1021/jm0503244
CHEMBL196534 71706 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 417 6 1 5 5.0 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(C5CCCCC5)cc4)n3)cc2)C1 10.1021/jm0503244
10430549 1048 39 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 10.1016/j.bmcl.2006.03.090
2929 1048 39 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 10.1016/j.bmcl.2006.03.090
CHEMBL194419 1048 39 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 391 7 1 5 4.1 CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C 10.1016/j.bmcl.2006.03.090
44233258 126970 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 456 9 1 5 5.6 CC(C)COc1ccc2c(C(=O)NCc3cccnc3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655535 126970 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 456 9 1 5 5.6 CC(C)COc1ccc2c(C(=O)NCc3cccnc3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
10151146 13211 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 425 14 3 3 5.4 CCCCCCCCOc1c(Cl)cc(CNCCCP(=O)(O)O)cc1Cl 10.1016/j.bmcl.2004.04.070
CHEMBL119116 13211 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 425 14 3 3 5.4 CCCCCCCCOc1c(Cl)cc(CNCCCP(=O)(O)O)cc1Cl 10.1016/j.bmcl.2004.04.070
44344210 13807 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 307 15 3 2 4.1 CCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL119562 13807 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 307 15 3 2 4.1 CCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
59762430 126906 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 486 8 1 5 6.0 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655470 126906 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 486 8 1 5 6.0 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
59762388 126924 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 487 8 2 3 7.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655489 126924 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 487 8 2 3 7.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCC3)cc2n1Cc1ccccc1 nan
10216035 11035 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 391 20 3 2 6.5 CCCCCCCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL117569 11035 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 391 20 3 2 6.5 CCCCCCCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
59762287 126936 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 7 1 5 5.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N3CCOCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655501 126936 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 7 1 5 5.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N3CCOCC3)cc2n1Cc1ccccn1 nan
11743459 140791 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 431 7 1 5 4.4 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(CCC(F)(F)F)cc4)n3)cc2)C1 10.1021/jm0503244
CHEMBL381872 140791 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 431 7 1 5 4.4 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(CCC(F)(F)F)cc4)n3)cc2)C1 10.1021/jm0503244
44234512 127417 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 8 1 5 5.4 CO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659693 127417 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 8 1 5 5.4 CO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
10125861 13200 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 16 3 2 5.0 CCCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL119110 13200 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 16 3 2 5.0 CCCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
44344412 13354 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.3 CCCCCCCc1ccc(CCCNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL119233 13354 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.3 CCCCCCCc1ccc(CCCNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
44232784 126852 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 7 1 4 5.9 CC(=O)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655418 126852 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 7 1 4 5.9 CC(=O)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44232786 126854 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.6 CC(C)C(=O)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655420 126854 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.6 CC(C)C(=O)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
10408874 72490 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 403 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(C5CCCC5)cc4)n3)cc2)C1 10.1021/jm0503244
CHEMBL198976 72490 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 403 6 1 5 4.6 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc(C5CCCC5)cc4)n3)cc2)C1 10.1021/jm0503244
59504166 126968 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 9 1 4 6.4 CCO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655533 126968 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 9 1 4 6.4 CCO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44233495 127402 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 8 1 4 7.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(/C=N/OC(C)(C)C)cc2n1Cc1ccccc1 nan
CHEMBL3659678 127402 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 8 1 4 7.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(/C=N/OC(C)(C)C)cc2n1Cc1ccccc1 nan
25060537 126954 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 9 2 3 6.2 CCCNC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655519 126954 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 9 2 3 6.2 CCCNC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44233497 127404 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 1 4 6.4 CO/N=C(\C)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3659680 127404 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 1 4 6.4 CO/N=C(\C)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
21455530 10142 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 363 19 3 2 5.6 CCCCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL115738 10142 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 363 19 3 2 5.6 CCCCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
59762339 126890 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 479 8 2 5 5.1 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)O)n(Cc3ccccn3)c2c1 nan
CHEMBL3655455 126890 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 479 8 2 5 5.1 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)O)n(Cc3ccccn3)c2c1 nan
59762277 126912 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 4 6.2 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3cccnc3)c2c1 nan
CHEMBL3655476 126912 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 4 6.2 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3cccnc3)c2c1 nan
44234257 127415 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 9 1 4 6.2 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659691 127415 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 9 1 4 6.2 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
44413430 138769 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 405 7 2 5 4.7 CC(C)Cc1ccc(-c2nc(-c3ccc([C@H]4C[C@@H](CC(=O)O)CN4)cc3)no2)cc1 10.1016/j.bmcl.2006.03.090
CHEMBL378061 138769 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 405 7 2 5 4.7 CC(C)Cc1ccc(-c2nc(-c3ccc([C@H]4C[C@@H](CC(=O)O)CN4)cc3)no2)cc1 10.1016/j.bmcl.2006.03.090
59762368 126921 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 8 2 4 6.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655485 126921 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 8 2 4 6.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccn1 nan
59762285 126901 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 8 1 5 7.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1ccccc1 nan
CHEMBL3655466 126901 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 8 1 5 7.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1ccccc1 nan
11555202 179731 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 504 10 4 5 4.4 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3Cl)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL474407 179731 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 504 10 4 5 4.4 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3Cl)cc2)cc1 10.1016/j.bmcl.2009.02.073
44234513 126427 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 382 8 3 3 4.1 O=P(O)(O)CCCNCc1ccc(-c2ccccc2)c(-c2ccccc2)n1 nan
CHEMBL3651716 126427 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 382 8 3 3 4.1 O=P(O)(O)CCCNCc1ccc(-c2ccccc2)c(-c2ccccc2)n1 nan
59762273 126878 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 8 2 5 5.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](CO)CO3)cc2n1Cc1ccccc1 nan
CHEMBL3655444 126878 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 8 2 5 5.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](CO)CO3)cc2n1Cc1ccccc1 nan
59762438 126927 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 8 2 4 6.6 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655492 126927 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 8 2 4 6.6 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
59504167 126439 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 461 6 2 4 5.7 O=C(NCc1ccc(F)c(F)c1)c1c(C2CCCC2)n(Cc2ccccn2)c2ccc(O)cc12 nan
CHEMBL3651727 126439 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 461 6 2 4 5.7 O=C(NCc1ccc(F)c(F)c1)c1c(C2CCCC2)n(Cc2ccccn2)c2ccc(O)cc12 nan
59762397 126872 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 8 1 4 6.6 CC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ccccc4)c3c2)=N1 nan
CHEMBL3655438 126872 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 8 1 4 6.6 CC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ccccc4)c3c2)=N1 nan
59762381 126910 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 6 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1cccnc1 nan
CHEMBL3655474 126910 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 6 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1cccnc1 nan
44394149 124027 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 377 15 3 3 4.5 CCCCCCCCCCCCCCN1CCC(C(O)P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
CHEMBL363008 124027 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 377 15 3 3 4.5 CCCCCCCCCCCCCCN1CCC(C(O)P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
10308738 10271 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 14 3 3 3.9 CCCCCCCCCc1ccc(CNCC(O)CC(=O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL116140 10271 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 14 3 3 3.9 CCCCCCCCCc1ccc(CNCC(O)CC(=O)O)cc1 10.1016/j.bmcl.2004.04.069
10286857 168104 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 353 14 2 2 5.4 CCCCCCCCCc1ccc(CNCCCP(C)(=O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL432809 168104 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 353 14 2 2 5.4 CCCCCCCCCc1ccc(CNCCCP(C)(=O)O)cc1 10.1016/j.bmcl.2004.04.069
25060262 126950 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 7 1 3 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C(=O)N3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655515 126950 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 7 1 3 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C(=O)N3CCCC3)cc2n1Cc1ccccc1 nan
44412416 78197 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 431 6 2 5 5.7 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc(C5CCCCC5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
CHEMBL210520 78197 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 431 6 2 5 5.7 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc(C5CCCCC5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
59762431 126895 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 433 6 2 3 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N)cc2n1Cc1ccccc1 nan
CHEMBL3655460 126895 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 433 6 2 3 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N)cc2n1Cc1ccccc1 nan
44233749 127407 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 5 5.5 CCOC(=O)c1ccc2c(C(=O)NCc3cccc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659683 127407 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 5 5.5 CCOC(=O)c1ccc2c(C(=O)NCc3cccc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
59762344 126896 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCOC3)cc2n1Cc1ccccc1 nan
CHEMBL3655461 126896 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCOC3)cc2n1Cc1ccccc1 nan
10384596 10136 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL115713 10136 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
10384596 10136 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL115713 10136 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
59762383 126882 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 516 8 1 5 6.0 CC[C@H]1COC(c2ccc3c(C(=O)NCc4cc(F)cc(F)c4)c(C(C)C)n(Cc4ccccn4)c3c2)=N1 nan
CHEMBL3655448 126882 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 516 8 1 5 6.0 CC[C@H]1COC(c2ccc3c(C(=O)NCc4cc(F)cc(F)c4)c(C(C)C)n(Cc4ccccn4)c3c2)=N1 nan
44341276 10106 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL115554 10106 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
10287034 66183 3 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 367 11 2 2 4.7 CCCCCCCCCc1ccc(CN2CCC(P(=O)(O)O)C2)cc1 10.1016/j.bmcl.2004.07.049
CHEMBL184349 66183 3 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 367 11 2 2 4.7 CCCCCCCCCc1ccc(CN2CCC(P(=O)(O)O)C2)cc1 10.1016/j.bmcl.2004.07.049
10287365 10573 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 389 12 3 2 5.1 CCCCCCc1ccc(-c2ccc(CNCCCP(=O)(O)O)cc2)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL116981 10573 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 389 12 3 2 5.1 CCCCCCc1ccc(-c2ccc(CNCCCP(=O)(O)O)cc2)cc1 10.1016/j.bmcl.2004.04.070
44234516 126429 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 396 8 3 3 4.2 CCc1ccc(-c2ccc(CNCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
CHEMBL3651718 126429 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 396 8 3 3 4.2 CCc1ccc(-c2ccc(CNCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
44234760 126432 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 397 8 3 4 3.6 CCc1ccc(-c2ccc(CNCCP(=O)(O)O)nc2-c2ccncc2)cc1 nan
CHEMBL3651720 126432 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 397 8 3 4 3.6 CCc1ccc(-c2ccc(CNCCP(=O)(O)O)nc2-c2ccncc2)cc1 nan
59504169 126967 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 455 8 1 5 5.3 CCOC(=O)c1ccc2c(C(=O)NCc3cccnc3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655532 126967 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 455 8 1 5 5.3 CCOC(=O)c1ccc2c(C(=O)NCc3cccnc3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762366 126939 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 467 8 1 5 5.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ncco3)c2c1 nan
CHEMBL3655504 126939 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 467 8 1 5 5.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ncco3)c2c1 nan
25059487 126424 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 462 8 1 3 6.4 CCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3651713 126424 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 462 8 1 3 6.4 CCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
25059487 126424 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 462 8 1 3 6.4 CCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3651713 126424 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 462 8 1 3 6.4 CCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44234005 127409 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 8 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOC3)cc2n1Cc1ccccn1 nan
CHEMBL3659685 127409 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 8 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOC3)cc2n1Cc1ccccn1 nan
44394153 66156 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 363 14 3 3 4.3 CCCCCCCCCCCCCCN1CCC(O)(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
CHEMBL184237 66156 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 363 14 3 3 4.3 CCCCCCCCCCCCCCN1CCC(O)(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
44394169 66683 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 16 2 2 5.7 CCCCCCCCCCCCCCN1CCCC1CCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
CHEMBL185447 66683 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 16 2 2 5.7 CCCCCCCCCCCCCCN1CCCC1CCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
44234763 126435 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 397 8 2 3 4.8 Cc1ccc(-c2ccc(COCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
CHEMBL3651723 126435 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 397 8 2 3 4.8 Cc1ccc(-c2ccc(COCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
127041987 136628 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 319 11 1 3 3.9 CCCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
CHEMBL3739878 136628 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 319 11 1 3 3.9 CCCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
25060263 126951 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 7 1 3 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C(=O)N(C)C)cc2n1Cc1ccccc1 nan
CHEMBL3655516 126951 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 7 1 3 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C(=O)N(C)C)cc2n1Cc1ccccc1 nan
44344456 10643 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 NC(CCCCCCCCCCc1ccccc1)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL117031 10643 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 NC(CCCCCCCCCCc1ccccc1)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
44344404 11361 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 349 18 3 2 5.2 CCCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL117973 11361 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 349 18 3 2 5.2 CCCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
11725751 12847 5 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
11725751 12847 5 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL118860 12847 5 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL118860 12847 5 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
10149985 13379 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 341 13 3 2 4.2 CCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL119256 13379 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 341 13 3 2 4.2 CCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
44394191 66309 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 381 12 3 2 5.3 CCCCCCCCCc1ccc(C2CCC(CCP(=O)(O)O)N2)cc1 10.1016/j.bmcl.2004.07.049
CHEMBL184879 66309 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 381 12 3 2 5.3 CCCCCCCCCc1ccc(C2CCC(CCP(=O)(O)O)N2)cc1 10.1016/j.bmcl.2004.07.049
44344194 11916 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 321 16 3 2 4.5 CCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL118265 11916 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 321 16 3 2 4.5 CCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
44394191 66309 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 381 12 3 2 5.3 CCCCCCCCCc1ccc(C2CCC(CCP(=O)(O)O)N2)cc1 10.1016/j.bmcl.2004.07.049
CHEMBL184879 66309 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 381 12 3 2 5.3 CCCCCCCCCc1ccc(C2CCC(CCP(=O)(O)O)N2)cc1 10.1016/j.bmcl.2004.07.049
44565717 189530 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 479 9 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
CHEMBL514170 189530 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 479 9 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
44565738 189753 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 445 11 4 5 3.8 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
CHEMBL515917 189753 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 445 11 4 5 3.8 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
44565717 189530 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 479 9 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2010.02.098
CHEMBL514170 189530 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 479 9 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2010.02.098
44232785 126853 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 8 1 4 6.3 CCC(=O)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655419 126853 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 8 1 4 6.3 CCC(=O)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762446 126928 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 487 8 2 3 7.0 CC(C)c1c(C(=O)NCc2cc(F)cc(F)c2)c2ccc(NC3CCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655493 126928 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 487 8 2 3 7.0 CC(C)c1c(C(=O)NCc2cc(F)cc(F)c2)c2ccc(NC3CCC3)cc2n1Cc1ccccc1 nan
10311227 169333 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 493 17 3 4 5.6 CCCCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL441826 169333 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 493 17 3 4 5.6 CCCCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
11540052 180567 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL475405 180567 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
11540052 180567 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2010.02.098
CHEMBL475405 180567 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 470 10 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2010.02.098
10217498 85086 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 481 7 1 4 6.2 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)c(Cl)c2)C1 10.1021/jm0492507
CHEMBL224571 85086 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 481 7 1 4 6.2 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)c(Cl)c2)C1 10.1021/jm0492507
46885742 7701 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 495 10 4 6 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(C#N)c1 10.1016/j.bmcl.2010.02.098
CHEMBL1088819 7701 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 495 10 4 6 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(C#N)c1 10.1016/j.bmcl.2010.02.098
25008420 8464 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 547 9 4 5 5.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)c(C(F)(F)F)c2)c[nH]1 10.1016/j.bmcl.2010.02.098
CHEMBL1093823 8464 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 547 9 4 5 5.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)c(C(F)(F)F)c2)c[nH]1 10.1016/j.bmcl.2010.02.098
25060261 126864 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 448 7 2 3 5.5 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CO)cc2n1Cc1ccccc1 nan
CHEMBL3655430 126864 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 448 7 2 3 5.5 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CO)cc2n1Cc1ccccc1 nan
11224984 8717 23 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation countingDisplacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation counting
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OC[C@@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
CHEMBL1095833 8717 23 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation countingDisplacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation counting
ChEMBL 460 8 2 6 4.3 CCC/N=C1\S/C(=C\c2ccc(OC[C@@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C 10.1021/jm100181s
59504164 126438 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 418 6 1 2 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccccc2n1Cc1ccccc1 nan
CHEMBL3651726 126438 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 418 6 1 2 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccccc2n1Cc1ccccc1 nan
11725751 12847 5 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL118860 12847 5 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
10149985 13379 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 341 13 3 2 4.2 CCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL119256 13379 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 341 13 3 2 4.2 CCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
59762348 126891 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 5 5.3 CC(=O)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
CHEMBL3655456 126891 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 477 8 1 5 5.3 CC(=O)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
59762396 126944 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 512 8 1 5 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3ccccn3)cc2n1Cc1ccccn1 nan
CHEMBL3655509 126944 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 512 8 1 5 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3ccccn3)cc2n1Cc1ccccn1 nan
59504168 126963 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 8 1 4 6.0 CO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655528 126963 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 8 1 4 6.0 CO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
11683935 179341 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 456 9 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473563 179341 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 456 9 4 5 3.7 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
44565716 179743 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 493 10 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
CHEMBL474418 179743 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 493 10 4 5 4.6 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCc3ccc(-c4ccccc4)cc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
10127776 11053 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 465 15 3 4 4.9 CCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL117723 11053 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 465 15 3 4 4.9 CCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
44413415 138690 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 461 7 2 4 6.1 O=C(O)CC1CNC(c2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1016/j.bmcl.2006.03.090
CHEMBL377855 138690 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 461 7 2 4 6.1 O=C(O)CC1CNC(c2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1016/j.bmcl.2006.03.090
10127776 11053 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 465 15 3 4 4.9 CCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1021/jm0492507
CHEMBL117723 11053 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 465 15 3 4 4.9 CCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1021/jm0492507
10215259 85107 5 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 331 11 1 2 4.9 CCCCCCCCCc1ccc(CN2CCC(C(=O)O)C2)cc1 10.1021/jm0492507
CHEMBL224703 85107 5 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 331 11 1 2 4.9 CCCCCCCCCc1ccc(CN2CCC(C(=O)O)C2)cc1 10.1021/jm0492507
11248292 143506 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 465 7 1 4 5.7 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)c(F)c2)C1 10.1021/jm0492507
CHEMBL389880 143506 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 465 7 1 4 5.7 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)c(F)c2)C1 10.1021/jm0492507
59762332 126914 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 495 7 1 3 7.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3ccncc3)cc2n1Cc1ccccc1 nan
CHEMBL3655478 126914 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 495 7 1 3 7.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3ccncc3)cc2n1Cc1ccccc1 nan
10287034 66183 3 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 367 11 2 2 4.7 CCCCCCCCCc1ccc(CN2CCC(P(=O)(O)O)C2)cc1 10.1021/jm0492507
CHEMBL184349 66183 3 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 367 11 2 2 4.7 CCCCCCCCCc1ccc(CN2CCC(P(=O)(O)O)C2)cc1 10.1021/jm0492507
44394330 66013 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 14 3 3 5.4 CCCCCCCCCCCCCCC1CC(O)(P(C)(=O)O)CCN1 10.1016/j.bmcl.2004.07.049
CHEMBL183688 66013 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 14 3 3 5.4 CCCCCCCCCCCCCCC1CC(O)(P(C)(=O)O)CCN1 10.1016/j.bmcl.2004.07.049
44394247 122216 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 16 3 2 6.0 CCCCCCCCCCCCCCNC1CCCCC1CP(=O)(O)O 10.1016/j.bmcl.2004.07.049
CHEMBL359762 122216 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 16 3 2 6.0 CCCCCCCCCCCCCCNC1CCCCC1CP(=O)(O)O 10.1016/j.bmcl.2004.07.049
44412364 78103 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
CHEMBL210257 78103 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
127037695 136575 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 333 12 1 3 4.3 CCCCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
CHEMBL3739440 136575 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 333 12 1 3 4.3 CCCCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
59762334 126941 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 586 8 1 7 7.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3ncc(Br)s3)cc2n1Cc1ncco1 nan
CHEMBL3655506 126941 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 586 8 1 7 7.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3ncc(Br)s3)cc2n1Cc1ncco1 nan
44233018 126957 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 9 2 3 6.5 CC(C)NCc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655522 126957 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 9 2 3 6.5 CC(C)NCc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44234515 126428 2 None - 0 Human 6.6 pIC50 = 6.6 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 396 8 3 3 4.4 Cc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
CHEMBL3651717 126428 2 None - 0 Human 6.6 pIC50 = 6.6 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 396 8 3 3 4.4 Cc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
91203058 126865 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 461 8 1 4 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CN=O)cc2n1Cc1ccccc1 nan
CHEMBL3655431 126865 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 461 8 1 4 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CN=O)cc2n1Cc1ccccc1 nan
44232783 126850 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 7 1 4 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(=O)N(C)C)cc2n1Cc1ccccc1 nan
CHEMBL3655416 126850 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 7 1 4 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(=O)N(C)C)cc2n1Cc1ccccc1 nan
59762375 126858 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 5 5.5 CCOC(=O)c1ccc2c(C(=O)NCc3cncc(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655424 126858 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 5 5.5 CCOC(=O)c1ccc2c(C(=O)NCc3cncc(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762301 126861 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 8 1 5 5.6 CCOC(=O)c1ccc2c(C(=O)NCc3cc(F)cc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655427 126861 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 8 1 5 5.6 CCOC(=O)c1ccc2c(C(=O)NCc3cc(F)cc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
59762342 126947 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 498 9 1 5 5.9 CCOC(=O)Cn1c(C(C)C)c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc21 nan
CHEMBL3655511 126947 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 498 9 1 5 5.9 CCOC(=O)Cn1c(C(C)C)c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc21 nan
44233748 127406 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 4 5.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCNC3)cc2n1Cc1ccccc1 nan
CHEMBL3659682 127406 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 4 5.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCNC3)cc2n1Cc1ccccc1 nan
59762355 126859 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 8 1 5 5.6 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3cccnc3)c2c1 nan
CHEMBL3655425 126859 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 8 1 5 5.6 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3cccnc3)c2c1 nan
25059999 126847 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 10 1 4 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OCCN(C)C)cc2n1Cc1ccccc1 nan
CHEMBL3655413 126847 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 10 1 4 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OCCN(C)C)cc2n1Cc1ccccc1 nan
59762312 126894 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 463 7 1 4 5.9 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc([N+](=O)[O-])cc2n1Cc1ccccc1 nan
CHEMBL3655459 126894 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 463 7 1 4 5.9 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc([N+](=O)[O-])cc2n1Cc1ccccc1 nan
59762384 126876 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccn1 nan
CHEMBL3655442 126876 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccn1 nan
44412165 77761 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
CHEMBL209076 77761 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
44565703 189532 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 444 9 4 5 3.2 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2cccc3ccccc23)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL514189 189532 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 444 9 4 5 3.2 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2cccc3ccccc23)cc1 10.1016/j.bmcl.2009.02.073
44233019 126958 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 9 2 3 6.1 CCNCc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655523 126958 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 9 2 3 6.1 CCNCc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
10310253 13506 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 435 14 3 3 4.8 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1Br 10.1016/j.bmcl.2004.04.070
CHEMBL119354 13506 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 435 14 3 3 4.8 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1Br 10.1016/j.bmcl.2004.04.070
10172513 10182 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 369 14 3 3 4.3 CCCCCCCCC(=O)c1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL115970 10182 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 369 14 3 3 4.3 CCCCCCCCC(=O)c1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
25059748 126844 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 524 9 1 3 7.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OCc3ccccc3)cc2n1Cc1ccccc1 nan
CHEMBL3655410 126844 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 524 9 1 3 7.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OCc3ccccc3)cc2n1Cc1ccccc1 nan
44159392 126959 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 10 2 3 6.5 CCCNCc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655524 126959 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 10 2 3 6.5 CCCNCc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44233496 127403 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 9 1 4 6.8 CCO/N=C(\C)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3659679 127403 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 9 1 4 6.8 CCO/N=C(\C)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762325 126893 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 506 9 1 6 5.5 CO/N=C(/C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
CHEMBL3655458 126893 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 506 9 1 6 5.5 CO/N=C(/C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
44394220 67003 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 15 3 2 5.8 CCCCCCCCCCCCCCNC1CCCC(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
CHEMBL186921 67003 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 15 3 2 5.8 CCCCCCCCCCCCCCNC1CCCC(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
44565714 179297 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 484 11 4 5 4.1 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473238 179297 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 484 11 4 5 4.1 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
10215741 11013 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 13 3 4 3.5 CCCCCCCOC(=O)c1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL117403 11013 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 13 3 4 3.5 CCCCCCCOC(=O)c1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
10172338 110547 3 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 13 3 2 4.4 CCCCCCCCc1ccc(CCC(N)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL325198 110547 3 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 13 3 2 4.4 CCCCCCCCc1ccc(CCC(N)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
137655932 158957 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 355 13 3 2 4.4 CCCCCCCCc1ccc(CC[C@@H](N)CCP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL4095976 158957 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 355 13 3 2 4.4 CCCCCCCCc1ccc(CC[C@@H](N)CCP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
59762427 126880 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 506 8 1 6 5.6 CC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ncco4)c3c2)=N1 nan
CHEMBL3655446 126880 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 506 8 1 6 5.6 CC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ncco4)c3c2)=N1 nan
10172338 110547 3 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 355 13 3 2 4.4 CCCCCCCCc1ccc(CCC(N)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL325198 110547 3 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 355 13 3 2 4.4 CCCCCCCCc1ccc(CCC(N)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
46885743 7702 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 504 10 4 5 4.4 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(Cl)c1 10.1016/j.bmcl.2010.02.098
CHEMBL1088820 7702 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 504 10 4 5 4.4 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(Cl)c1 10.1016/j.bmcl.2010.02.098
44234004 127411 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 493 10 1 5 5.4 COCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659687 127411 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 493 10 1 5 5.4 COCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
59762421 126907 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 474 9 1 5 5.7 CC(C)COc1ccc2c(C(=O)NCc3cncc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655471 126907 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 474 9 1 5 5.7 CC(C)COc1ccc2c(C(=O)NCc3cncc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
57554674 136799 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 399 12 3 4 4.5 CCCCCCCCOc1ccc([C@@H]2CC[C@](N)(COP(=O)(O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
CHEMBL3741414 136799 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 399 12 3 4 4.5 CCCCCCCCOc1ccc([C@@H]2CC[C@](N)(COP(=O)(O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
25059486 126841 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 10 1 3 7.2 CCCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655407 126841 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 10 1 3 7.2 CCCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
25160863 126845 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 8 1 3 7.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655411 126845 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 8 1 3 7.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ccccc1 nan
44234003 127410 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 1 4 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
CHEMBL3659686 127410 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 1 4 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
11725751 12847 5 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.07.049
CHEMBL118860 12847 5 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 355 14 3 2 4.6 CCCCCCCCCc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.07.049
44344193 114912 5 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 17 3 2 4.8 CCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL334213 114912 5 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 17 3 2 4.8 CCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
44344193 114912 5 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 335 17 3 2 4.8 CCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1021/jm0492507
CHEMBL334213 114912 5 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 335 17 3 2 4.8 CCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1021/jm0492507
44591264 179979 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)c(F)c1 10.1016/j.bmcl.2008.11.072
CHEMBL474688 179979 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)c(F)c1 10.1016/j.bmcl.2008.11.072
44344193 114912 5 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 335 17 3 2 4.8 CCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
CHEMBL334213 114912 5 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 335 17 3 2 4.8 CCCCCCCCCCCCCCNCCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
10363915 135193 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 405 7 1 5 4.6 CCC(C)(C)c1ccc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)cc1 10.1021/jm0503244
CHEMBL372066 135193 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 405 7 1 5 4.6 CCC(C)(C)c1ccc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)cc1 10.1021/jm0503244
44394220 67003 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 15 3 2 5.8 CCCCCCCCCCCCCCNC1CCCC(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
CHEMBL186921 67003 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 15 3 2 5.8 CCCCCCCCCCCCCCNC1CCCC(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
59504172 126437 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 460 6 2 3 6.3 O=C(NCc1ccc(F)c(F)c1)c1c(C2CCCC2)n(Cc2ccccc2)c2ccc(O)cc12 nan
CHEMBL3651725 126437 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 460 6 2 3 6.3 O=C(NCc1ccc(F)c(F)c1)c1c(C2CCCC2)n(Cc2ccccc2)c2ccc(O)cc12 nan
44565622 179340 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 428 11 4 5 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCC2CCCCC2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473562 179340 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 428 11 4 5 3.6 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCCCC2CCCCC2)cc1 10.1016/j.bmcl.2009.02.073
44413447 138683 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 431 6 2 5 5.6 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc(C5CCCCC5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
CHEMBL377828 138683 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 431 6 2 5 5.6 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc(C5CCCCC5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
25160740 126840 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 434 6 2 3 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(O)cc2n1Cc1ccccc1 nan
CHEMBL3655406 126840 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 434 6 2 3 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(O)cc2n1Cc1ccccc1 nan
25059747 126843 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 12 1 3 8.0 CCCCCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655409 126843 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 12 1 3 8.0 CCCCCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
49787250 126433 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 424 10 3 3 5.0 CCCc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
CHEMBL3651721 126433 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 424 10 3 3 5.0 CCCc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
24752909 126440 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 410 9 3 3 4.6 CCc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
CHEMBL3651728 126440 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 410 9 3 3 4.6 CCc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
44341466 10014 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@H](N)C[C@@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL114976 10014 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@H](N)C[C@@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
44341291 10137 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL115714 10137 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
44234006 127412 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 4 5.4 C#CCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659688 127412 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 4 5.4 C#CCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
46885745 8410 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 484 10 4 5 4.0 Cc1cc(NC(=O)[C@@](C)(N)COP(=O)(O)O)ccc1OCCc1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2010.02.098
CHEMBL1093424 8410 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 484 10 4 5 4.0 Cc1cc(NC(=O)[C@@](C)(N)COP(=O)(O)O)ccc1OCCc1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2010.02.098
59762297 126873 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 7 1 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccc1 nan
CHEMBL3655439 126873 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 7 1 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccc1 nan
25060265 126953 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 2 3 5.8 CCNC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655518 126953 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 2 3 5.8 CCNC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
24804606 126436 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 434 6 2 3 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2cc(O)ccc2n1Cc1ccccc1 nan
CHEMBL3651724 126436 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 434 6 2 3 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2cc(O)ccc2n1Cc1ccccc1 nan
59762420 126870 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 498 8 1 5 5.8 CC[C@H]1COC(c2ccc3c(C(=O)NCc4cncc(F)c4)c(C(C)C)n(Cc4ccccc4)c3c2)=N1 nan
CHEMBL3655436 126870 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 498 8 1 5 5.8 CC[C@H]1COC(c2ccc3c(C(=O)NCc4cncc(F)c4)c(C(C)C)n(Cc4ccccc4)c3c2)=N1 nan
10125882 165584 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 337 14 2 2 4.9 CCCCCCCCCc1ccc(CNCC(F)CC(=O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL424254 165584 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 337 14 2 2 4.9 CCCCCCCCCc1ccc(CNCC(F)CC(=O)O)cc1 10.1016/j.bmcl.2004.04.069
59762303 126860 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 481 8 1 6 5.2 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ncco3)c2c1 nan
CHEMBL3655426 126860 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 481 8 1 6 5.2 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ncco3)c2c1 nan
59762418 126867 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 487 7 1 4 5.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=NCCO3)cc2n1Cc1ccccc1 nan
CHEMBL3655433 126867 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 487 7 1 4 5.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=NCCO3)cc2n1Cc1ccccc1 nan
59762298 126902 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 4 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655467 126902 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 4 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOCC3)cc2n1Cc1ccccc1 nan
59762305 126904 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 519 8 1 5 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655469 126904 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 519 8 1 5 6.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOCC3)cc2n1Cc1ccccn1 nan
44233017 126955 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 8 1 3 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CN3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655520 126955 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 8 1 3 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CN3CCCC3)cc2n1Cc1ccccc1 nan
10125862 11625 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 14 3 3 3.9 CCCCCCCCCc1ccc(CNCCC(O)C(=O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL118068 11625 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 335 14 3 3 3.9 CCCCCCCCCc1ccc(CNCCC(O)C(=O)O)cc1 10.1016/j.bmcl.2004.04.069
44394248 66249 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 361 15 3 2 5.4 CCCCCCCCCCCCCCNC1CCC(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
CHEMBL184591 66249 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 361 15 3 2 5.4 CCCCCCCCCCCCCCNC1CCC(P(=O)(O)O)C1 10.1016/j.bmcl.2004.07.049
44565595 179271 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 476 10 4 6 3.8 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3cccs3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL473016 179271 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 476 10 4 6 3.8 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3cccs3)cc2)cc1 10.1016/j.bmcl.2009.02.073
59762320 126934 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 499 7 1 5 5.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3ccnn3C)cc2n1Cc1ccccn1 nan
CHEMBL3655499 126934 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 499 7 1 5 5.8 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3ccnn3C)cc2n1Cc1ccccn1 nan
59762432 126925 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 8 2 3 7.4 CC(C)c1c(C(=O)NCc2cc(F)cc(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655490 126925 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 8 2 3 7.4 CC(C)c1c(C(=O)NCc2cc(F)cc(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
59762280 126943 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 507 8 1 5 6.6 Cc1cc(Cn2c(C(C)C)c(C(=O)NCc3ccc(F)c(F)c3)c3ccc(OC4CCCC4)cc32)no1 nan
CHEMBL3655508 126943 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 507 8 1 5 6.6 Cc1cc(Cn2c(C(C)C)c(C(=O)NCc3ccc(F)c(F)c3)c3ccc(OC4CCCC4)cc32)no1 nan
44412165 77761 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
CHEMBL209076 77761 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
11503967 8021 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 482 10 4 5 3.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(C(=O)CCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2010.02.098
CHEMBL1090796 8021 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 482 10 4 5 3.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(C(=O)CCc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2010.02.098
91433973 126892 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 492 9 1 6 5.9 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)N=O)n(Cc3ccccn3)c2c1 nan
CHEMBL3655457 126892 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 492 9 1 6 5.9 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)N=O)n(Cc3ccccn3)c2c1 nan
44233016 126855 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 478 9 1 4 6.0 COCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655421 126855 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 478 9 1 4 6.0 COCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
10193676 13739 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 2 2 5.2 CCCCCCCCCc1ccc(CNCCC(F)(F)C(=O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL119516 13739 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 2 2 5.2 CCCCCCCCCc1ccc(CNCCC(F)(F)C(=O)O)cc1 10.1016/j.bmcl.2004.04.069
59762407 126935 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 514 7 1 5 6.7 Cc1noc(C)c1-c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655500 126935 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 514 7 1 5 6.7 Cc1noc(C)c1-c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
59762390 126887 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 6 4.9 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C3=NCCO3)n(Cc3ccccn3)c2c1 nan
CHEMBL3655452 126887 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 6 4.9 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C3=NCCO3)n(Cc3ccccn3)c2c1 nan
59762449 126938 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 467 9 1 5 5.8 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ncco3)c2c1 nan
CHEMBL3655503 126938 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 467 9 1 5 5.8 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ncco3)c2c1 nan
25160865 126851 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 7 1 4 7.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(=O)C(C)(C)C)cc2n1Cc1ccccc1 nan
CHEMBL3655417 126851 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 7 1 4 7.0 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(=O)C(C)(C)C)cc2n1Cc1ccccc1 nan
25060538 126961 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 10 1 4 7.0 CCCCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655526 126961 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 10 1 4 7.0 CCCCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44344413 110545 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.3 CCCCCCCCc1ccc(CCNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL325193 110545 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 355 14 3 2 4.3 CCCCCCCCc1ccc(CCNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
44394273 64578 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 395 12 3 2 5.6 CCCCCCCCCc1ccc(CN[C@H]2CCC[C@H](P(=O)(O)O)C2)cc1 10.1016/j.bmcl.2004.07.049
CHEMBL181597 64578 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 395 12 3 2 5.6 CCCCCCCCCc1ccc(CN[C@H]2CCC[C@H](P(=O)(O)O)C2)cc1 10.1016/j.bmcl.2004.07.049
10126584 13595 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 391 14 3 3 4.7 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1Cl 10.1016/j.bmcl.2004.04.070
CHEMBL119413 13595 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 391 14 3 3 4.7 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1Cl 10.1016/j.bmcl.2004.04.070
9796603 164321 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 307 14 3 2 4.2 CCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL421234 164321 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 307 14 3 2 4.2 CCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
127037694 136655 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 347 13 1 3 4.7 CCCCCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
CHEMBL3740062 136655 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 347 13 1 3 4.7 CCCCCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
59762318 126881 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2cc(F)cc(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccn1 nan
CHEMBL3655447 126881 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2cc(F)cc(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccn1 nan
44234761 126434 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 411 9 2 3 5.1 CCc1ccc(-c2ccc(COCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
CHEMBL3651722 126434 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 411 9 2 3 5.1 CCc1ccc(-c2ccc(COCCCP(=O)(O)O)nc2-c2ccccc2)cc1 nan
11575787 70632 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 439 6 1 5 4.8 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1021/jm0503244
CHEMBL195014 70632 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 439 6 1 5 4.8 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1021/jm0503244
59762422 126913 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 468 8 1 3 7.0 CC(C)Cn1c(C(C)C)c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc21 nan
CHEMBL3655477 126913 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 468 8 1 3 7.0 CC(C)Cn1c(C(C)C)c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc21 nan
44394161 67025 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 16 2 2 6.1 CCCCCCCCCCCCCC1CCCCN1CCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
CHEMBL187061 67025 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 16 2 2 6.1 CCCCCCCCCCCCCC1CCCCN1CCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
59762398 126916 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 496 7 1 4 6.5 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3ccncc3)cc2n1Cc1ccccn1 nan
CHEMBL3655480 126916 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 496 7 1 4 6.5 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3ccncc3)cc2n1Cc1ccccn1 nan
44159394 126971 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 472 8 1 4 6.1 CCOC(=O)c1ccc2c(C(=O)NCc3cccc(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655536 126971 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 472 8 1 4 6.1 CCOC(=O)c1ccc2c(C(=O)NCc3cccc(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
11604577 72325 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 439 6 1 5 4.8 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc([C@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1021/jm0503244
CHEMBL198415 72325 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 439 6 1 5 4.8 O=C(O)C1CN(Cc2ccc(-c3noc(-c4ccc([C@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1021/jm0503244
59762399 126869 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 7 1 5 5.4 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccc1 nan
CHEMBL3655435 126869 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 7 1 5 5.4 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccc1 nan
44233493 126972 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 472 8 1 4 6.1 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)cc3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655537 126972 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 472 8 1 4 6.1 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)cc3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
10174548 12801 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 507 18 3 4 6.0 CCCCCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL118815 12801 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 507 18 3 4 6.0 CCCCCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
11271470 137584 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 475 8 1 4 6.1 CCc1cc(CN2CC(C(=O)O)C2)ccc1OCc1cc(-c2ccccc2)c(C(F)(F)F)s1 10.1021/jm0492507
CHEMBL375488 137584 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 475 8 1 4 6.1 CCc1cc(CN2CC(C(=O)O)C2)ccc1OCc1cc(-c2ccccc2)c(C(F)(F)F)s1 10.1021/jm0492507
10309462 13632 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 385 14 3 3 4.7 CCCCCCCCOc1c(C)cc(CNCCCP(=O)(O)O)cc1C 10.1016/j.bmcl.2004.04.070
CHEMBL119440 13632 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 385 14 3 3 4.7 CCCCCCCCOc1c(C)cc(CNCCCP(=O)(O)O)cc1C 10.1016/j.bmcl.2004.04.070
59762317 126879 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1cccnc1 nan
CHEMBL3655445 126879 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1cccnc1 nan
59762406 126899 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 8 2 3 7.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655464 126899 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 8 2 3 7.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
44233494 126973 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.6 CC(C)OC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655538 126973 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.6 CC(C)OC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
46885796 8411 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 538 10 4 5 4.8 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(C(F)(F)F)c1 10.1016/j.bmcl.2010.02.098
CHEMBL1093429 8411 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 538 10 4 5 4.8 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)c(C(F)(F)F)c1 10.1016/j.bmcl.2010.02.098
44344270 110116 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 395 13 3 5 3.9 CCCCCCCc1nc(-c2ccc(CNCCCP(=O)(O)O)cc2)no1 10.1016/j.bmcl.2004.04.070
CHEMBL323617 110116 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 395 13 3 5 3.9 CCCCCCCc1nc(-c2ccc(CNCCCP(=O)(O)O)cc2)no1 10.1016/j.bmcl.2004.04.070
59762335 126874 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 531 9 1 5 5.8 COC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ccccc4)c3c2)=N1 nan
CHEMBL3655440 126874 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 531 9 1 5 5.8 COC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ccccc4)c3c2)=N1 nan
44413365 77382 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 467 6 2 5 5.8 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc(C5CCC(F)(F)CC5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
CHEMBL208648 77382 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 467 6 2 5 5.8 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc(C5CCC(F)(F)CC5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
44344446 114821 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 349 17 3 2 5.4 CCCCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
CHEMBL334144 114821 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 349 17 3 2 5.4 CCCCCCCCCCCCCCCC(N)CCP(=O)(O)O 10.1016/j.bmcl.2004.04.069
59762347 126868 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 7 1 4 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=NC(C)(C)CO3)cc2n1Cc1ccccc1 nan
CHEMBL3655434 126868 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 7 1 4 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=NC(C)(C)CO3)cc2n1Cc1ccccc1 nan
59762321 126883 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 7 1 5 5.4 CC(C)c1c(C(=O)NCc2ccc(F)cc2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccn1 nan
CHEMBL3655449 126883 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 7 1 5 5.4 CC(C)c1c(C(=O)NCc2ccc(F)cc2)c2ccc(C3=N[C@@H](C)CO3)cc2n1Cc1ccccn1 nan
59762323 126903 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 536 8 1 5 6.9 CC(C)c1c(C(=O)NCc2ccc(C(F)(F)F)nc2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655468 126903 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 536 8 1 5 6.9 CC(C)c1c(C(=O)NCc2ccc(C(F)(F)F)nc2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
44413274 138711 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 447 6 2 4 5.7 O=C(O)C1CNC(c2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1016/j.bmcl.2006.03.090
CHEMBL377968 138711 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 447 6 2 4 5.7 O=C(O)C1CNC(c2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1016/j.bmcl.2006.03.090
59762313 126888 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 463 8 1 5 4.9 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C=O)n(Cc3ccccn3)c2c1 nan
CHEMBL3655453 126888 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 463 8 1 5 4.9 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C=O)n(Cc3ccccn3)c2c1 nan
59762322 126871 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 7 1 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@H](C)CO3)cc2n1Cc1ccccc1 nan
CHEMBL3655437 126871 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 7 1 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@H](C)CO3)cc2n1Cc1ccccc1 nan
101863648 158487 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 303 10 1 2 4.1 CCCCCCCCc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL4090982 158487 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranesDisplacement of [33P]-S1P from human S1P3 receptor expressed in CHO cell membranes
ChEMBL 303 10 1 2 4.1 CCCCCCCCc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.6b01575
10149721 85097 5 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 317 11 1 2 4.5 CCCCCCCCCc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/jm0492507
CHEMBL224623 85097 5 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 317 11 1 2 4.5 CCCCCCCCCc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/jm0492507
25059488 126425 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 476 9 1 3 6.8 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3651714 126425 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 476 9 1 3 6.8 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
25059488 126425 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 9 1 3 6.8 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3651714 126425 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 9 1 3 6.8 CCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762293 126908 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 6 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1ccccn1 nan
CHEMBL3655472 126908 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 6 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1ccccn1 nan
59762353 126911 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 1 4 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1cccnc1 nan
CHEMBL3655475 126911 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 1 4 6.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1cccnc1 nan
44234256 127413 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 9 1 4 6.5 CC(C)COc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659689 127413 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 9 1 4 6.5 CC(C)COc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
44394279 67150 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 16 3 2 5.8 CCCCCCCCCCCCCC[C@H]1CC[C@H](CCP(=O)(O)O)N1 10.1016/j.bmcl.2004.07.049
CHEMBL187588 67150 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 16 3 2 5.8 CCCCCCCCCCCCCC[C@H]1CC[C@H](CCP(=O)(O)O)N1 10.1016/j.bmcl.2004.07.049
44591265 179981 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 425 13 4 5 4.1 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2008.11.072
CHEMBL474689 179981 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 425 13 4 5 4.1 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1 10.1016/j.bmcl.2008.11.072
44591266 179300 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 443 13 4 5 4.2 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1F 10.1016/j.bmcl.2008.11.072
CHEMBL473269 179300 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 443 13 4 5 4.2 CCCCCCCCOc1ccc(-c2c[nH]c([C@@](C)(N)COP(=O)(O)O)n2)cc1F 10.1016/j.bmcl.2008.11.072
44591249 180636 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 402 13 4 5 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2008.11.072
CHEMBL475495 180636 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 402 13 4 5 3.2 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1 10.1016/j.bmcl.2008.11.072
44591250 189754 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1F 10.1016/j.bmcl.2008.11.072
CHEMBL515921 189754 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 420 13 4 5 3.3 CCCCCCCCOc1ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc1F 10.1016/j.bmcl.2008.11.072
44565712 189813 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 484 10 4 5 4.0 Cc1ccccc1-c1ccc(CCOc2ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL516380 189813 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 484 10 4 5 4.0 Cc1ccccc1-c1ccc(CCOc2ccc(NC(=O)[C@@](C)(N)COP(=O)(O)O)cc2)cc1 10.1016/j.bmcl.2009.02.073
59762319 126920 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 464 7 1 5 5.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc([N+](=O)[O-])cc2n1Cc1ccccn1 nan
CHEMBL3655484 126920 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 464 7 1 5 5.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc([N+](=O)[O-])cc2n1Cc1ccccn1 nan
59762282 126866 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 499 8 2 3 5.4 C#CCNC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655432 126866 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 499 8 2 3 5.4 C#CCNC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762349 126898 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 7 1 3 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N3CCCC3=O)cc2n1Cc1ccccc1 nan
CHEMBL3655463 126898 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 501 7 1 3 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N3CCCC3=O)cc2n1Cc1ccccc1 nan
59762413 126929 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 469 8 2 3 6.8 CC(C)c1c(C(=O)NCc2ccc(F)cc2)c2ccc(NC3CCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655494 126929 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 469 8 2 3 6.8 CC(C)c1c(C(=O)NCc2ccc(F)cc2)c2ccc(NC3CCC3)cc2n1Cc1ccccc1 nan
72555272 126932 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 8 1 4 6.1 C=C(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
CHEMBL3655497 126932 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 8 1 4 6.1 C=C(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
44394211 67163 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 14 2 3 5.4 CCCCCCCCCCCCCCN1CCC(O)(P(C)(=O)O)CC1 10.1016/j.bmcl.2004.07.049
CHEMBL187645 67163 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 375 14 2 3 5.4 CCCCCCCCCCCCCCN1CCC(O)(P(C)(=O)O)CC1 10.1016/j.bmcl.2004.07.049
10271422 9937 1 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 385 14 4 3 3.8 CCCCCCCCc1ccc(CCC(N)(CO)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL114584 9937 1 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 385 14 4 3 3.8 CCCCCCCCc1ccc(CCC(N)(CO)CCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
127037696 136807 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 305 10 1 3 3.6 CCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
CHEMBL3741496 136807 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB methodDisplacement of [33P]S1P from S1P3 receptor (unknown origin) expressed in HEK cell membranes after 45 to 60 mins by scintillation counting based RLB method
ChEMBL 305 10 1 3 3.6 CCCCCCCOc1ccc(CN2CC(C(=O)O)C2)cc1 10.1021/acs.jmedchem.5b00928
59762429 126940 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 508 8 1 7 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1ncco1 nan
CHEMBL3655505 126940 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 508 8 1 7 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(Oc3nccs3)cc2n1Cc1ncco1 nan
10127475 166029 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 447 7 1 4 5.5 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1016/j.bmcl.2006.03.090
CHEMBL425563 166029 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 447 7 1 4 5.5 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1016/j.bmcl.2006.03.090
10127475 166029 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 447 7 1 4 5.5 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1021/jm0492507
CHEMBL425563 166029 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 447 7 1 4 5.5 O=C(O)C1CN(Cc2ccc(OCc3cc(-c4ccccc4)c(C(F)(F)F)s3)cc2)C1 10.1021/jm0492507
59762336 126942 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 439 6 2 5 5.0 Cc1cc(Cn2c(C(C)C)c(C(=O)NCc3ccc(F)c(F)c3)c3ccc(O)cc32)no1 nan
CHEMBL3655507 126942 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 439 6 2 5 5.0 Cc1cc(Cn2c(C(C)C)c(C(=O)NCc3ccc(F)c(F)c3)c3ccc(O)cc32)no1 nan
54582607 62459 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibition of S1P3 receptorInhibition of S1P3 receptor
ChEMBL 375 3 2 3 5.8 Cc1cc(O)cc(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 10.1016/j.bmcl.2011.04.097
CHEMBL1779895 62459 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibition of S1P3 receptorInhibition of S1P3 receptor
ChEMBL 375 3 2 3 5.8 Cc1cc(O)cc(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1 10.1016/j.bmcl.2011.04.097
44344298 13544 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 395 13 3 6 3.0 CCCCCCCn1nnc(-c2ccc(CNCCCP(=O)(O)O)cc2)n1 10.1016/j.bmcl.2004.04.070
CHEMBL119382 13544 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 395 13 3 6 3.0 CCCCCCCn1nnc(-c2ccc(CNCCCP(=O)(O)O)cc2)n1 10.1016/j.bmcl.2004.04.070
59762414 126915 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 486 8 1 5 6.0 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1cccnc1 nan
CHEMBL3655479 126915 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 486 8 1 5 6.0 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(OC3CCCC3)cc2n1Cc1cccnc1 nan
44159276 126839 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 448 7 1 3 6.0 COc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655405 126839 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 448 7 1 3 6.0 COc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44234002 127408 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 8 1 5 5.6 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659684 127408 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 8 1 5 5.6 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
59762364 126933 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 497 7 1 5 5.9 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3cncnc3)cc2n1Cc1ccccn1 nan
CHEMBL3655498 126933 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 497 7 1 5 5.9 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3cncnc3)cc2n1Cc1ccccn1 nan
10317453 70418 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 377 7 1 5 3.9 CCCc1ccc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)cc1 10.1021/jm0503244
CHEMBL194578 70418 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cellsConcentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 3 expressed in CHO cells
ChEMBL 377 7 1 5 3.9 CCCc1ccc(-c2nc(-c3ccc(CN4CC(C(=O)O)C4)cc3)no2)cc1 10.1021/jm0503244
59762338 124417 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 486 7 1 5 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3nnco3)cc2n1Cc1ccccc1 nan
CHEMBL3639543 124417 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 486 7 1 5 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(-c3nnco3)cc2n1Cc1ccccc1 nan
10150372 112908 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 14 3 3 4.4 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1C 10.1016/j.bmcl.2004.04.070
CHEMBL331054 112908 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 371 14 3 3 4.4 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1C 10.1016/j.bmcl.2004.04.070
44565739 178960 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 459 12 4 5 4.2 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
CHEMBL470511 178960 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 459 12 4 5 4.2 C[C@](N)(COP(=O)(O)O)c1nc(-c2ccc(OCCCCCc3ccccc3)cc2)c[nH]1 10.1016/j.bmcl.2009.02.073
25059745 126426 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 476 8 1 3 6.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3651715 126426 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.FLIPR Assay: FLIPR assay using S1P3 receptor inhibitor.
ChEMBL 476 8 1 3 6.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
25059745 126426 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 8 1 3 6.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3651715 126426 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 476 8 1 3 6.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
25060000 126848 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOC3)cc2n1Cc1ccccc1 nan
CHEMBL3655414 126848 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.2 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOC3)cc2n1Cc1ccccc1 nan
44233020 126856 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.5 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCO3)cc2n1Cc1ccccc1 nan
CHEMBL3655422 126856 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 504 8 1 4 6.5 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCO3)cc2n1Cc1ccccc1 nan
24812110 10750 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 373 13 4 4 3.3 CCCCCCCCc1ccc(CCC(N)(CO)OP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
CHEMBL117130 10750 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 373 13 4 4 3.3 CCCCCCCCc1ccc(CCC(N)(CO)OP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.069
11452022 3596 39 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]S1P from human S1P3R expressed in CHO cell membranesDisplacement of [33P]S1P from human S1P3R expressed in CHO cell membranes
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/ml100227q
6996 3596 39 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]S1P from human S1P3R expressed in CHO cell membranesDisplacement of [33P]S1P from human S1P3R expressed in CHO cell membranes
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/ml100227q
CHEMBL366208 3596 39 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]S1P from human S1P3R expressed in CHO cell membranesDisplacement of [33P]S1P from human S1P3R expressed in CHO cell membranes
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N 10.1021/ml100227q
2924 1640 43 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm0492507
44398069 1640 43 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm0492507
9908268 1640 43 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm0492507
CHEMBL114606 1640 43 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1021/jm0492507
2924 1640 43 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2004.02.106
44398069 1640 43 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2004.02.106
9908268 1640 43 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2004.02.106
CHEMBL114606 1640 43 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 387 14 4 4 3.3 CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N 10.1016/j.bmcl.2004.02.106
46905530 10292 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 14 5 6 2.6 CCCCCCCCc1ccc(CCC(N)(CO)CO[PH](O)(O)O)cc1 10.1016/j.bmcl.2004.07.049
CHEMBL1161691 10292 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 389 14 5 6 2.6 CCCCCCCCc1ccc(CCC(N)(CO)CO[PH](O)(O)O)cc1 10.1016/j.bmcl.2004.07.049
25059749 126846 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 492 10 1 4 6.0 COCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655412 126846 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 492 10 1 4 6.0 COCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
10173327 11052 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 421 15 3 4 4.7 CCCCCCCCOc1c(Cl)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL117715 11052 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 421 15 3 4 4.7 CCCCCCCCOc1c(Cl)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
9885762 9734 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CCC(N)CC(O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL113344 9734 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CCC(N)CC(O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
11690779 189715 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 442 8 4 5 3.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(Oc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
CHEMBL515603 189715 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptorDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL 442 8 4 5 3.9 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(Oc2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2009.02.073
59762379 126886 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 492 9 1 5 5.1 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(CN(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655451 126886 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 492 9 1 5 5.1 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(CN(C)C)n(Cc3ccccn3)c2c1 nan
25060264 126952 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 3 6.2 CC(C)NC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655517 126952 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 3 6.2 CC(C)NC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762294 126909 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 435 6 2 4 5.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(O)cc2n1Cc1cccnc1 nan
CHEMBL3655473 126909 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 435 6 2 4 5.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(O)cc2n1Cc1cccnc1 nan
10125714 110517 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 319 13 2 2 4.7 CCCCCCCCc1ccc(CCC(N)CCC(=O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL325050 110517 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 319 13 2 2 4.7 CCCCCCCCc1ccc(CCC(N)CCC(=O)O)cc1 10.1016/j.bmcl.2004.02.106
59762300 126930 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 488 8 2 4 6.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655495 126930 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 488 8 2 4 6.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(NC3CCC3)cc2n1Cc1ccccn1 nan
44412415 78178 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 419 8 2 5 5.3 CC(C)Cc1ccc(-c2nc(-c3ccc([C@@H]4CC[C@@H](CCC(=O)O)N4)cc3)no2)cc1 10.1016/j.bmcl.2006.03.038
CHEMBL210468 78178 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 419 8 2 5 5.3 CC(C)Cc1ccc(-c2nc(-c3ccc([C@@H]4CC[C@@H](CCC(=O)O)N4)cc3)no2)cc1 10.1016/j.bmcl.2006.03.038
44233747 127405 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 603 8 1 5 7.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCN(C(=O)OC(C)(C)C)C3)cc2n1Cc1ccccc1 nan
CHEMBL3659681 127405 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 603 8 1 5 7.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCN(C(=O)OC(C)(C)C)C3)cc2n1Cc1ccccc1 nan
10172545 9625 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.4 CCCCCCCCc1ccc(CCC(N)C(O)CP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL112655 9625 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.4 CCCCCCCCc1ccc(CCC(N)C(O)CP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
59762315 126889 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 465 8 2 5 4.6 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(CO)n(Cc3ccccn3)c2c1 nan
CHEMBL3655454 126889 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 465 8 2 5 4.6 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(CO)n(Cc3ccccn3)c2c1 nan
59762403 126863 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 5 5.5 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)cc3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655429 126863 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 473 8 1 5 5.5 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)cc3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
44413349 77639 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 453 6 2 5 5.4 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
CHEMBL208838 77639 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]S1P from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]S1P from human S1P3 receptor expressed in CHO cells
ChEMBL 453 6 2 5 5.4 O=C(O)C[C@@H]1CN[C@@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)C1 10.1016/j.bmcl.2006.03.090
10271422 9937 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHO cell membranesDisplacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHO cell membranes
ChEMBL 385 14 4 3 3.8 CCCCCCCCc1ccc(CCC(N)(CO)CCP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
CHEMBL114584 9937 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHO cell membranesDisplacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHO cell membranes
ChEMBL 385 14 4 3 3.8 CCCCCCCCc1ccc(CCC(N)(CO)CCP(=O)(O)O)cc1 10.1021/acs.jmedchem.6b01575
25060002 126857 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 8 1 4 6.2 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655423 126857 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 490 8 1 4 6.2 CCOC(=O)c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
69228911 126877 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 516 8 1 5 6.0 CC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ccccn4)c3c2)=N1 nan
CHEMBL3655443 126877 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 516 8 1 5 6.0 CC[C@H]1COC(c2ccc3c(C(=O)NCc4ccc(F)c(F)c4)c(C(C)C)n(Cc4ccccn4)c3c2)=N1 nan
59762358 126917 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 1 4 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCC3)cc2n1Cc1cccnc1 nan
CHEMBL3655481 126917 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 1 4 6.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCC3)cc2n1Cc1cccnc1 nan
44394212 67170 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 373 15 2 2 6.5 CCCCCCCCCCCCCC1CCCC(CCP(C)(=O)O)N1 10.1016/j.bmcl.2004.07.049
CHEMBL187692 67170 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 373 15 2 2 6.5 CCCCCCCCCCCCCC1CCCC(CCP(C)(=O)O)N1 10.1016/j.bmcl.2004.07.049
59762417 126926 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 483 8 2 3 7.2 CC(C)c1c(C(=O)NCc2ccc(F)cc2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655491 126926 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 483 8 2 3 7.2 CC(C)c1c(C(=O)NCc2ccc(F)cc2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
59762438 126927 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 8 2 4 6.6 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655492 126927 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 484 8 2 4 6.6 CC(C)c1c(C(=O)NCc2cncc(F)c2)c2ccc(NC3CCCC3)cc2n1Cc1ccccc1 nan
46885797 8030 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 538 10 4 5 4.8 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1C(F)(F)F 10.1016/j.bmcl.2010.02.098
CHEMBL1090828 8030 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation countingDisplacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL 538 10 4 5 4.8 C[C@](N)(COP(=O)(O)O)C(=O)Nc1ccc(OCCc2ccc(-c3ccccc3)cc2)cc1C(F)(F)F 10.1016/j.bmcl.2010.02.098
44341399 206967 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 724 25 7 5 7.9 CCCCCCCCc1ccc(CCC(N)/C=C/P(=O)(O)O)cc1.CCCCCCCCc1ccc(CCC(N)C(O)CP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL91283 206967 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 724 25 7 5 7.9 CCCCCCCCc1ccc(CCC(N)/C=C/P(=O)(O)O)cc1.CCCCCCCCc1ccc(CCC(N)C(O)CP(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
10126736 110488 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 401 16 3 4 4.5 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1OCC 10.1016/j.bmcl.2004.04.070
CHEMBL324820 110488 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 401 16 3 4 4.5 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1OCC 10.1016/j.bmcl.2004.04.070
10288527 85029 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 461 7 1 4 5.8 Cc1cc(CN2CC(C(=O)O)C2)ccc1OCc1cc(-c2ccccc2)c(C(F)(F)F)s1 10.1021/jm0492507
CHEMBL224005 85029 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cellsDisplacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL 461 7 1 4 5.8 Cc1cc(CN2CC(C(=O)O)C2)ccc1OCc1cc(-c2ccccc2)c(C(F)(F)F)s1 10.1021/jm0492507
44412353 166228 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 435 6 2 5 5.5 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc(C5CCCC5)c(F)c4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
CHEMBL426688 166228 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 435 6 2 5 5.5 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc(C5CCCC5)c(F)c4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
59762425 126919 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 533 9 1 4 5.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C[N+]3(C)CCCC3)n(Cc3ccccn3)c2c1 nan
CHEMBL3655483 126919 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 533 9 1 4 5.8 CC(C)Oc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C[N+]3(C)CCCC3)n(Cc3ccccn3)c2c1 nan
10309022 10037 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 355 13 2 3 4.1 CCCCCCCCc1ccc(CCC(N)CCS(=O)(=O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL115131 10037 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 355 13 2 3 4.1 CCCCCCCCc1ccc(CCC(N)CCS(=O)(=O)O)cc1 10.1016/j.bmcl.2004.02.106
59762374 126875 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@H](C)CO3)cc2n1Cc1cccnc1 nan
CHEMBL3655441 126875 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 502 7 1 5 5.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(C3=N[C@H](C)CO3)cc2n1Cc1cccnc1 nan
44412165 77761 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
CHEMBL209076 77761 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [33P]S1P from S1P3 expressed in CHO cellsDisplacement of [33P]S1P from S1P3 expressed in CHO cells
ChEMBL 453 6 2 5 5.6 O=C(O)C[C@@H]1CC[C@H](c2ccc(-c3noc(-c4ccc([C@@H]5CCC(F)(F)C5)cc4)n3)cc2)N1 10.1016/j.bmcl.2006.03.038
162650548 180131 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Immunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assayImmunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assay
ChEMBL 366 4 1 4 4.9 CCC/N=C1\S/C(=C\c2ccc(O)c(C)c2)C(=O)N1c1ccccc1C 10.1021/acsmedchemlett.8b00616
CHEMBL4748743 180131 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Immunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assayImmunomodulatory activity in human S1PR3 expressed in CHO-K1 EDG1 beta-arrestin cells assessed as stimulation of beta-arrestin recruitment incubated for 90 mins at 37 degC followed by incubated for 15 mins in room temperature by pathhunter beta-arrestin assay
ChEMBL 366 4 1 4 4.9 CCC/N=C1\S/C(=C\c2ccc(O)c(C)c2)C(=O)N1c1ccccc1C 10.1021/acsmedchemlett.8b00616
44234259 127414 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 10 1 4 6.6 CCCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3659690 127414 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 491 10 1 4 6.6 CCCCOc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
44394212 67170 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 373 15 2 2 6.5 CCCCCCCCCCCCCC1CCCC(CCP(C)(=O)O)N1 10.1016/j.bmcl.2004.07.049
CHEMBL187692 67170 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 373 15 2 2 6.5 CCCCCCCCCCCCCC1CCCC(CCP(C)(=O)O)N1 10.1016/j.bmcl.2004.07.049
10172354 113786 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 357 14 3 3 4.1 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
CHEMBL332373 113786 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 357 14 3 3 4.1 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1 10.1016/j.bmcl.2004.04.070
44159278 126849 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 5 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOC3=O)cc2n1Cc1ccccc1 nan
CHEMBL3655415 126849 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 518 8 1 5 5.7 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCOC3=O)cc2n1Cc1ccccc1 nan
9824415 110556 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 437 13 3 4 4.1 CCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL325247 110556 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 437 13 3 4 4.1 CCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
10174181 11269 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity towards human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity towards human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 479 16 3 4 5.2 CCCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL117910 11269 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity towards human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity towards human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 479 16 3 4 5.2 CCCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
10384596 10136 2 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
CHEMBL115713 10136 2 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 371 13 4 3 3.7 CCCCCCCCc1ccc(CC[C@@H](N)C[C@H](O)P(=O)(O)O)cc1 10.1016/j.bmcl.2004.02.106
44233257 126965 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 468 8 1 5 5.9 CC(C)c1c(C(=O)NCc2cccnc2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
CHEMBL3655530 126965 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 468 8 1 5 5.9 CC(C)c1c(C(=O)NCc2cccnc2)c2ccc(OC3CCCC3)cc2n1Cc1ccccn1 nan
59762412 126923 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 8 1 3 7.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N(C)C3CCCC3)cc2n1Cc1ccccc1 nan
CHEMBL3655488 126923 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 8 1 3 7.4 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(N(C)C3CCCC3)cc2n1Cc1ccccc1 nan
59762389 126948 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 493 8 1 6 4.9 COC(=O)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
CHEMBL3655512 126948 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 493 8 1 6 4.9 COC(=O)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC(C)C)cc2n1Cc1ccccn1 nan
59762299 126862 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 474 8 1 6 4.8 CCOC(=O)c1ccc2c(C(=O)NCc3cncc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
CHEMBL3655428 126862 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 474 8 1 6 4.8 CCOC(=O)c1ccc2c(C(=O)NCc3cncc(F)c3)c(C(C)C)n(Cc3ccccn3)c2c1 nan
44159393 126964 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 10 1 4 7.0 CC(C)CO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655529 126964 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 517 10 1 4 7.0 CC(C)CO/N=C/c1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762286 126897 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 3 6.6 CC(C)C(=O)Nc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655462 126897 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 503 8 2 3 6.6 CC(C)C(=O)Nc1ccc2c(C(=O)NCc3ccc(F)c(F)c3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
59762434 126900 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 9 1 5 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OCc3ncco3)cc2n1Cc1ccccc1 nan
CHEMBL3655465 126900 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 515 9 1 5 6.6 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OCc3ncco3)cc2n1Cc1ccccc1 nan
44233255 126962 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 8 1 5 5.9 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCO3)cc2n1Cc1ccccn1 nan
CHEMBL3655527 126962 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 505 8 1 5 5.9 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(OC3CCCO3)cc2n1Cc1ccccn1 nan
44233256 126966 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 454 8 1 4 5.9 CCOC(=O)c1ccc2c(C(=O)NCc3ccccc3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
CHEMBL3655531 126966 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 454 8 1 4 5.9 CCOC(=O)c1ccc2c(C(=O)NCc3ccccc3)c(C(C)C)n(Cc3ccccc3)c2c1 nan
44394116 66350 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 349 17 2 2 5.2 CCCCCCCCCCCCCCN(C)CCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
CHEMBL185100 66350 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranesInhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL 349 17 2 2 5.2 CCCCCCCCCCCCCCN(C)CCCP(=O)(O)O 10.1016/j.bmcl.2004.07.049
44234511 127416 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 1 5 5.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(/C=N/N(C)C)cc2n1Cc1ccccn1 nan
CHEMBL3659692 127416 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 489 8 1 5 5.3 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(/C=N/N(C)C)cc2n1Cc1ccccn1 nan
10289318 114027 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 513 14 3 3 5.6 CCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1Br 10.1016/j.bmcl.2004.04.070
CHEMBL332667 114027 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 513 14 3 3 5.6 CCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1Br 10.1016/j.bmcl.2004.04.070
10287343 12319 0 None - 0 Human 7.0 pIC50 = 7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 387 15 3 4 4.1 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
CHEMBL118508 12319 0 None - 0 Human 7.0 pIC50 = 7 Binding
Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligandBinding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL 387 15 3 4 4.1 CCCCCCCCOc1ccc(CNCCCP(=O)(O)O)cc1OC 10.1016/j.bmcl.2004.04.070
44159279 126956 0 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 8 1 3 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CN(C)C)cc2n1Cc1ccccc1 nan
CHEMBL3655521 126956 0 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.Inhibition Assay: Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL 475 8 1 3 6.1 CC(C)c1c(C(=O)NCc2ccc(F)c(F)c2)c2ccc(CN(C)C)cc2n1Cc1ccccc1 nan
59495631 157253 0 None -1318 2 Human 6.0 pKi = 6.0 Binding
Displacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assayDisplacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assay
ChEMBL 430 8 1 6 5.0 COCc1cc(-c2nc(-c3cccc(OCC(=O)O)c3)no2)ccc1-c1ccccc1C 10.1021/acs.jmedchem.6b01575
CHEMBL4076530 157253 0 None -1318 2 Human 6.0 pKi = 6.0 Binding
Displacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assayDisplacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assay
ChEMBL 430 8 1 6 5.0 COCc1cc(-c2nc(-c3cccc(OCC(=O)O)c3)no2)ccc1-c1ccccc1C 10.1021/acs.jmedchem.6b01575
137644547 158039 0 None -758 2 Human 5.7 pKi = 5.7 Binding
Displacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assayDisplacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assay
ChEMBL 494 7 1 5 7.0 COCc1cc(-c2nc(-c3ccc(-c4ccc(C(=O)O)c(F)c4)cc3)no2)ccc1-c1ccccc1C 10.1021/acs.jmedchem.6b01575
CHEMBL4085783 158039 0 None -758 2 Human 5.7 pKi = 5.7 Binding
Displacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assayDisplacement of [33P]-S1P from S1P3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by microbeta scintillation proximity assay
ChEMBL 494 7 1 5 7.0 COCc1cc(-c2nc(-c3ccc(-c4ccc(C(=O)O)c(F)c4)cc3)no2)ccc1-c1ccccc1C 10.1021/acs.jmedchem.6b01575
11545181 4015 6 None -31 2 Human 6.5 pKi = 6.5 Binding
Displacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cellsDisplacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cells
ChEMBL 370 12 4 3 3.4 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N 10.1016/j.bmc.2006.10.060
2930 4015 6 None -31 2 Human 6.5 pKi = 6.5 Binding
Displacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cellsDisplacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cells
ChEMBL 370 12 4 3 3.4 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N 10.1016/j.bmc.2006.10.060
CHEMBL389033 4015 6 None -31 2 Human 6.5 pKi = 6.5 Binding
Displacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cellsDisplacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cells
ChEMBL 370 12 4 3 3.4 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N 10.1016/j.bmc.2006.10.060
44342175 85520 0 None -10 2 Human 6.5 pKi = 6.5 Binding
Displacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cellsDisplacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cells
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
CHEMBL227371 85520 0 None -10 2 Human 6.5 pKi = 6.5 Binding
Displacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cellsDisplacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cells
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
CHEMBL422074 85520 0 None -10 2 Human 6.5 pKi = 6.5 Binding
Displacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cellsDisplacement of [32P]S1P from human S1P3 receptor expressed in HEK293T cells
ChEMBL 372 12 4 4 3.0 CCCCCCCCc1ccc(NC(=O)[C@H](N)COP(=O)(O)O)cc1 10.1016/j.bmc.2006.10.060
57699087 103597 0 None -19 2 Human 5.3 pKi = 5.3 Binding
Inhibition of S1P3 receptor (unknown origin)Inhibition of S1P3 receptor (unknown origin)
ChEMBL 362 6 1 6 2.1 CCn1c(OC)nnc1[C@@H](C)NS(=O)(=O)c1ccc(F)c(Cl)c1 10.1016/j.bmcl.2013.09.058
CHEMBL3086532 103597 0 None -19 2 Human 5.3 pKi = 5.3 Binding
Inhibition of S1P3 receptor (unknown origin)Inhibition of S1P3 receptor (unknown origin)
ChEMBL 362 6 1 6 2.1 CCn1c(OC)nnc1[C@@H](C)NS(=O)(=O)c1ccc(F)c(Cl)c1 10.1016/j.bmcl.2013.09.058
11363176 3149 47 None - 0 Human 5.7 pIC50 = 5.7 Binding
In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>
Guide to Pharmacology 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 20446681
5446 3149 47 None - 0 Human 5.7 pIC50 = 5.7 Binding
In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>
Guide to Pharmacology 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 20446681
9320 3149 47 None - 0 Human 5.7 pIC50 = 5.7 Binding
In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>
Guide to Pharmacology 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 20446681
CHEMBL1096146 3149 47 None - 0 Human 5.7 pIC50 = 5.7 Binding
In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>
Guide to Pharmacology 460 8 2 6 4.3 CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C 20446681
10883396 3649 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10446161
10883396 3649 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17170199
10883396 3649 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 9988698
5283560 3649 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10446161
5283560 3649 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17170199
5283560 3649 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 9988698
911 3649 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10446161
911 3649 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17170199
911 3649 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 9988698
CHEMBL225155 3649 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 10446161
CHEMBL225155 3649 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 17170199
CHEMBL225155 3649 45 None -1 4 Human 8.6 pKd = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 17 4 4 4.0 CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O 9988698
11588811 4012 45 None -85 2 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 15590668
136212600 4012 45 None -85 2 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 15590668
3324 4012 45 None -85 2 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 15590668
CHEMBL228102 4012 45 None -85 2 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 372 12 4 4 3.0 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N 15590668
11545181 4015 6 None -31 2 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 370 12 4 3 3.4 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N 17113298
2930 4015 6 None -31 2 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 370 12 4 3 3.4 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N 17113298
CHEMBL389033 4015 6 None -31 2 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 370 12 4 3 3.4 CCCCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N 17113298
10310 3889 0 None - 1 Human 7.0 pKi = 7.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 4 2 3 5.3 Clc1ccc(cc1)NNC(=Nc1ccc(cc1)Cl)C(=O)C(C)(C)C 20097776
16046248 3889 0 None - 1 Human 7.0 pKi = 7.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 4 2 3 5.3 Clc1ccc(cc1)NNC(=Nc1ccc(cc1)Cl)C(=O)C(C)(C)C 20097776
CHEMBL4303550 3889 0 None - 1 Human 7.0 pKi = 7.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 4 2 3 5.3 Clc1ccc(cc1)NNC(=Nc1ccc(cc1)Cl)C(=O)C(C)(C)C 20097776
6992 4009 0 None -23 5 Human 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 369 11 3 3 4.3 CCCCCCCCc1cccc(c1)C1CC(C1)(N)COP(=O)(O)O 21632869
73755254 4009 0 None -23 5 Human 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 369 11 3 3 4.3 CCCCCCCCc1cccc(c1)C1CC(C1)(N)COP(=O)(O)O 21632869